AS FILED WITH THE SECURITIES AND EXCHANGE COMMISSION ON NOVEMBER 10, 2004
REGISTRATION NO. 333-[ ]
- --------------------------------------------------------------------------------
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM SB-2
REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933
----------------
MARKLAND TECHNOLOGIES, INC.
---------------------------
(Name of small business issuer in its charter)
FLORIDA 84-1334434
------- ----------
(State or other jurisdiction (I.R.S. employer
of incorporation or organization) identification number)
3829
----
(Primary Standard Industrial Classification Code Number)
54 DANBURY ROAD, #207
RIDGEFIELD, CT 06877
(203) 894-9700
(Address and telephone number of principal executive offices)
KENNETH DUCEY, JR.
PRESIDENT AND CHIEF FINANCIAL OFFICER
54 DANBURY ROAD, #207
RIDGEFIELD, CT 06877
(203) 894-9700
(Name, address and telephone number of agent for service)
COPIES TO:
DAVID A. BROADWIN, ESQ.
FOLEY HOAG LLP
155 SEAPORT BOULEVARD
BOSTON, MASSACHUSETTS 02210
(617) 832-1000
----------------
APPROXIMATE DATE OF PROPOSED SALE TO THE PUBLIC: As soon as practicable
after this Registration Statement becomes effective.
If any of the securities being registered on this form are to be
offered on a delayed or continuous basis pursuant to Rule 415 under the
Securities Act, check the following box. [X]
If this Form is filed to register additional securities for an offering
pursuant to Rule 462(b) under the Securities Act of 1933, as amended, check the
following box and list the Securities Act registration statement number of the
earlier effective registration statement for the same offering. [ ]
If this Form is a post-effective amendment filed pursuant to Rule
462(c) under the Securities Act, check the following box and list the Securities
Act registration statement number of the earlier effective registration
statement for the same offering. [ ]
If this Form is a post-effective amendment filed pursuant to Rule
462(d) under the Securities Act, check the following box and list the Securities
Act registration statement number of the earlier effective registration
statement for the same offering. [ ]
If delivery of the prospectus is expected to be made pursuant to Rule
434, please check the following box. [ ]
----------------
CALCULATION OF REGISTRATION FEE
Proposed Proposed
Maximum Maximum
Title of Each Class of Securities Amount to be Offering Price Aggregate Amount of
to be Registered Registered (1) Per Share Offering Price Registration Fee
- ---------------- -------------- --------- -------------- ----------------
Common Stock, par value $0.0001 per share 6,500,000 (2) $0.8000(3) $ 5,200,000.00 $ 658.84
Common Stock, par value $0.0001 per share 6,500,000 (4) $1.5000(5) $ 9,750,000.00 $ 1,235.33
Common Stock, par value $0.0001 per share 1,500,000 (6) $1.5000(5) $ 2,250,000.00 $ 285.08
Common Stock, par value $0.0001 per share 1,625,000 (7) $0.6875(8) $ 1,117,187.50 $ 141.55
Common Stock, par value $0.0001 per share 7,875,000 (9) $0.6875(8) $ 5,414,062.50 $ 685.96
Common Stock, par value $0.0001 per share 3,396,529 (10) $0.6875(11) $ 2,335,113.69 $ 295.86
Common Stock, par value $0.0001 per share 3,000,000 (12) $0.6875(8) $ 2,062,500.00 $ 261.32
Common Stock, par value $0.0001 per share 2,193,750 (13) $0.8000(3) $ 1,755,000.00 $ 222.36
Common Stock, par value $0.0001 per share 2,193,750 (14) $1.5000(5) $ 3,290,625.00 $ 416.92
Common Stock, par value $0.0001 per share 548,438 (15) $0.6875(8) $ 377,051.13 $ 47.77
Common Stock, par value $0.0001 per share 2,657,813 (16) $0.6875(8) $ 1,827,246.44 $ 231.51
Common Stock, par value $0.0001 per share 1,012,500 (17) $0.6875(8) $ 696,093.75 $ 88.20
----------
$ 4,570.70
==========
(1) Pursuant to Rule 416(a), the number of shares of common stock being
registered will be adjusted to include any additional shares which may
become issuable as a result of stock splits, stock dividends, or
similar transactions in accordance with the anti-dilution provisions
contained in certain notes and warrants we issued in connection with
the September 21, 2004 and November 9, 2004 private placements, the
underlying shares of which are being registered hereunder.
(2) Represents the number of shares of our common stock issuable upon an
assumed conversion as of November 5, 2004 of notes issued to the
investors in the September 21, 2004 private placement.
(3) Represents the conversion price as of November 5, 2004 of the notes
issued to the investors in the September 21, 2004 and November 9, 2004
private placements (assuming, solely for the purpose of calculating
the registration fee, that all such notes were outstanding as of
November 5, 2004).
(4) Represents the number of shares of our common stock issuable upon the
exercise of warrants issued to the investors in the September 21, 2004
private placement.
(5) Represents the exercise price as of November 5, 2004 of the warrants
issued in connection with the September 21, 2004 and November 9, 2004
private placements (assuming, solely for the purpose of calculating
the registration fee, that all such warrants were outstanding as of
November 5, 2004).
(6) Represents the number of shares of our common stock issuable upon the
exercise of warrants issued as compensation in connection with the
September 21, 2004 private placement.
(7) We are registering 125% of the number of shares presently issuable upon
conversion of the notes issued to the investors in the September 21,
2004 private placement, representing our good faith estimate of the
number of shares that may become issuable in the future as a result of
conversion price adjustments. Under the terms of the note, in the event
a prepayment is not made by March 15, 2005, the conversion price will
be adjusted from a fixed price of $0.80 per share to a floating rate
equal to the average closing price per share of our common stock for
the five trading days preceding conversion or $0.80, whichever is less.
The conversion price of the notes is also subject to adjustment in the
event of issuance of common stock or common stock equivalents at an
issue price, or conversion or exercise price, as the case may be, of
less than the conversion price of the warrants in effect at the time of
such issuance. If the number of shares issuable upon conversion of the
notes exceeds the registered amount, we will not rely on Rule 416 to
cover the additional shares, but will instead file a new registration
statement.
(8) Conversion price which would become applicable in the event additional
shares of our common stock become issuable as a result of price
adjustments are unknown as of the time of filing of this registration
statement. In accordance with Rule 457(g)(3) of Regulation C, the
maximum offering price represents the offering price of securities of
the same class included in the registration statement. The maximum
offering price has been estimated solely for the purpose of determining
our registration fee pursuant to Rule 457(c) as the average of the high
and low sales prices of our common stock on November 5, 2004, as
quoted on the OTC Bulletin Board by the National Association of
Securities Dealers, Inc., of $0.705 and $0.670, respectively.
(9) We are registering approximately 220% of the number of shares presently
issuable upon exercise of the warrants issued in connection with the
September 21, 2004 private placement, representing a good faith
estimate of the number of shares that may become issuable in the future
as a result of exercise price adjustments. In the event we do not make
a prepayment by March 15, 2005 on the notes issued to the investors in
the September 21, 2004 private placement, the exercise price of the
warrants will be reduced to from $1.50 to $0.792 (equal to 110% of the
closing price of our common stock on the date of grant) or 80% of the
average closing price of our common stock for the five trading days
preceding March 15, 2005, whichever is less. The exercise price of the
warrants is also subject to adjustment in the event of issuance of
common stock or common stock equivalents at an issue price, or
conversion or exercise price, as the case may be, of less than the
exercise price of the warrants in effect at the time of such issuance.
Upon the occurrence of any of the foregoing adjustments to the exercise
price, the number of shares into which the warrants are exercisable
will be increased such that the aggregate exercise price of the
underlying shares following the adjustment will be equal to the
aggregate exercise price prior to the adjustment. If the number of
shares issuable upon exercise of the warrants exceeds the registered
amount, we will not rely on Rule 416 to cover the additional shares,
but will instead file a new registration statement.
(10) Outstanding shares of our common stock being registered pursuant to
piggy-back rights.
(11) Estimated solely for the purpose of determining our registration fee
pursuant to Rule 457(c), based on the average of the high and low sales
prices of our common stock on November 5, 2004, as reported on the OTC
Bulletin Board of by the National Association of Securities Dealers,
Inc., of $0.705 and $0.670, respectively.
(12) Represents a good faith estimate of the number of shares which may
become issuable in satisfaction of liquidated damages arising from the
Registration Rights Agreement dated September 21, 2004.
(13) Represents the number of shares of our common stock issuable upon an
assumed conversion as of November 5, 2004 of notes issued to the
investors in the November 9, 2004 private placement (assuming, solely
for the purpose of calculating the registration fee, that all such
notes were outstanding as of November 5, 2004).
(14) Represents the number of shares of our common stock issuable upon the
exercise of warrants issued to the investors in the November 9, 2004
private placement.
(15) We are registering 125% of the number of shares presently issuable upon
conversion of the notes issued to the investors in the November 9, 2004
private placement, representing our good faith estimate of the number
of shares that may become issuable in the future as a result of
conversion price adjustments. Under the terms of the note, in the event
a prepayment is not made by March 15, 2005, the conversion price will
be adjusted from a fixed price of $0.80 per share to a floating rate
equal to the average closing price per share of our common stock for
the five trading days preceding conversion or $0.80, whichever is less.
The conversion price of the notes is also subject to adjustment in the
event of issuance of common stock or common stock equivalents at an
issue price, or conversion or exercise price, as the case may be, of
less than the conversion price of the warrants in effect at the time of
such issuance. If the number of shares issuable upon conversion of the
notes exceeds the registered amount, we will not rely on Rule 416 to
cover the additional shares, but will instead file a new registration
statement.
(16) We are registering approximately 220% of the number of shares presently
issuable upon exercise of the warrants issued in connection with the
November 9, 2004 private placement, representing a good faith estimate
of the number of shares that may become issuable in the future as a
result of exercise price adjustments. In the event we do not make a
prepayment by March 15, 2005 on the notes issued to the investors in
the November 9, 2004 private placement, the exercise price of the
warrants will be reduced to from $1.50 to $0.781 (equal to 110% of the
closing price of our common stock on the date of grant) or 80% of the
average closing price of our common stock for the five trading days
preceding March 15, 2005, whichever is less. The exercise price of the
warrants is also subject to adjustment in the event of issuance of
common stock or common stock equivalents at an issue price, or
conversion or exercise price, as the case may be, of less than the
exercise price of the warrants in effect at the time of such issuance.
Upon the occurrence of any of the foregoing adjustments to the exercise
price, the number of shares into which the warrants are exercisable
will be increased such that the aggregate exercise price of the
underlying shares following the adjustment will be equal to the
aggregate exercise price prior to the adjustment. If the number of
shares issuable upon exercise of the warrants exceeds the registered
amount, we will not rely on Rule 416 to cover the additional shares,
but will instead file a new registration statement.
(17) Represents a good faith estimate of the number of shares which may
become issuable in satisfaction of liquidated damages arising from our
Securities Purchase Agreement dated November 9, 2004.
THE REGISTRANT HEREBY AMENDS THIS REGISTRATION STATEMENT ON SUCH DATE OR
DATES AS MAY BE NECESSARY TO DELAY ITS EFFECTIVE DATE UNTIL THE REGISTRANT SHALL
FILE A FURTHER AMENDMENT WHICH SPECIFICALLY STATES THAT THIS REGISTRATION
STATEMENT SHALL THEREAFTER BECOME EFFECTIVE IN ACCORDANCE WITH SECTION 8(a) OF
THE SECURITIES ACT OF 1933 OR UNTIL THE REGISTRATION STATEMENT SHALL BECOME
EFFECTIVE ON SUCH DATE AS THE COMMISSION, ACTING PURSUANT TO SAID SECTION 8(a),
MAY DETERMINE.
THE INFORMATION IN THIS PROSPECTUS IS NOT COMPLETE AND MAY BE CHANGED WITHOUT
NOTICE. THE SELLING STOCKHOLDERS MAY NOT SELL THESE SECURITIES UNTIL THE
REGISTRATION STATEMENT FILED WITH THE SECURITIES AND EXCHANGE COMMISSION IS
EFFECTIVE. THIS PROSPECTUS IS NOT AN OFFER TO SELL THESE SECURITIES, AND THE
SELLING STOCKHOLDERS ARE NOT SOLICITING OFFERS TO BUY THESE SECURITIES. IN ANY
STATE WHERE THE OFFER OR SALE OF THESE SECURITIES IS NOT PERMITTED.
PRELIMINARY PROSPECTUS SUBJECT TO COMPLETION, DATED NOVEMBER 10, 2004
39,002,780 SHARES OF COMMON STOCK
MARKLAND TECHNOLOGIES, INC.
----------------------
This prospectus relates to the resale, from time to time, of up to
39,002,780 shares of our common stock by the stockholders referred to throughout
this prospectus as "selling stockholders" including:
o 3,396,529 shares of our common stock which are currently outstanding;
o 24,000,000 shares of our common stock which are issuable upon the
exercise of warrants and conversion of notes issued on September 21,
2004, or which may become issuable as a result of adjustments
contemplated by the terms of the notes and warrants;
o 7,593,751 shares of our common stock which are issuable upon the
exercise of warrants and conversion of notes issued on November 9,
2004, or which may become issuable as a result of adjustments
contemplated by the terms of the notes and warrants;
o 3,000,000 shares of our common stock which may be issued as liquidated
damages as contemplated by a Registration Rights Agreement dated
September 21, 2004; and
o 1,012,500 shares of our common stock which may be issued as liquidated
damages as contemplated by a Securities Purchase Agreement dated
November 9, 2004.
The selling stockholders may sell the common stock being offered
pursuant to this prospectus from time to time (directly or through agents or
dealers) on terms to be determined at the time of sale. The prices at which the
selling stockholders may sell their shares may be determined by the prevailing
market price for the shares or in negotiated transactions.
The selling stockholders will receive all of the proceeds from the
sales made under this prospectus. Accordingly, we will receive no part of the
proceeds from sales made under this prospectus. We are paying the expenses
incurred in registering the shares, but all selling and other expenses incurred
by the selling stockholders will be borne by the selling stockholders.
----------------------
Our common stock is quoted on the OTC Bulletin Board by the National
Association of Securities Dealers, Inc. under the symbol "MRKL.OB." On November
9, 2004, the last reported sale price of our common stock on the OTC Bulletin
Board was $0.675 per share.
----------------------
INVESTING IN OUR COMMON STOCK INVOLVES A HIGH DEGREE OF RISK.
SEE RISK FACTORS BEGINNING ON PAGE 9 OF THIS PROSPECTUS.
----------------------
NEITHER THE SECURITIES AND EXCHANGE COMMISSION NOR ANY STATE SECURITIES
COMMISSION HAS APPROVED OR DISAPPROVED OF THESE SECURITIES OR PASSED ON THE
ADEQUACY OR ACCURACY OF THIS PROSPECTUS. ANY REPRESENTATION TO THE CONTRARY IS A
CRIMINAL OFFENSE.
----------------------
The date of this prospectus is [ ], 2004
----------------------
TABLE OF CONTENTS
Prospectus Summary...............................................................................1
Risk Factors.....................................................................................9
Special Note Regarding Forward-Looking Statements...............................................16
Use of Proceeds.................................................................................17
Price Range for Common Stock and Dividend Policy................................................17
Selling Stockholders............................................................................17
Management's Discussion and Analysis of Financial Condition and Results of Operations...........25
Changes in Accountants..........................................................................35
Business........................................................................................36
Property........................................................................................43
Legal Proceedings...............................................................................43
Directors, Executive Officers, Promoters and Control Persons....................................45
Compensation of Directors and Executive Officers................................................46
Security Ownership of Certain Beneficial Owners and Management..................................49
Disclosure of Commission Position on Indemnification for Securities Act Liabilities.............50
Certain Relationships and Related Transactions..................................................50
Description of Securities.......................................................................53
Plan of Distribution............................................................................58
Available Information...........................................................................60
Legal Matters...................................................................................60
Experts.........................................................................................61
----------------
No dealer, salesperson or other person has been authorized to give any
information or to make any representations other than those contained or
incorporated by reference in this prospectus in connection with the offer
contained in this prospectus and, if given or made, such information or
representations must not be relied upon as having been authorized by us.
Neither the delivery of this prospectus nor any sale made hereunder
shall under any circumstances create an implication that there has been no
change in our affairs since the date hereof. This prospectus does not constitute
an offer to sell or a solicitation of an offer to buy securities other than
those specifically offered hereby or of any securities offered hereby in any
jurisdiction where, or to any person to whom, it is unlawful to make such offer
or solicitation. The information contained in this prospectus speaks only as of
the date of this prospectus unless the information specifically indicates that
another date applies.
This prospectus has been prepared based on information provided by us
and by other sources that we believe are reliable. This prospectus summarizes
certain documents and other information in a manner we believe to be accurate,
but we refer you to the actual documents, if any, for a more complete
understanding of what we discuss in this prospectus. In making a decision to
invest in the common stock, you must rely on your own examination of our company
and the terms of the offering and the common stock, including the merits and
risks involved.
We are not making any representation to you regarding the legality of
an investment in the common stock by you under any legal investment or similar
laws or regulations. You should not consider any information in this prospectus
to be legal, business, tax or other advice. You should consult your own
attorney, business advisor and tax advisor for legal, business and tax advice
regarding an investment in the common stock.
----------------
In this prospectus, "Markland," "the Company," "we," "us" and "our"
refer to Markland Technologies, Inc. and its subsidiaries, taken as a whole,
unless the context otherwise requires.
----------------
The information in this prospectus reflects our 1-for-60 reverse stock
split effective October 27, 2003.
----------------
This prospectus contains trademarks, service marks and registered marks
of Markland Technologies, Inc. and its subsidiaries and other companies, as
indicated. Unless otherwise provided in this prospectus, as amended and
supplemented from time to time, trademarks identified by (R) and (TM) are
registered trademarks or trademarks, respectively, of Markland Technologies,
Inc. or its subsidiaries. All other trademarks are the properties of their
respective owners.
----------------
Our executive offices are located at 54 Danbury Road, #207, Ridgefield,
CT 06877, and our phone number is (203) 894-9700.
----------------
PROSPECTUS SUMMARY
THE FOLLOWING SUMMARY HIGHLIGHTS CERTAIN MATERIAL ASPECTS OF THE
OFFERING FOR RESALE OF COMMON STOCK BY THE SELLING STOCKHOLDERS COVERED BY THIS
PROSPECTUS BUT MAY NOT CONTAIN ALL OF THE INFORMATION THAT IS IMPORTANT TO YOU.
YOU SHOULD READ THIS SUMMARY TOGETHER WITH THE MORE DETAILED INFORMATION
REGARDING THE OFFERING, OUR COMPANY, OUR COMMON STOCK AND OUR FINANCIAL
STATEMENTS AND NOTES TO THOSE STATEMENTS APPEARING ELSEWHERE IN THIS PROSPECTUS,
INCLUDING THE "RISK FACTORS" BEGINNING ON PAGE 9.
BUSINESS
Markland Technologies, Inc. ("Markland", the "Company" or "we") is an
integrated homeland security and defense company incorporated under the laws of
the State of Florida.
WHO WE ARE
We are the successor to a variety of businesses dating back to 1995.
Our business, as it exists today, consists of four business areas:
o sensor systems for military and intelligence applications;
o chemical detectors;
o border security systems; and
o advanced technologies.
We provide to the United States Department of Defense ("DOD") and to
various other United States Intelligence Agencies ("INTEL") remote sensing
technology products, and services to protect our country's military personnel
and infrastructure assets. We also provide to the Department of Homeland
Security ("Homeland Security"); products, services and emerging technologies to
protect our country's borders, infrastructure assets and personnel.
Our mission is to build world-class integrated solutions for the
Homeland Security, DOD and INTEL marketplaces through expansion of our existing
contracts, development of our emerging technologies and acquisition of
synergistic revenue producing assets.
Prior to the acquisition of E-OIR Technologies, Inc. ("EOIR"), our
primary sources of operating revenue were sales of our automatic chemical agent
detection and alarm system, border security logistics products and services, and
Small Business Investment Research ("SBIR") funded research grants for the
development of gas plasma antenna technology.
As result of the acquisition of EOIR, now a wholly-owned subsidiary of
Markland, our primary sources of operating revenues will be the sales of remote
sensing technology products and services to the United States Department of
Defense and to various other United States Intelligence Agencies. We expect that
our remote sensing technology products and services will continue to be our most
significant revenue-producing business areas going forward.
Our strategy is to grow through organic means through increased
acceptance by our customers of our present products and services offerings and
also through synergistic acquisitions of assets that provide products or
services to Homeland Security, DOD, or INTEL.
RECENT DEVELOPMENTS
ACQUISITION OF EOIR
This summary highlights selected information regarding the acquisition
of EOIR. We have included a description of the acquisition and the agreements we
entered into in order to effect this transaction in our current report on Form
8-K filed with the Securities and Exchange Commission (SEC) on June 30, 2004
(File No. 000-28863). The Stock Purchase Agreement, the form of promissory note,
the Security Agreement, the 2004 Stock Incentive Plan, forms of non-statutory
stock options, the Preferred Securities Purchase Agreement, the Pledge and
Security Agreement related to this acquisition were also filed with the SEC on
June 30, 2004 as exhibits to our current report on Form 8-K (File No.
000-28863). In addition, on September 13, 2004, we also filed with the SEC a
current report on Form 8-K/A (File No. 000-28863) with EOIR audited financial
statements for the years ended December 31, 2003 and December 31, 2002 and EOIR
unaudited financial statements for the quarter ended March 31, 2004. These
filings are public documents available on the SEC's web site at www.sec.gov. We
urge you to obtain and read carefully copies of these documents and this
registration statement before making an investment decision.
1
On June 29, 2004, we acquired all of the outstanding stock of EOIR for
$8,000,000 in cash and $11,000,000 in principal amount of five-year notes
secured by the assets and stock of EOIR.
EOIR is a provider of technology and services to the United States Army
Night Vision and Electronic Sensors Directorate, as well as other United States
Department of Defense and Intelligence Agencies. It has significant expertise in
wide-area remote sensing using both electro-optic and infrared technologies. We
intend to continue to use the assets of EOIR for this purpose and to also
broaden our product base and offerings to the Department of Homeland Security.
We plan to combine certain EOIR technology assets in the areas of chemical
detection with those of our other operating subsidiary Science and Technology
Research Inc. to provide a more complete integrated product line offering for
both "stand off" and "point" chemical detection systems. EOIR will represent a
vast majority of our revenue as we expect that EOIR will continue to be our most
significant revenue producing business area in the next fiscal year.
In connection with this acquisition, we have also adopted a Stock
Incentive Plan pursuant to which we have issued options to purchase 9,345,740
shares of our common stock to key employees of EOIR who are continuing
employment following the acquisition for an exercise price of $.3775 per share
These options will vest in five equal annual installments. We have also granted
to the other key employees of EOIR who are continuing employment following the
acquisition options to purchase an additional number of shares equal to $471,983
divided by one-half of the market price for the common stock at the date of
vesting. These options will vest in five equal annual installments. We have also
agreed to grant options to purchase an additional 5,000,000 shares of common
stock to employees of EOIR in the future. We expect these options to vest over
five years after the date of grant and to have an exercise price equal to the
fair market value of the common stock on the date of grant.
We intend to file a registration statement on Form S-8 to register
27,030,000 shares of our common stock issued or issuable, as applicable, under
(i) our 2004 Stock Incentive Plan and (ii) our employment agreements with
Kenneth P. Ducey, Robert Tarini and Darylene Wanek.
In connection with this acquisition, we have also raised $2 million
through a private placement of an additional 3,500 shares of its Series D
Preferred Stock to a single institutional investor. The Series D preferred stock
is convertible at the option of the stockholder at any time. The number of
shares of our common stock into which each share of Series D preferred is
convertible is determined by dividing $1,000 by the discounted bid price. The
"discounted" bid price is the average closing bid price of our common stock
during the five business days immediately preceding the conversion date
multiplied by the applicable discount factor, as set forth below.
Average Closing Bid Price (1) Discount Factor
- ---------------------------------------------------- ----------------
$15.00 or less 80%
more than $15.00, but less than or equal to $30.00 75%
more than $30.00, but less than or equal to $45.00 70%
more than $45.00 65%
- --------------------
(1) After an adjustment for a 1-for-60 reverse stock split effective October 27,
2003.
The Series D preferred stock can be converted only to the extent that
the Series D stockholder will not, as a result of the conversion, hold in excess
of 9.999% of the total outstanding shares of our common stock. For a complete
description of the terms and conditions of the Series D Preferred Stock please
refer to Markland's annual report on Form 10-KSB for the fiscal year ended June
30, 2003.
2
SEPTEMBER 21, 2004 PRIVATE PLACEMENT
THIS SUMMARY HIGHLIGHTS SELECTED INFORMATION REGARDING THIS RECENT
PRIVATE PLACEMENT. A PURCHASE AGREEMENT, A SECURITY AGREEMENT, FORMS OF WARRANTS
AND CONVERTIBLE NOTES, A REGISTRATION RIGHTS AGREEMENT, LOCK-UP AGREEMENTS AND
WAIVER AGREEMENTS WERE FILED WITH THE SEC ON SEPTEMBER 23, 2004 AS EXHIBITS TO
OUR CURRENT REPORT ON FORM 8-K (FILE NO. 000-28863). THESE FILINGS ARE PUBLIC
DOCUMENTS AVAILABLE ON THE SEC'S WEB SITE AT WWW.SEC.GOV. WE URGE YOU TO OBTAIN
AND READ CAREFULLY THESE DOCUMENTS AND THIS REGISTRATION STATEMENT BEFORE MAKING
AN INVESTMENT DECISION.
On September 21, 2004, we entered into a Purchase Agreement (the
"Purchase Agreement") with DKR Soundshore Oasis Holding Fund, Ltd. and DKR
Soundshore Strategic Holding Fund, Ltd. (together the "Initial Investors")
pursuant to which we sold warrants to purchase shares of our common stock and
secured convertible promissory notes for the aggregate consideration of
$4,000,000. We received net proceeds of $3,480,000 from this private placement.
We also issued to Greenfield Capital Partners, LLC, David Stefansky and Richard
Rosenblum warrants to purchase an aggregate of 1,500,000 shares of our common
stock at an exercise price of $1.50 as compensation in connection with this
private placement. The resale of the shares underlying these warrants is covered
by this registration statement. We intend to use the proceeds from this offering
for working capital.
The offer and sale of these notes and warrants was made in reliance on
Section 4(2) of Securities Act of 1933, as amended. The Initial Investors are
stockholders of the Company and "accredited investors" within the meaning of
Regulation D.
Subject to conditions set forth in the Purchase Agreement, we may
require the Initial Investors to purchase $1,000,000 of additional notes by
delivering to the Investors a written notice between March 15, 2005 and March
30, 2005. We may only exercise the right to require the purchase of additional
notes on a single occasion. Shares issuable upon the conversion of additional
notes, if any, have not been registered in this registration statement.
The Purchase Agreement also contains standard representations,
covenants and events of default. Occurrence of an event of default allows the
Initial Investors to accelerate the payment of the notes and/or exercise other
legal remedies, including foreclosing on collateral.
The Notes
---------
The notes issued in connection with this private placement are in the
aggregate principal amount of five million two hundred thousand dollars
($5,200,000) and accrue interest daily at the rate of eight percent (8%) per
year on the then outstanding and unconverted principal balance of the notes. The
notes will mature on September 21, 2005.
At any time, and at the option of the Initial Investors, the
outstanding principal and accrued interest of the notes may be converted into
shares of our common stock at an initial conversion price per share of $0.80.
Under the terms of these notes, we are required to pay to the Initial
Investors $4,000,000 of the outstanding principal and interest by March 15,
2005, and the remaining outstanding balance by September 21, 2005. If we do not
make the March 15, 2005 prepayment, the conversion price will be adjusted from
$0.80 per share to the lower of (i) $0.80 and (ii) a floating rate equal to 80%
of average closing price per share of our common stock for the five trading days
preceding conversion.
In the event we issue common stock or common stock equivalents at a
price per share below the then effective conversion price of the convertible
notes, the conversion price will be reduced to that lower price per share.
The Warrants
------------
The warrants issued in connection with this private placement entitle
the Initial Investors to purchase an aggregate of 6,500,000 shares of our common
stock, at any time and from time to time, through September 21, 2009, at an
initial exercise price of $1.50 per share. The warrants are subject to the
following adjustments provisions:
o Under the terms of the warrants, if we do not make a prepayment of an
aggregate of $4,000,000 in principal, plus any interest having accrued
thereon, on the notes issued to the Initial Investors in this private
placement by March 15, 2005, the exercise price of the warrant will be
reduced from $1.50 to the lesser of (i) $0.792 and (ii) 80% of the
average closing price per share of our common stock on the date the
adjustment is made.
3
o Adjustments are also required in the event that we issue common stock
or common stock equivalents at a price per share below the then
effective exercise price of the warrants. The exercise price will be
reduced to that lower price per share.
o In the event any of the foregoing adjustments are made, the warrants
will become exercisable for a number of shares equal to the aggregate
exercise price (i.e., the exercise price per share multiplied by the
number of underlying shares) prior to the adjustment divided by the
adjusted exercise price per share.
Liquidated Damages
------------------
If either:
(i) this registration statement is not declared effective by
December 20, 2004, or within five trading days after the SEC
notifies us that the registration will not be reviewed or is
not subject to further review or comments; or
(ii) this registration statement is suspended for more than an
aggregate of 20 trading days, whether or not consecutive, in
any twelve-month period,
we will be required to pay each of the investors in this private
placement liquidated damages in an amount equal to 2% of such Initial
Investor's investment amount, half of which may, at our option, be paid
in common stock of equivalent value. Such value shall be determined
based on the lower of (i) the average of the closing price of our
common stock for the five days preceding the payment date and (ii) the
closing price of our common stock on the day preceding the date that
stock is delivered to the Initial Investors.
As a result, we are registering 3,000,000 shares of our common stock
representing our good faith estimate of the shares we may be required to issue
in satisfaction of the liquidiated damages provisions.
Other Agreements
----------------
In connection with this private placement:
o We have granted a security interest in and a lien on
substantially all of our assets to the Initial Investors
pursuant to the terms of a Security Agreement dated September
21, 2004.
o We have agreed to prepare and file with the SEC this
registration statement covering the resale of all of the
shares of our common stock issuable upon conversion of the
notes and the exercise of the warrants issued in this private
placement, as provided in the Registration Rights Agreement
dated September 21, 2004.
o We entered into a lock-up agreement with James LLC, the holder
of 17,627 shares of our Series D Convertible Preferred Stock
(the "Series D Shares"), pursuant to which James LLC has
agreed not to sell any Series D Shares until the first to
occur of (i) notice from us and the Initial Investors that the
transactions contemplated by the Purchase Agreement have been
terminated in accordance with their terms, or (ii) March 15,
2005. However, under to the terms of the lock-up agreement,
James LLC may still convert their Series D shares and sell the
underlying shares of common stock in accordance with Rule 144
of the Securities Act of 1933, as amended. In exchange, we
agreed that under certain conditions, if we did not redeem the
Series D stock by January 15, 2005, we would issue to James
LLC a warrant to purchase 1,088,160 shares of our common stock
at $0.80 per share.
o We entered into a lock-up agreement with Robert Tarini, our
Chief Executive Officer, and Kenneth P. Ducey, Jr., our Chief
Financial Officer, dated September 21, 2004. Pursuant to this
agreement, Mr. Tarini and Mr. Ducey have agreed not to sell
any securities of the Company until the earlier of (i) notice
from us and the Initial Investors that the transactions
contemplated by the Purchase Agreement have been terminated in
accordance with their terms or (ii) sixty days after the
effectiveness of the registration statement related to the
Registration Rights Agreement.
4
o Certain investors waived their rights of first refusal and
entered into other agreements in accordance with the terms of
a Waiver Agreement dated September 21, 2004.
NOVEMBER 9, 2004 PRIVATE PLACEMENT
THIS SUMMARY HIGHLIGHTS SELECTED INFORMATION REGARDING THIS RECENT
PRIVATE PLACEMENT. A SECURITIES PURCHASE AGREEMENT, A SUBORDINATION AGREEMENT,
FORMS OF WARRANTS AND CONVERTIBLE NOTES AND A CONDITIONAL WAIVER AND CONSENT
AGREEMENT WERE FILED WITH THE SEC ON NOVEMBER 10, 2004 AS EXHIBITS TO THIS
REGISTRATION STATEMENT. BECAUSE THESE AGREEMENTS REFER TO THE SEPTEMBER 21, 2004
PRIVATE PLACEMENT YOU SHOULD ALSO REVIEW OUR CURRENT REPORT ON FORM 8-K (FILE
NO. 000-28863). THESE FILINGS ARE PUBLIC DOCUMENTS AVAILABLE ON THE SEC'S WEB
SITE AT WWW.SEC.GOV. WE URGE YOU TO OBTAIN AND READ CAREFULLY THESE DOCUMENTS
AND THIS REGISTRATION STATEMENT BEFORE MAKING AN INVESTMENT DECISION.
On November 9, 2004, we entered into a Securities Purchase Agreement
(the "Securities Purchase Agreement") with Harborview Master Fund L.P. and
Southridge Partners LP (the "Additional Investors") pursuant to which we sold
warrants to purchase shares of our common stock and secured convertible
promissory notes for the aggregate consideration of $1,350,000. We received net
proceeds of $1,174,500 from this private placement. We also issued to Greenfield
Capital Partners, LLC, David Stefansky and Richard Rosenblum warrants to
purchase an aggregate of 337,500 shares of our common stock at an exercise price
of $1.50 as compensation in connection with this private placement. The resale
of the shares underlying these warrants is not covered by this registration
statement. We intend to use the proceeds from this offering for working capital.
The offer and sale of these securities was made in reliance on Section
4(2) of Securities Act of 1933, as amended. The Additional Investors are
stockholders of the Company and "accredited investors" within the meaning of
Regulation D.
Unless otherwise noted, the terms of the notes and warrants issued in
this private placement are identical to the terms of the notes and warrants
issued on September 21, 2004. The Securities Purchase Agreement contains
standard representations, covenants and events of default. Occurrence of an
event of default allows the Additional Investors to accelerate the payment of
the notes and/or exercise other legal remedies, including foreclosing on
collateral.
The Notes
---------
The notes issued in connection with this private placement are in the
aggregate principal amount of one million seven hundred and fifty-five thousand
dollars ($1,755,000) and accrue interest daily at the rate of eight percent (8%)
per year on the then outstanding and unconverted principal balance of the notes.
The notes will mature on November 9, 2005.
At any time, and at the option of the Additional Investors, the
outstanding principal and accrued interest of the notes may be converted into
shares of our common stock at an initial conversion price per share of $0.80.
Under the terms of each these notes, we are required to pay a principal
amount on each note equal to the consideration paid by the Additional Investor
holding such note plus any accrued interest by March 15, 2005, and the remaining
outstanding balance by November 9, 2005. In the event we do not make these
prepayments, the conversion price of the note will be subject to the adjustment
described in connection with the September 21, 2004 private placement.
The Warrants
------------
The warrants issued in connection with this private placement entitle
the Additional Investors to purchase an aggregate of 2,193,750 shares of our
common stock, at any time and from time to time, through November 9, 2009.
The warrants are subject to substantially the same adjustment
provisions as the warrants issued in connection with the September 21, 2004
private placement.
Liquidated Damages
------------------
We are subject to substantially the same liquidated damages provisions
as those discussed in connection with the September 21, 2004 private placement.
We are registering an additional 1,012,500 shares of our common stock
representing our good faith estimate of the number of shares of common stock
we may be required to issue in satisfaction of liquidated damages arising from
the Securities Purchase Agreement with the Additional Investors.
5
OTHER RELATED AGREEMENTS
------------------------
In connection with this transaction:
o We have granted a security interest in and a lien on
substantially all of our assets to the Additional Investors
pursuant to the terms of a Security Agreement, dated November
9, 2004. This security interest is subordinated to the
security interests granted in connection with the acquisition
of EOIR and the September 21, 2004 private placement, as
contemplated in the Subordination Agreement dated November 9,
2004.
o We have agreed to prepare and file with the SEC this
registration statement covering the resale of all of the
shares of our common stock issuable upon conversion of the
notes and the exercise of the warrants issued in connection
with this private placement, as provided in the Securities
Purchase Agreement dated November 9, 2004.
o The Initial Investors have consented to Markland filing the
registration statement related to the September 21, 2004
private placement on November 10, 2004, instead of November 5,
2004. The Initial Investors have also agreed to waive other
rights contemplated in the Registration Rights Agreements
dated September 21, 2004.
o Under the terms of the Securities Purchase Agreement dated
November 9, 2004, the Additional Investors in this private
placement are prohibited from selling any of the securities
issued to them in connection with this transaction (including
any securities issued upon conversion or exercise thereof)
until the 40th trading day following the date the SEC declares
this registration statement effective.
o Under the terms of the Subordination Agreement between the
Company, the Initial Investors and the Additional Investors,
the Additional Investors have agreed that their security
interest in our assets are subordinated to the security
interest of the Initial Investors. Moreover, the Additional
Investors are not entitled to any payments under their notes
(other than periodic interest payments and liquidated damages,
if any), and they may not declare any amounts payable or
exercise any rights or remedies it may have under the notes,
until the Initial Investors' notes are paid in full.
RESIGNATION OF GREGORY A. WILLIAMS
On November 1, 2004, Gregory A. Williams notified our Board of
Directors of his resignation from the Board and his positions as Director,
Executive Vice President, Chief Financial Officer, and Chief Operating Officer
of our wholly owned subsidiary, EOIR Technologies, Inc. Mr. Williams was a
shareholder of EOIR prior to the acquisition of EOIR on June 29, 2004. To our
knowledge, Mr. Williams' resignation was not in connection with any disagreement
concerning matters relating to the Company's operations, policies or practices.
On November 1, 2004, we entered into an agreement with Mr. Williams and
EOIR detailing the terms and conditions of Mr. Williams' resignation, including,
among other things, (a) payment to Mr. Williams of twelve months of severance
and all accrued and unused vacation time, (b) continuation of benefits until the
earlier of December 31, 2005 or when Mr. Williams finds new employment, (c)
acceleration of vesting of 40% of the non-statutory stock options held by Mr.
Williams; and (d) reaffirmation by Mr. Williams of his confidentiality and
non-competition obligations and an agreement not to compete with or solicit
employees from EOIR for a period of twelve (12) months.
After giving effect to the resignation of Mr. Williams, our board of
directors consists of the following members: Robert Tarini, Kenneth P. Ducey,
Jr. and Joseph P. Mackin.
6
THE OFFERING
The selling stockholders are offering up to 39,002,780 shares of our
common stock consisting of 3,396,529 outstanding shares of our common stock,
31,593,751 shares of common stock issuable upon the exercise of warrants and
conversion of notes issued in connection with the September 21, 2004 and
November 9, 2004 private placements or which may become issuable as a result
of conversion or exercise price adjustments and 4,012,500 shares of our common
stock which may be issued as liquidated damages under our Registration Rights
Agreement dated September 21, 2004 and our Securities Purchase Agreement dated
November 9, 2004.
ISSUER: Markland Technologies, Inc.
SECURITIES OFFERED: up to 39,002,780 shares of our common stock.
OTC SYMBOL: MRKL.OB
USE OF PROCEEDS: We will not receive any of the proceeds from
the sale by any selling stockholder of our
common stock.
OFFERING PRICE: To be determined by the prevailing market
price for the shares at the time of the
sale or in negotiated transactions.
RISK FACTORS: You should read the "Risk Factors" section
beginning on page 9 (along with other
matters referred to and incorporated by
reference in this prospectus) to ensure that
you understand the risks associated with an
investment in our common stock.
TERMS OF THE SALE: To be determined at the time of the sale.
TOTAL SHARES OF OUR COMMON STOCK 51,564,458
OUTSTANDING AS OF NOVEMBER 5, 2004:
The selling stockholders acquired the securities covered by this
registration statement in connection with the following transactions.
SEPTEMBER 21, 2004 PRIVATE PLACEMENT
Some of the selling stockholders are offering up to 27,000,000 shares
of our common stock, including
o 24,000,000 shares of our common stock which (i) are issuable upon
the exercise of warrants and conversion of notes issued in
connection with the September 21, 2004 private placement or (ii)
may become issuable as a result of adjustments contemplated by our
agreements with certain selling stockholders; and
o 3,000,000 shares of our common stock which may be issued as
liquidated damages as contemplated by our agreements with certain
selling stockholders.
We received gross proceeds of $4,000,000 and net proceeds of $3,480,000
from this private placement (after deducting fees and transaction costs). We
also issued to Greenfield Capital Partners, LLC, David Stefansky and Richard
Rosenblum warrants to purchase an aggregate of 1,500,000 shares of our common
stock at an exercise price of $1.50 as compensation in connection with this
private placement. The resale of the shares underlying these warrants is covered
by this registration statement.
NOVEMBER 9, 2004 PRIVATE PLACEMENT TRANSACTION
Some of the selling stockholders are offering up to 8,606,251 shares of
our common stock, including
o 7,593,751 shares of our common stock which (i) are issuable
upon the exercise of warrants and conversion of notes issued
in connection with the November 9, 2004 private placement or
(ii) may become issuable as a result of adjustments
contemplated by our agreements with certain selling
stockholders; and
o 1,012,500 shares of our common stock which may be issued as
liquidated damages as contemplated by our Securities Purchase
Agreement dated November 9, 2004.
7
We received gross proceeds of $1,350,000 and net proceeds of $1,174,500
from this private placement (after deducting fees and transaction costs). We
also issued to Greenfield Capital Partners, LLC, David Stefansky and Richard
Rosenblum warrants to purchase an aggregate of 337,500 shares of our common
stock at an exercise price of $1.50 as compensation in connection with this
private placement. The resale of the shares underlying these warrants is not
covered by this registration statement.
ADDITIONAL SELLING STOCKHOLDERS WITH ADDITIONAL PIGGY BACK REGISTRATION
RIGHTS
Some of the selling stockholders are offering up to 3,396,529
outstanding shares of our common stock as follows:
o 2,246,381 shares of our common stock held by Verdi Consulting,
Inc. pursuant to consulting agreements for services rendered
to us; and
o 1,150,148 shares of our common stock held David Stefansky.
We have agreed to registered these securities pursuant to piggy back
registration rights granted with respect to these shares of our common stock.
SUMMARY FINANCIAL INFORMATION
The following table provides selected financial and operating data for
the years ended June 30, 2004 and June 30, 2003.
YEAR ENDED JUNE 30,
2004 2003
-------------- -------------
Revenue $ 6,013,930 $ 658,651
Gross Profit $ 1,339,337 $ 213,433
Loss from Continuing Operations $ (10,150,866) $ (3,614,093)
Net Loss $ (10,511,213) $ (2,836,881)
Current Assets $ 6,740,425
Current Liabilities $ 9,481,147
Total Assets $ 32,963,963
Long-term Debt $ 7,774,980
8
RISK FACTORS
YOU SHOULD CAREFULLY CONSIDER THE RISKS DESCRIBED BELOW BEFORE MAKING
AN INVESTMENT DECISION. THE RISKS AND UNCERTAINTIES DESCRIBED BELOW ARE NOT THE
ONLY ONES FACING US. ADDITIONAL RISKS AND UNCERTAINTIES NOT PRESENTLY KNOWN TO
US OR THAT WE CURRENTLY DEEM IMMATERIAL MAY ALSO IMPAIR OUR BUSINESS. IF ANY OF
THE FOLLOWING RISKS ACTUALLY OCCUR, OUR BUSINESS COULD BE ADVERSELY AFFECTED. IN
THOSE CASES, THE TRADING PRICE OF OUR COMMON STOCK COULD DECLINE, AND YOU MAY
LOSE ALL OR PART OF YOUR INVESTMENT.
RISKS RELATED TO OUR BUSINESS
WE HAVE A HISTORY OF OPERATING LOSSES, AND THERE IS NO ASSURANCE THAT WE WILL
ACHIEVE PROFITABILITY IN THE FUTURE.
We have a history of operating losses. We cannot predict when, or if,
we will ever achieve profitability. Our current business operations began in
2002 and have resulted in losses in each fiscal year. As of June 30, 2004, we
had an accumulated deficit of $20,283,948. If we continue to experience
operating losses, an investment in our common stock is at risk of being lost.
WE HAVE A GOING-CONCERN QUALIFICATION IN THE REPORTS BY OUR INDEPENDENT
REGISTERED PUBLIC ACCOUNTING FIRMS FOR OUR FINANCIAL STATEMENTS FOR THE YEARS
ENDED JUNE 30, 2004, AND JUNE 30, 2003, WHICH MAY MAKE CAPITAL RAISING MORE
DIFFICULT AND MAY REQUIRE US TO SCALE BACK OR CEASE OPERATIONS, PUTTING OUR
INVESTORS' FUNDS AT RISK.
The reports of our independent registered public accounting firms, for
fiscal years 2004 and 2003, includes a going-concern qualification, which
indicates an absence of obvious or reasonably assured sources of future funding
that will be required by us to maintain ongoing operations. If we are unable to
obtain additional funding, we may not be able to continue operations. In fiscal
year 2004, we have raised a total of $15,345,000 in new capital. Subsequent to
June 30, 2004, we raised $4,000,000 in the form of convertible promissory notes.
There is no guarantee that we will be able to attract additional equity or debt
investors. To date, we have funded our operations through equity investments and
issuances of debt. Additionally, we have an accumulated deficit of $20,283,948
as of June 30, 2004. This deficit indicates that we may be unable to meet our
future obligations unless additional funding sources are obtained.
WE MAY BE UNABLE TO OBTAIN ADDITIONAL CAPITAL REQUIRED TO FUND OUR OPERATIONS
AND FINANCE OUR GROWTH.
The development of our technologies will require additional capital,
and our business plan is to acquire additional revenue-producing assets. We
incurred net losses applicable to our common stockholders of $15,095,461 and
$7,598,852 for the fiscal years ended June 30, 2004 and June 30, 2003
respectively. Additionally, we had a working capital deficiency of $2,740,722 at
June 30, 2004. We may be unable to obtain additional funds in a timely manner or
on acceptable terms, which would render us unable to fund our operations or
expand our business. If we are unable to obtain capital when needed, we may have
to restructure our business or delay or abandon our development and expansion
plans. Although we have been successful in the past in obtaining financing for
working capital and acquisitions, we will have ongoing capital needs as we
expand our business. If we raise additional funds through the sale of equity or
convertible securities, your ownership percentage of our common stock will be
reduced. In addition, these transactions may dilute the value of our common
stock. We may have to issue securities that have rights, preferences and
privileges senior to our common stock. The terms of any additional indebtedness
may include restrictive financial and operating covenants that would limit our
ability to compete and expand.
9
WE MAY FAIL TO REALIZE SOME OR ALL OF THE OF THE ANTICIPATED BENEFITS FROM OUR
ACQUISITION OF EOIR TECHNOLOGIES
Our combined company may fail to realize some or all of the anticipated
benefits and synergies of the transaction as a result of, among other things,
lower than expected order rates from customers of EOIR, unanticipated costs,
deterioration in the U.S. economy and other factors. There can be no assurance
that we will receive new orders under our existing contract with the United
States Army Night Vision and Electronic Sensors Directorate. In addition, the
integration of EOIR business and operations with those of Markland may take
longer than anticipated, may be more costly than anticipated and may have
unanticipated adverse results relating to Markland's or EOIR's existing
businesses or customer base.
FAILURE TO COMPLETE OUR INCOME TAX FILINGS MAY ADVERSELY AFFECT OUR RESULTS
We have failed to complete our federal and state income tax filings for
the years 2001 through 2003. The Company has been organized as a C corporation
under the laws of the State of Florida and expects to be treated as such for
federal income tax purposes. In addition to federal income taxes, we are subject
to tax regulation in each state and city in which we operate. We believe that
the Company does not currently have any material income tax liability. However,
if there is any material difference between our assumptions concerning the tax
regulatory environment and the actual regulatory requirements, we may have an
additional tax liability. In addition, if we are required to pay penalties or
fines, our results of operations and our business projections may be materially
and adversely affected.
OUR CURRENT AND FUTURE EXPECTED REVENUES ARE DERIVED FROM A SMALL NUMBER OF
CUSTOMERS SUCH THAT THE LOSS OF ANY ONE ULTIMATE CUSTOMER COULD MATERIALLY
REDUCE OUR REVENUES.
During the fiscal year ended June 30, 2004, and 2003, we derived
substantially all of our revenue from contracts with the U.S. Government,
including the U.S. Navy, the Department of Defense, and the Department of
Homeland Security. We have a contract with the United States Army Night Vision
and Electronic Sensors Directorate that may provide for revenues of up to
approximately $406,000,000 depending upon the U.S. Army's needs of which our
subsidiary EOIR recognized in excess of $35,000,000 in revenues for calendar
year ended December 31, 2003. We expect this contract to account for a
substantial majority of our revenues in fiscal 2005.
The loss of this customer due to cutbacks, competition, or other
reasons would materially reduce our revenue base. Annual or quarterly losses may
occur if there are material gaps or delays in orders from one of our largest
customers that are not replaced by other orders or other sources of income.
MANY OF OUR TECHNOLOGIES ARE UNPROVEN AND THEIR SUCCESS IN THE MARKETPLACE IS
UNKNOWN.
Our Gas plasma antenna, Vehicle stopping system, Acoustic Core(TM)
signature analysis, APTIS(TM) human screening portal, and cryptography software
have not reached commercial viability. There is no guarantee that these products
will be successful in the marketplace. Although we currently sell automatic
chemical detection and alarm systems, we do not know for how long the U.S. Navy
will continue to buy this product, nor do we know if we will be able to sell
this product or others like it to other customers. If we do not successfully
exploit our technology, our financial condition, results of operations and
business prospects would be adversely affected. The development of our
technology is subject to certain factors beyond our control, including the
production of certain components by our suppliers. Commercially viable plasma
antenna technology systems may not be successfully and timely produced by our
original equipment manufacturers due to the inherent risk of technology
development, new product introduction, limitations on financing, competition,
obsolescence, loss of key technical personnel or other factors. The development
and introduction of our technologies could be subject to additional delays. Our
various projects are high risk in nature, and unanticipated technical obstacles
can arise at any time and result in lengthy and costly delays or a determination
that further exploitation is unfeasible.
10
THE HOMELAND SECURITY INDUSTRY IS CHARACTERIZED BY RAPID TECHNOLOGICAL CHANGE
AND EVOLVING INDUSTRY STANDARDS, AND UNLESS WE KEEP PACE WITH THE CHANGING
TECHNOLOGIES, WE COULD LOSE CUSTOMERS AND FAIL TO WIN NEW CUSTOMERS.
Our future success will depend, in part, upon our ability to develop
and introduce a variety of new products and services and enhancements to these
new product and services in order to address the changing and sophisticated
needs of the homeland security marketplace. Delays in introducing new products,
services and enhancements, the failure to choose correctly among technical
alternatives or the failure to offer innovative products and services at
competitive prices may cause customers to forego purchases of our products and
services and purchase those of our competitors. Frequently, technical
development programs in the homeland security industry require assessments to be
made of the future directions of technology and technology markets generally,
which are inherently risky and difficult to predict.
WE FACE INTENSE COMPETITION, WHICH COULD RESULT IN LOWER REVENUES AND HIGHER
RESEARCH AND DEVELOPMENT EXPENDITURES AND COULD ADVERSELY AFFECT OUR RESULTS OF
OPERATIONS.
Current political tensions throughout the world have heightened
interest in the homeland security industry, and we expect competition in this
field, which is already substantial, to intensify. If we do not develop new and
enhanced products, or if we are not able to invest adequately in our research
and development activities, our business, financial condition and results of
operations could be negatively impacted. Many of our competitors have
significantly more cash and resources than we have. Our competitors may
introduce products that are competitively priced, have increased performance or
functionality, or incorporate technological advances that we have not yet
developed or implemented. To remain competitive, we must continue to develop,
market and sell new and enhanced systems and products at competitive prices,
which will require significant research and development expenditures.
SOME OF OUR COMPETITORS ARE MUCH LARGER THAN WE ARE, HAVE BETTER NAME
RECOGNITION THAN WE DO AND HAVE FAR GREATER FINANCIAL AND OTHER RESOURCES THAN
WE DO.
With the U.S. government's large appropriation of money for homeland
security programs, many companies are competing for the same homeland security
contracts and there can be no assurance that Markland will effectively compete
with large companies who have more resources and funds than we do. Several
companies have been working on issues relevant to the safety of the American
people for the past several years. Lockheed Martin and Northrop Grumman are
providers of hardware engineering and systems engineering solutions. Computer
Sciences Corporation and EDS provided computer and computer software solutions.
Defense companies, such as General Dynamics, Boeing and Raytheon are solutions
providers that could easily expand their business into the homeland security
business and are currently allocating resources to develop programs in this
area. Because of the services and additional human and financial resources that
these larger companies can provide, they may be more attractive to the U.S.
Government.
IF WE CANNOT EFFECTIVELY MANAGE OUR GROWTH, OUR BUSINESS MAY SUFFER.
Recently, we have expanded our operations to pursue existing and
potential new market opportunities. This growth has placed, and is expected to
continue to place, a strain on our personnel, management, financial and other
resources. To manage our growth effectively, we must, among other things:
o upgrade and expand our manufacturing facilities and capacity in a
timely manner;
o successfully attract, train, motivate and manage a larger number
of employees for manufacturing, sales and customer support
activities;
o control higher inventory and working capital requirements; and
o improve the efficiencies within our operating, administrative,
financial and accounting systems, procedures and controls.
If we fail to manage our growth properly, we may incur unnecessary
expenses and the efficiency of our operations may decline.
11
WE MAY BE UNABLE TO HIRE AND RETAIN THE SKILLED PERSONNEL WE NEED TO EXPAND OUR
OPERATIONS.
To meet our growth objectives, we must attract and retain highly
skilled technical, operational, managerial and sales and marketing personnel. If
we fail to attract and retain the necessary personnel, we may be unable to
achieve our business objectives and may lose our competitive position, which
could lead to a significant decline in net sales. We face significant
competition for these skilled professionals from other companies, research and
academic institutions, government entities and other organizations.
OUR SUCCESS DEPENDS ON THE SERVICES OF OUR EXECUTIVE OFFICERS AND KEY EMPLOYEES.
Our future success depends to a significant degree on the skills and
efforts of Robert Tarini, our chief executive officer. If we lost the services
of Mr. Tarini, our business and operating results could be adversely affected.
We also depend on the ability of our other executive officers and members of
senior management to work effectively as a team. The loss of one or more of our
executive officers or senior management members could impair our ability to
manage our business effectively.
OUR LARGEST CUSTOMERS ARE THE U.S. ARMY, THE U.S. NAVY, THE DEPARTMENT OF
HOMELAND SECURITY, AND VARIOUS OTHER U.S. INTELLIGENCE AGENCIES WHOSE OPERATIONS
ARE SUBJECT TO UNIQUE POLITICAL AND BUDGETARY CONSTRAINTS, INVOLVE COMPETITIVE
BIDDING, AND OUR CONTACTS WITH THESE CUSTOMERS MAY BE SUBJECT TO CANCELLATION
WITH OR WITHOUT PENALTY, WHICH MAY PRODUCE VOLATILITY IN OUR EARNINGS AND
REVENUE.
Our largest customers are the U.S. Army, the U.S. Navy, the Department
of Homeland Security, and various other U.S. Intelligence agencies. Due to
political and budgetary processes and other scheduling delays that may
frequently occur relating to the contract or bidding process, some government
agency orders may be canceled or delayed, and the receipt of revenues or
payments may be substantially delayed. This irregular and unpredictable revenue
stream makes it difficult for our business to operate smoothly. Obtaining
contracts from government agencies is challenging, and government contracts
often include provisions that are not standard in private commercial
transactions. For example, government contracts may:
o include provisions that allow the government agency to terminate
the contract without penalty under some circumstances;
o be subject to purchasing decisions of agencies that are subject to
political influence;
o contain onerous procurement procedures; and
o be subject to cancellation if government funding becomes
unavailable.
In addition, federal government agencies routinely audit government
contracts. These agencies review a contractor's performance on its contract,
pricing practices, cost structure and compliance with applicable laws,
regulations and standards. These audits may occur several years after completion
of the audited work. An audit could result in a substantial adjustment to our
revenues because we would not be reimbursed for any costs improperly allocated
to a specific contract, and we would be forced to refund any improper costs
already reimbursed. If a government audit uncovers improper or illegal
activities, we may be subject to civil and criminal penalties and administrative
sanctions, including termination of contracts forfeiture of profits, suspension
of payments, fines and suspension or debarment from doing business with federal
government agencies. In addition, our reputation could be harmed if allegations
of impropriety were made against us.
OUR BUSINESS MAY SUFFER IF WE CANNOT PROTECT OUR PROPRIETARY TECHNOLOGY.
Our ability to compete depends significantly upon our patents, our
trade secrets, our source code and our other proprietary technology. The steps
we have taken to protect our technology may be inadequate to prevent others from
using what we regard as our technology to compete with us. Our patents could be
challenged, invalidated or circumvented, in which case the rights we have under
our patents could provide no competitive advantages. Existing trade secrets,
copyright and trademark laws offer only limited protection. In addition, the
laws of some foreign countries do not protect our proprietary technology to the
same extent as the laws of the United States, which could increase the
likelihood of misappropriation. Furthermore, other companies could independently
develop similar or superior technology without violating our intellectual
property rights. Any misappropriation of our technology or the development of
competing technology could seriously harm our competitive position, which could
lead to a substantial reduction in net sales.
12
If we resort to legal proceedings to enforce our intellectual property
rights, the proceedings could be burdensome, disruptive and expensive, distract
the attention of management, and there can be no assurance that we would
prevail.
CLAIMS BY OTHERS THAT WE INFRINGE THEIR INTELLECTUAL PROPERTY RIGHTS COULD HARM
OUR BUSINESS AND FINANCIAL CONDITION.
Our industries are characterized by the existence of a large number of
patents and frequent claims and related litigation regarding patent and other
intellectual property rights. We cannot be certain that our products do not and
will not infringe issued patents, patents that may be issued in the future, or
other intellectual property rights of others.
We do not conduct exhaustive patent searches to determine whether the
technology used in our products infringes patents held by third parties. In
addition, product development is inherently uncertain in a rapidly evolving
technological environment in which there may be numerous patent applications
pending, many of which are confidential when filed, with regard to similar
technologies.
We may face claims by third parties that our products or technology
infringe their patents or other intellectual property rights. Any claim of
infringement could cause us to incur substantial costs defending against the
claim, even if the claim is invalid, and could distract the attention of our
management. If any of our products are found to violate third-party proprietary
rights, we may be required to pay substantial damages. In addition, we may be
required to re-engineer our products or obtain licenses from third parties to
continue to offer our products. Any efforts to re-engineer our products or
obtain licenses on commercially reasonable terms may not be successful, which
would prevent us from selling our products, and, in any case, could
substantially increase our costs and have a material adverse effect on our
business, financial condition and results of operations.
NEW CORPORATE GOVERNANCE REQUIREMENTS ARE LIKELY TO INCREASE OUR COSTS AND MAKE
IT MORE DIFFICULT TO ATTRACT QUALIFIED DIRECTORS.
We face new corporate governance requirements under the Sarbanes-Oxley
Act of 2002, as well as rules adopted by the SEC. We expect that these laws,
rules and regulations will increase our legal and financial compliance costs and
make some activities more difficult, time-consuming and costly. We also expect
that these new requirements will make it more difficult and more expensive for
us to obtain director and officer liability insurance. We may be required to
accept reduced coverage or incur significantly higher costs to obtain coverage.
These new requirements are also likely to make it more difficult for us to
attract and retain qualified individuals to serve as members of our board of
directors or committees of the board, particularly the audit committee.
FUTURE ACQUISITIONS OF OTHER COMPANIES MAY RESULT IN DISRUPTIONS TO OUR BUSINESS
AND ADDITIONAL EXPENSES.
We have completed the acquisitions of several companies, we plan to
review potential acquisition candidates, and our business and our strategy may
include building our business through acquisitions. However, acceptable
acquisition candidates may not be available in the future or may not be
available on terms and conditions acceptable to us.
Acquisitions involve numerous risks including among others,
difficulties and expenses incurred in the consummation of acquisitions and
assimilations of the operations, personnel, and services and products of the
acquired companies. Additional risks associated with acquisitions include the
difficulties of operating new businesses, the diversion of management's
attention from other business concerns and the potential loss of key employees
of the acquired company. If we do not successfully integrate the businesses we
may acquire in the future, our business will suffer.
WE FACE RISKS ASSOCIATED WITH OUR PLANS TO MARKET, DISTRIBUTE AND SERVICE OUR
PRODUCTS INTERNATIONALLY.
We intend to market, distribute and service our products
internationally subject to applicable U.S. Governmental approval and regulation
on sales of sensitive U.S. technology. Our success in international markets will
depend, in part, on our ability to secure relationships with foreign
sub-distributors and on our ability to meet foreign regulatory and commercial
requirements.
13
In March 2004, Markland signed an agreement with Tradeways, Ltd.
Tradeways, founded in 1974, is the principal worldwide exporter of U.S. Military
Special Nuclear, Biological and Chemical (NBC) Equipment, and has fulfilled
contracts for NBC products in more than 30 countries. Tradeways provides a
complete range of NBC products, as well as training and service. The process of
selling to foreign militaries is lengthy, and Markland cannot give any
assurances that it will be successful. If Tradeways is unsuccessful in selling
Markland's products, it would decrease Markland's success with foreign military
sales. To date, we have not sold any products through this channel.
WE ARE NOT SUBJECT TO THE SAME CORPORATE GOVERNANCE STANDARDS AS LISTED
COMPANIES, INCLUDING WITHOUT LIMITATION, THE REQUIREMENT THAT THE COMPANY HAVE A
MAJORITY OF INDEPENDENT DIRECTORS.
Registered exchanges and the Nasdaq National Market have enhanced
corporate governance requirements that apply to issuers that list their
securities on those markets. Our common stock is quoted on the OTC Bulletin
Board, which does not have comparable requirements. For instance, we are not
required to have any independent directors or to adopt a code of ethics.
Currently, we have no independent directors and therefore management
has significant influence over decisions made on behalf of the stockholders. In
certain circumstances, management may not have the same interests as the
shareholders and conflicts of interest may arise.
Furthermore, certain relationships with our officers, directors and
affiliates may also involve inherent conflicts of interest. We do not have a
policy to resolve conflicts of interest. Notwithstanding the exercise of their
fiduciary duties as directors and executive officers and any other duties that
they may have to us or our other stockholders in general, these persons may have
interests different than yours.
RISKS RELATED TO OUR COMMON STOCK
IT MAY BE DIFFICULT FOR YOU TO RESELL YOUR SHARES IF AN ACTIVE AND LIQUID MARKET
FOR OUR COMMON STOCK DOES NOT DEVELOP
Our common stock is not actively traded on a registered securities
exchange and we do not meet the initial listing criteria for any registered
securities exchange or the NASDAQ National Market System. It is quoted on the
less recognized OTC Bulletin Board. This factor may further impair your ability
to sell your shares when you want and/or could depress our stock price. As a
result, you may find it difficult to dispose of, or to obtain accurate
quotations of the price of, our securities because smaller quantities of shares
could be bought and sold, transactions could be delayed and security analyst and
news coverage of our company may be reduced. These factors could result in lower
prices and larger spreads in the bids and ask prices for our shares.
Due to the current price of our common stock, many brokerage firms may
not be willing to effect transactions in our securities, particularly because
low-priced securities are subject to an SEC rule that imposes additional sales
requirements on broker-dealers who sell low-priced securities (generally those
below $5.00 per share).
These factors severely limit the liquidity of our common stock, and
would likely have a material adverse effect on its market price and on our
ability to raise additional capital. We cannot predict the extent to which
investor interest in our stock, if any, will lead to an increase in its market
price or the development of a more active trading market or how liquid that
market might become.
THE MARKET PRICE OF OUR COMMON STOCK MAY BE VOLATILE.
Our stock price has been volatile. From July 1, 2003 to November 5,
2004, the trading price of our common stock ranged from a low price of $0.13 per
share to a high price of $9.00 per share. Many factors may cause the market
price of our common stock to fluctuate, including:
o variations in our quarterly results of operations;
o the introduction of new products by us or our competitors;
o acquisitions or strategic alliances involving us or our
competitors;
o future sales of shares of common stock in the public market; and
14
o market conditions in our industries and the economy as a whole.
In addition, the stock market has recently experienced extreme price
and volume fluctuations. These fluctuations are often unrelated to the operating
performance of particular companies. These broad market fluctuations may
adversely affect the market price of our common stock. When the market price of
a company's stock drops significantly, stockholders often institute securities
class action litigation against that company. Any litigation against us could
cause us to incur substantial costs, divert the time and attention of our
management and other resources or otherwise harm our business.
IF WE ISSUE SUBSTANTIAL SHARES OF OUR COMMON STOCK (I) PURSUANT TO OUR PRIVATE
EQUITY CREDIT AGREEMENT, (II) UPON CONVERSION OF THE OUTSTANDING SERIES D
CONVERTIBLE PREFERRED STOCK, (III) UPON EXERCISE OF OUR COMMON STOCK PURCHASE
WARRANTS, (IV) UPON CONVERSION OF THE SECURED CONVERTIBLE PROMISSORY NOTES, AND
(V) PURSUANT TO EMPLOYMENT AGREEMENTS AND OUR STOCK INCENTIVE PLAN,
YOU COULD SUFFER SUBSTANTIAL DILUTION OF YOUR INVESTMENT AND OUR STOCK
PRICE COULD DECLINE SIGNIFICANTLY.
We have entered into a private equity credit agreement with Brittany
Capital Management Limited, an offshore investment fund, on September 10, 2003,
whereby we can require Brittany Capital to purchase up to $10,000,000 of our
common stock at a discount, provided we have an effective registration statement
on file with the SEC covering these shares. While we have not filed a
registration statement with the SEC to cover these shares of common stock, we
intend to file one in the future.
In addition, our 2004 Stock Incentive Plan contemplates the issuance of
up to 25,000,000 shares of our common stock, and our agreements with two of our
executives and a consultant contemplate a series of issuances expressed as a
percentage of our fully diluted outstanding common stock (i.e., including shares
of our common stock for which any options, warrants, convertible preferred, or
other common stock equivalents are currently convertible or exercisable, as
applicable), currently estimated at 10,416,496 shares (based on our fully
diluted outstanding common stock as of November 5, 2004). Moreover, because
these grants are expressed as a percentage of our fully diluted common stock,
any increase to the fully diluted common stock (whether the result of new
issuances or, with respect to future-priced instruments, decreases in our stock
price) will result in an increase in the number of shares granted under these
agreements.
We are also obligated to issue a substantial number of shares of common
stock upon (i) the conversion of our Series D convertible preferred stock and
common stock purchase warrants; (ii) the conversion of our secured convertible
promissory notes issued on September 21, 2004 and on November 9, 2004; and
(iii) the exercise of our warrants issued on September 21, 2004 and on November
9, 2004.
Should a significant number of these securities be issued, exercised or
converted, the resulting increase in the amount of the common stock in the
public market could have a substantial dilutive effect on our outstanding common
stock. The conversion and exercise of a substantial amount of the aforementioned
securities or the issuance of new shares of common stock may also adversely
affect the terms under which we could obtain additional equity capital. The
price, which we may receive for the shares of common stock, that are issuable
upon conversion or exercise of such securities, may be less than the market
price of the common stock at the time of such conversions or exercise.
FLUCTUATIONS IN OUR QUARTERLY NET SALES AND RESULTS OF OPERATIONS COULD DEPRESS
THE MARKET PRICE OF OUR COMMON STOCK.
Our future net sales and results of operations are likely to vary
significantly from quarter to quarter due to a number of factors, many of which
are outside our control. Accordingly, you should not rely on quarter-to-quarter
comparisons of our results of operations as an indication of future performance.
It is possible that our net sales or results of operations in a quarter will
fall below the expectations of securities analysts or investors. If this occurs,
the market price of our common stock could fall significantly. Our results of
operations in any quarter can fluctuate for many reasons, including:
o Timing of orders from our largest customers, the U.S. Navy, the
Department of Defense, the Department of Homeland Security and the
United States Night Vision and Electronic Sensors Directorate;
o our ability to manufacture, test and deliver products in a timely
and cost-effective manner;
o our success in winning competitions for orders;
15
o the timing of new product introductions by us or our competitors;
o the mix of products we sell;
o competitive pricing pressures; and
o general economic climate.
A large portion of our expenses, including expenses for facilities,
equipment, and personnel, are relatively fixed. Accordingly, if our net sales
decline or do not grow as much as we anticipate, we might be unable to maintain
or improve our operating margins. Any failure to achieve anticipated net sales
could therefore significantly harm our operating results for a particular fiscal
period.
THE HOLDERS OF OUR PREFERRED STOCK HAVE CERTAIN RIGHTS AND PRIVILEGES THAT ARE
SENIOR TO OUR COMMON STOCKHOLDERS, AND WE MAY ISSUE ADDITIONAL SHARES OF
PREFERRED STOCK WITHOUT STOCKHOLDER APPROVAL THAT COULD ADVERSELY AFFECT THE
PRICE OF OUR COMMON STOCK.
Our board of directors has the authority to issue, without any further
vote or action by you and the other common stockholders, a total of up to
5,000,000 shares of preferred stock and to fix the rights, preferences,
privileges, and restrictions, including voting rights, of the preferred stock,
which typically are senior to the rights of the common stockholders. We have
issued and outstanding 30,000 shares of our Series A Non-Voting Redeemable
Convertible Preferred Stock, 17,725 shares of our Series D Convertible Preferred
Stock and may, from time to time in the future, issue additional preferred stock
for financing or other purposes with rights, preferences or privileges senior to
the common stock. Your rights will be subject to, and may be adversely affected
by, the rights of the holders of the preferred stock that have been issued or
might be issued in the future. Preferred stock also could make it more difficult
for a third party to acquire a majority of our outstanding voting stock. This
could delay, defer or prevent a change in control. Furthermore, holders of
preferred stock may have other rights, including economic rights, senior to the
holders of our common stock. As a result, the existence and issuance of
preferred stock could have a material adverse effect on the market value of the
common stock.
WE HAVE NEVER PAID DIVIDENDS ON OUR CAPITAL STOCK, AND WE DO NOT ANTICIPATE
PAYING DIVIDENDS IN THE FORESEEABLE FUTURE.
We have not paid dividends on any of our classes of capital stock to
date, and we currently intend to retain our future earnings, if any, to fund the
development and growth of our business. As a result, capital appreciation, if
any, of our common stock will be your sole source of gain for the foreseeable
future. In addition, the terms of our Exchange Agreement with Eurotech, Ltd.
prohibit us from declaring dividends.
In addition, pursuant to the Purchase Agreement between the Company and
DKR Soundshore Oasis Holding Fund, Ltd, and DKR Soundshore Strategic Holding
Fund, Ltd., dated September 21, 2004, we have covenanted that so long as any of
the notes issued pursuant to such agreement are outstanding, we will not
declare, pay or make any provision for any cash dividend or cash distribution
with respect to our common stock or preferred stock, without first obtaining the
approval of the investors party the agreement.
SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS
Except for historical facts, the statements in this prospectus are
forward-looking statements. Forward-looking statements are merely our current
predictions of future events. These statements are inherently uncertain, and
actual events could differ materially from our predictions. Important factors
that could cause actual events to vary from our predictions include those
discussed under the headings "Risk Factors," "Management's Discussion and
Analysis of Financial Condition and Results of Operations" and "Business." We
assume no obligation to update our forward-looking statements to reflect new
information or developments. We urge readers to review carefully the risk
factors described in this prospectus and the other documents that we file with
the Securities and Exchange Commission. You can read these documents at
WWW.SEC.GOV.
WE UNDERTAKE NO OBLIGATION TO PUBLICLY UPDATE OR REVISE ANY
FORWARD-LOOKING STATEMENTS WHETHER AS A RESULT OF NEW INFORMATION, NEW EVENTS OR
ANY OTHER REASON, OR REFLECT ANY EVENTS OR CIRCUMSTANCES AFTER THE DATE OF THIS
PROSPECTUS OR THE DATE OF ANY APPLICABLE PROSPECTUS SUPPLEMENT OR THE DATE OF
DOCUMENTS INCORPORATED BY REFERENCE INTO THIS PROSPECTUS THAT INCLUDE
FORWARD-LOOKING STATEMENTS.
16
USE OF PROCEEDS
The shares of common stock offered by this prospectus are being offered
by the selling stockholders. We will not receive any proceeds from the sale of
shares by the selling stockholders. For information about the selling
stockholders, see "Selling Stockholders."
PRICE RANGE FOR COMMON STOCK AND DIVIDEND POLICY
MARKET INFORMATION
Our common stock is quoted on the OTC Bulletin Board by The National
Association of Securities Dealers, Inc. under the symbol "MRKL.OB." The
following table provides, for the periods indicated, the high and low closing
prices for our common stock as reported on the OTC Bulletin Board. These
over-the-counter market quotations reflect inter-dealer prices, without retail
mark-up, mark-down or commission, and may not represent actual transactions. The
prices reflect a 1-for-60 reverse stock split effective October 27, 2003. Prior
to December 2003, the common stock of the Company was thinly traded. We believe
that the variability of the share price may, in part, be due to thin trading.
YEAR ENDED JUNE 30, 2003 HIGH LOW
----------------------------- --------- --------
First quarter $ 4.80 $ 1.20
Second quarter $ 33.00 $ 0.60
Third quarter $ 18.60 $ 7.80
Fourth quarter $ 15.00 $ 3.36
YEAR ENDED JUNE 30, 2004
----------------------------- --------- ---------
First quarter $ 9.00 $ 2.40
Second quarter $ 5.70 $ 1.90
Third quarter $ 2.70 $ 0.69
Fourth quarter $ 4.40 $ 0.59
There is no public trading market for our preferred stock.
HOLDERS
On November 5, 2004, the last sale price of our common stock as
reported on the OTC Bulletin Board was $0.68 per share. On November 5, 2004,
we had approximately 716 holders of record of our common stock and 3 holders of
records of our Series D Convertible Preferred Stock respectively. This number
does not include stockholders for whom shares were held in a "nominee" or
"street" name.
DIVIDENDS
We have never declared or paid cash dividends on our capital stock, and
we do not plan to pay any cash dividends in the foreseeable future. We currently
intend to retain any future earnings to finance our operations and future
growth.
RESTRICTIONS ON MARKLAND'S ABILITY TO PAY DIVIDENDS ON COMMON STOCK
Pursuant to the Exchange Agreement dated December 9, 2002, with
Eurotech, Ltd., and the other parties named therein, any and all cash and other
liquid assets held by our Company or its subsidiaries shall be exclusively used
for working capital or investment purposes, and we shall not, and shall not
permit our subsidiaries to, directly or indirectly divert or upstream cash or
other current assets whether in the form of a loan, contract for services,
declaration of dividend, or other arrangement in contravention of such
restriction until the second anniversary of the closing date of the exchange
transaction.
Pursuant to the Purchase Agreement between the Company and DKR
Soundshore Oasis Holding Fund, Ltd, and DKR Soundshore Strategic Holding Fund,
Ltd. dated September 21, 2004, we have covenanted that so long as any of the
notes issued pursuant to such agreement are outstanding, we will not declare,
pay or make any provision for any cash dividend or cash distribution with
respect to our common stock or preferred stock, without first obtaining the
approval of the investors party the agreement.
SELLING STOCKHOLDERS
Up to 39,002,780 shares are being offered under this prospectus, all of
which are being registered for sale for the account of the selling stockholders.
17
SEPTEMBER 21, 2004 PRIVATE PLACEMENT TRANSACTION
On September 21, 2004, we sold warrants to purchase shares of our
common stock and secured convertible promissory notes for the aggregate
consideration of $4,000,000. We received net proceeds of $3,480,000 from this
private placement. We also issued to Greenfield Capital Partners, LLC, David
Stefansky and Richard Rosenblum warrants to purchase an aggregate of 1,500,000
shares of our common stock at an exercise price of $1.50 as compensation in
connection with this private placement. The resale of the shares underlying
these warrants is covered by this registration statement. We intend to use the
proceeds from this offering for working capital.
The selling stockholders who participated in the September 21, 2004
private placement transaction are offering up to 27,000,000 shares of our common
stock issuable pursuant to convertible notes and warrants issued in connection
with this transaction, including:
(i) up to 6,500,000 shares of our common stock issuable upon
the conversion of notes issued to the investors;
(ii) up to 6,500,000 shares of our common stock issuable upon
the exercise of warrants issued to the investors; and
(iii) up to 1,500,000 shares of our common stock issuable upon
the exercise of warrants issued as compensation in connection with this
transaction.
We are also registering in connection with this transaction an
additional 9,500,000 shares to cover shares of our common stock which may become
issuable as the result of adjustments to the conversion or exercise prices of
the notes and warrants, as discussed below.
Finally, we are registering an additional 3,000,000 shares of our
common stock which we may be required to issue in satisfaction of liquidated
damages arising from the Registration Rights Agreement entered into by the
investors and us in connection with this private placement. The circumstances
giving rise to future adjustments or liquidated damages are discussed below.
Conversion Price Adjustments
----------------------------
We are registering a number of shares of our common stock equal to 125%
of the shares issuable, as of November 5, 2004, upon conversion in full of the
notes. The additional shares represent a good faith estimate of the number of
additional shares that may become issuable in the future as a result of
adjustments to the conversion price of the notes.
In particular, under the terms of these notes, we are required to pay
to the Initial Investors $4,000,000 of the outstanding principal and interest by
March 15, 2005, and the remaining outstanding balance by September 21, 2005. If
we do not make the March 15, 2005 prepayment, the conversion price will be
adjusted from $0.80 per share to the lower of (i) $0.80 and (ii) a floating rate
equal to 80% of average closing price per share of our common stock for the five
trading days preceding conversion.
In the event we issue common stock or common stock equivalents at a
price per share below the then effective conversion price of the convertible
notes, the conversion price will be reduced to that lower price per share.
Exercise Price Adjustments
--------------------------
We are registering a number of shares of our common stock equal to
approximately 220% of the number of shares issuable, as of November 5, 2004,
upon the exercise in full of the warrants issued to investors in this
transaction. The additional shares represent a good faith estimate of the number
of shares which may become issuable as a result of adjustments to the exercise
price of the warrants.
In particular, under the terms of the warrants, if we do not make a
prepayment of an aggregate of $4,000,000 in principal, plus any interest having
accrued thereon, on the notes issued to the Initial Investors in this private
placement by March 15, 2005, the exercise price of the warrant will be reduced
from $1.50 to the lesser of (i) $0.792 and (ii) 80% of the average closing price
per share of our common stock five trading days preceding the date the
adjustment is made.
In the event we issue common stock or common stock equivalents at a
price per share below the then effective exercise price of the warrants, the
exercise price will be reduced to that lower price per share.
18
In the event any of the foregoing adjustments are made, the warrants
will become exercisable for a number of shares equal to the aggregate exercise
price (i.e., the exercise price per share multiplied by the number of underlying
shares) prior to the adjustment divided by the post adjustment exercise price
per share.
Liquidated Damages
------------------
We are registering an additional 3,000,000 shares of our common stock
representing a good faith estimate of the number of shares of common stock
we may be required to issue in satisfaction of liquidated damages arising from
the Registration Rights Agreement entered into by the investors and us in
connection with this private placement. Under this agreement, if:
(i) this registration statement is not declared effective by December
20, 2004, or within five trading days after the SEC notifies us that the
registration will not be reviewed or is not subject to further review or
comments; or
(ii) this registration statement is suspended for more than an
aggregate of 20 trading days, whether or not consecutive, in any twelve-month
period, we will be required to pay each of the investors in this private
placement liquidated damages in an amount equal to 2% of such investor's
investment amount, half of which may, at our option, be paid in common stock of
equivalent value (such value to be determined based on the lower of (i) the
average of the closing price of our common stock for the five days preceding the
payment date and (ii) the closing price of our common stock on the day preceding
the date such stock is delivered to the investors).
NOVEMBER 9, 2004 PRIVATE PLACEMENT
On November 9, 2004, we sold warrants to purchase shares of our common
stock and secured convertible promissory notes for the aggregate consideration
of $1,350,000. Unless otherwise noted, the terms of the notes and warrants
issued in this private placement are substantially the same as the terms of the
notes and warrants we issued on September 21, 2004. We received net proceeds of
$1,174,500 from this private placement. We also issued to Greenfield Capital
Partners, LLC, David Stefansky and Richard Rosenblum warrants to purchase an
aggregate of 337,500 shares of our common stock at an exercise price of $1.50 as
compensation in connection with this private placement. The resale of the shares
underlying these warrants is not covered by this registration statement. We
intend to use the proceeds from this offering for working capital.
The selling stockholders who participated in the November 9, 2004
private placement transaction are offering up to 7,593,751 shares of our common
stock issuable pursuant to convertible notes and warrants issued in connection
with this transaction, including:
(i) up to 2,193,750 shares of our common stock issuable upon
the conversion of notes;
(ii) up to 2,193,750 shares of our common stock issuable upon
the exercise of warrants.
We are also registering up to 3,206,251 shares to cover shares of our
common stock which may become issuable as the result of adjustments to the
conversion or exercise prices of the notes and warrants, as discussed below.
As in the case of the notes and warrants issued in the September 21,
2004 private placement, we are registering a number of shares of our common
stock equal to 125% of the shares issuable upon conversion in full of the notes
and 220% of the shares issuable upon exercise in full of the warrants in each
case as of November 5, 2004, representing a good faith estimate of the number of
shares that may become issuable under these instruments in the event of
conversion or exercise price adjustments.
Under the terms of each of these notes, we are required to pay a
principal amount on each note equal to the consideration paid by the Additional
Investor holding such note plus any accrued interest by March 15, 2005, and the
remaining outstanding balance by November 9, 2005. In the event we do not make
these prepayments, the conversion price of the notes and exercise price of the
warrants will be subject to the adjustments described above in connection with
the September 21, 2004 private placement.
Like the notes and warrants issued in the September 21, 2004 private
placement, the conversion price of the notes and exercise price of the warrants
are also subject to adjustment in the event we issue common stock or common
stock equivalents at a price per share below the then effective conversion or
exercise price of the notes or warrants, as applicable.
19
Liquidated Damages
------------------
In the event this registration statement is not declared effective on
or before February 7th, 2005, we will be required to pay each of the Additional
Investors liquidated damages in an amount equal to 2% of such Additional
Investor's investment amount, half of which may, at our option, be paid in
common stock of equivalent value.
The value of the stock to be issued as liquidated damages will be
determined based on the lower of:
(i) the average of the closing price of our common stock for
the five days preceding the payment date and
(ii) the closing price of our common stock on the day
preceding the date the stock is delivered to the Additional Investors.
REGISTRATION RIGHTS IN CONNECTION WITH THE SEPTEMBER 21, 2004 AND NOVEMBER 9,
2004 PRIVATE PLACEMENTS
In connection with the September 21, 2004 and November 9, 2004 private
placement, we entered into a Registration Rights Agreement with the Initial
Investors and a Securities Purchase Agreement with the Additional Investors
respectively pursuant to which we agreed to file with the SEC a registration
statement covering the resale of the shares of our common stock covered by this
prospectus pursuant to Rule 415 of the Securities Act of 1933. In accordance
with the terms of the Registration Rights Agreement and the Securities Purchase
Agreement, we are filing this registration statement on Form SB-2 covering the
resale of the following shares of common stock by the selling stockholders
identified in this prospectus.
Specifically, in connection with the September 21, 2004 private
placement, we are registering an aggregate of 27,000,000 shares representing:
(i) 14,500,000 shares of our common stock issuable upon
conversion of notes and the exercise of warrants;
(ii) 9,500,000 shares of our common stock representing our
good faith estimate of the number of shares of our common stock that
may become issuable upon adjustments to the conversion price or
exercise price of the notes or warrants, respectively, in accordance
with their terms; and
(iii) 3,000,000 shares of our common stock representing our
good faith estimate of the number of shares of our common stock which
may become issuable in satisfaction of liquidated damages arising under
this Registration Rights Agreement.
In the event the number of shares underlying the notes and warrants
exceeds the number of shares registered under this registration statement, of
which this prospectus is a part, we will be required to file an additional
registration statement covering such shares.
In connection with the November 9, 2004 private placement, we are
registering an aggregate of 8,606,251 shares of our common stock representing:
(i) 4,387,500 shares of our common stock issuable upon
conversion of notes and the exercise of warrants;
(ii) 3,206,251 shares of our common stock representing our
good faith estimate of the number of shares of our common stock that
may become issuable upon adjustments to the conversion price or
exercise price of the notes or warrants, respectively, in accordance
with their terms; and
(iii) 1,012,500 shares of our common stock representing our
good faith estimate of the number of shares of our common stock which
may become issuable in satisfaction of liquidated damages arising under
this Registration Rights Agreement.
In the event the number of shares issuable upon conversion and exercise
of the notes and warrants issued in the September 21, 2004 and November 9, 2004
private placements exceeds the number of shares registered under this
registration statement, we will file an additional registration statement
covering such shares. We do not intend to rely on Rule 416 to cover the issuance
of these shares.
20
We have agreed to use our commercially reasonable efforts to cause this
registration statement to be declared effective under the Securities Act of
1933, as amendment, as promptly as possible after filing, and to keep it
effective until the earlier of:
(i) two years following the date of effectiveness;
(ii) the date on which all of the shares of our common stock
registered hereunder are sold by the selling stockholders; and
(iii) the date on which the shares of common stock registered
hereunder may be sold pursuant Rule 144(k) of the Securities Act,
subject to restrictions.
ADDITIONAL SELLING STOCKHOLDERS WITH PIGGY-BACK REGISTRATION RIGHTS
The selling stockholders with piggy-back registration rights are
offering up to 3,396,529 shares of our common stock, which are being registered
for resale hereunder, consisting of:
o 2,246,381 shares of our common stock held directly or indirectly
by Verdi Consulting, Inc. and issued as compensation for
consulting services; and
o 1,150,148 shares of our common stock held by David Stefansky.
SELLING STOCKHOLDERS TABLE
The following table sets forth the approximate number of shares
beneficially owned as of November 5, 2004, by each of the selling stockholders
and their pledgees, assignees and successors-in-interest. Please consider the
following when reviewing the information presented in the table and the notes:
o The number of shares beneficially owned by the selling
stockholders is determined under rules promulgated by the SEC.
o The "Right to Acquire" column reflects beneficial ownership of
shares subject to warrants and convertible preferred stock that
may be exercised and converted within 60 days after November 5,
2004.
o The "Shares Offered" column reflects all of the shares that each
selling stockholder may offer under this prospectus. Percentage
ownership is based on 51,564,458 shares of our common stock issued
and outstanding as of November 5, 2004.
o Information concerning the selling stockholders may change from
time to time and changed information will be presented in a
supplement to this prospectus if and when necessary and required.
o The selling stockholders may have sold, transferred or otherwise
disposed of the warrants issued in the September 21, 2004 and
November 9, 2004 private placements in transactions exempt from
the registration requirements of the Securities Act of 1933, as
amended, since the date the selling stockholders provided the
information regarding their securities holdings.
o As indicated in the notes to this table, certain of the
individuals with voting and investment control have indicated that
they exercise such control through a corporate or other
organizational structure, which structural information has not
been included.
o The table assumes that the selling stockholders will sell all of
the shares. No assurances can be given as to the actual number of
shares that will be resold by the selling stockholders or that
will be held by the selling stockholders after completion of the
resales.
21
BENEFICIAL OWNERSHIP PRIOR TO OFFERING TOTAL OWNERSHIP SHARES
--------------------------------------------- WITHOUT REGARD TO OFFERED
RIGHT TO CONTRACTUAL UNDER THIS
NAME OF BENEFICIAL OWNER OUTSTANDING ACQUIRE TOTAL LIMITATIONS PROSPECTUS
- ------------------------ ----------- --------------- --------------- ----------------- ------------------
DKR Soundshore Oasis
Holding Fund, Ltd. (1) 0 2,713,347(2)(3) 2,713,347(2)(3) 10,400,000(4) 20,400,000(5)(6)(7)
DKR Soundshore Strategic
Holding Fund, Ltd. (1) 0 2,713,347(2)(3) 2,713,347(2)(3) 2,600,000(4) 5,100,000(5)(6)(7)
Harborview Master Fund
L.P. (1)(15) 0 2,713,347(2) 2,713,347(2) 3,250,000(4) 6,375,000(8)(9)(10)
Southridge Partners LP 584,006 1,137,500 1,721,506 1,721,506 2,231,251(8)(9)(10)
Greenfield Capital
Partners,LLC (11) 0 750,000(12) 750,000 750,000 750,000
Verdi Consulting, Inc. (1) 2,246,381(14) 0 2,246,381 2,246,381 2,246,381
David Stefansky (15) 1,150,148 375,000(12) 1,525,148 1,525,148 1,525,148
Richard Rosenblum (15) 0 375,000(12) 375,000 375,000 375,000
BENEFICIAL OWNERSHIP AFTER OFFERING
-----------------------------------
RIGHT TO
NAME OF BENEFICIAL OWNER OUTSTANDING ACQUIRE PERCENT
- ------------------------ ----------- ----------- --------
DKR Soundshore Oasis
Holding Fund, Ltd. (1) 0 750,000(16) 1.4%
DKR Soundshore Strategic
Holding Fund, Ltd. (1) 0 750,000(16) 1.4%
Harborview Master Fund L.P.
(1)(15) 0 0 *
Southridge Partners LP 0 0 *
Greenfield Capital
Partners, LLC (11) 0 0 *
Verdi Consulting, Inc. (1) 0 0 *
David Stefansky (10) 0 0 *
Richard Rosenblum (10) 0 0 *
(1) The selling securityholder has represented in the Selling
Securityholder Notice and Questionnaire that it is not a broker-dealer.
(2) Represents the aggregate maximum number of shares that the selling
stockholder can own at one time (and therefore, offer for resale at any
one time) due to the 4.999% limitation, further described in Note 3
below.
(3) In accordance with Rule 13d-3 under the Securities Exchange Act of
1934, as amended, DKR Soundshore Oasis Holding Fund, Ltd. may be deemed
to be the beneficial owners of the shares held by DKR Soundshore
Strategic Holding Fund, Ltd. and their holdings have been aggregated
for the purposes of determining beneficial ownership. The notes and
warrants issued to these entities limit conversion or exercise, as
applicable, to the extent necessary to ensure that, after giving effect
to such conversion or exercise, the beneficial ownership of each
entity, including affiliates, does not exceed 4.999% of our outstanding
common stock.
(4) Represents the number of shares the selling stockholder would receive
upon conversion and exercise in full as of November 5, 2004 of the
stockholder's note and warrant without regard to the 4.999% limitation,
further described in Note 3.
22
(5) Represents the maximum number of shares which the selling stockholder
may offer under this prospectus, including a good faith estimate of
shares which may become issuable upon conversion or exercise of notes
or warrants issued in connection with the September 21, 2004 private
placement, as applicable, in the future as a result of conversion or
exercise price adjustments as further described in Notes 6 and 7, and
an additional pro rata share (based on the amount of the selling
stockholders investment) of 3,000,000 shares which may become issuable
in satisfaction of liquidated damages arising from our agreements with
the investors in the September 21, 2004 private placement.
(6) Includes a good faith estimate of the number of shares issuable upon
conversion of the note held by the selling stockholder based on 125% of
the number of shares into which such note is convertible as of November
5, 2004. Because the number of shares of common stock issuable upon
conversion of the note may become dependent in part upon the market
price of the stock at the time of conversion, the actual number of
shares that will be issuable upon conversion may fluctuate daily and
cannot be determined at this time. Specifically, in the event we do not
prepay on March 15, 2005 $4,000,000 in principal amount plus any
accrued interest on the notes issued in connection with the September
21, 2004 private placement, the conversion price will be adjusted from
a fixed price of $.80 a share to (i) 80% of a floating rate equal to
the average closing price per share of our common stock for the five
trading days preceding conversion or (ii) $0.80, whichever is less. For
the purposes of the note, the market price of our common stock on a
given date is equal to the average closing price for the five trading
days preceding that date. In addition, the conversion price of the note
may be lowered in the event that we issue common stock or common stock
equivalents at a price per share below the conversion price then in
effect. If the number of shares issuable upon conversion of the note
exceeds the registered amount, we will not rely on Rule 416 to cover
the additional shares, but will instead file a new registration
statement.
(7) Includes a good faith estimate of the number of shares issuable upon
exercise of the warrant held by the selling stockholder based on
approximately 220% of the number of shares into which the warrant is
exercised as of November 5, 2004. Because the number of shares of
common stock issuable upon exercise of the warrant may become dependent
in part upon the market price of the stock as of March 15, 2005, the
actual number of shares that will be issuable upon exercise cannot be
determined at this time. Specifically, in the event we do not prepay on
March 15, 2005 $4,000,000 in principal amount plus any accrued interest
on the notes issued in connection with the September 21, 2004 private
placement, the exercise price will be adjusted from $1.50 to $0.792 or
80% of the market price of our common stock on March 15, 2005,
whichever is less. In addition, the exercise price of the warrants may
be lowered in the event that we issue common stock or common stock
equivalents at a price per share below the exercise price then in
effect. If the number of shares issuable upon exercise of the warrant
exceeds the registered amount, we will not rely on Rule 416 to cover
the additional shares, but will instead file a new registration
statement.
(8) Represents the maximum number of shares which the selling stockholder
may offer under this prospectus, including a good faith estimate of
shares which may become issuable upon conversion or exercise of notes
or warrants issued in connection with the November 9, 2004 private
placement, as applicable, in the future as a result of conversion or
exercise price adjustments as further described in Notes 9 and 10 and
an additional pro rata share (based on the amount of the selling
stockholders investment) of 1,012,500 shares which may become issuable
in satisfaction of liquidated damages arising from our agreements with
the investors in the November 9, 2004 private placement.
(9) Includes a good faith estimate of the number of shares issuable upon
conversion of the note held by the selling stockholder based on 125% of
the number of shares into which the notes is convertible as of November
5, 2004. Because the number of shares of common stock issuable upon
conversion the note may become dependent in part upon the market price
of the stock at the time of conversion, the actual number of shares
that will be issuable upon conversion may fluctuate daily and cannot be
determined at this time. Specifically, in the event we do not prepay on
23
March 15, 2005 a principal amount on each note equal to the amount
invested by the holder of such note in the November 9, 2004 transaction
(plus any accrued interest) the conversion price for each such note
will be adjusted from a fixed price of $0.80 a share to (i) 80% of a
floating rate equal to the average closing price per share of our
common stock for the five trading days preceding conversion or (ii)
$0.80, whichever is less. For the purposes of the note, the market
price of our common stock on a given date is equal to the average
closing price for the five trading days preceding that date. In
addition, the conversion price of the note may be lowered in the event
that we issue common stock or common stock equivalents at a price per
share below the conversion price then in effect. If the number of
shares issuable upon conversion of the note exceeds the registered
amount, we will not rely on Rule 416 to cover the additional shares,
but will instead file a new registration statement.
(10) Includes a good faith estimate of the number of shares issuable upon
exercise of the warrants held by the selling stockholder based on
approximately 220% of the number of shares into which the warrant is
exercised as of November 5, 2004. Because the number of shares of
common stock issuable upon exercise of the warrant may become dependent
in part upon the market price of the stock as of March 15, 2005, the
actual number of shares that will be issuable upon exercise cannot be
determined at this time. Specifically, in the event we do not prepay on
March 15, 2005 a principal amount on each note issued in the November
9, 2004 transaction equal to the amount invested by the holder of such
note (plus any accrued interest), the exercise price will be adjusted
from $1.50 to $0.792 or 80% of the market price of our common stock on
March 15, 2005, whichever is less. In addition, the exercise price of
the note may be lowered in the event that we issue common stock or
common stock equivalents at a price per share below the exercise price
then in effect. If the number of shares issuable upon exercise of the
warrant exceeds the registered amount, we will not rely on Rule 416 to
cover the additional shares, but will instead file a new registration
statement.
(11) The selling securityholder has represented in the Selling
Securityholder Notice and Questionnaire that it is a broker-dealer
registered pursuant to the Securities Exchange Act of 1934.
(12) Represents shares issuable upon the exercise of warrants issued as
compensation in connection with the September 21, 2004 private
placement.
(13) The selling securityholder has represented in the Selling
Securityholder Notice and Questionnaire that it is not a broker-dealer.
(14) Includes shares held by (i) Verdi Consulting, Inc., a corporation
wholly owned and operated by Chad A. Verdi, and (ii) Chad A. Verdi. We
issued these shares pursuant to consulting agreements.
(15) The selling securityholder has represented in the Selling
Securityholder Notice and Questionnaire that he is an "affiliate" of a
broker-dealer.
(16) Represents shares issuable upon exercise of a warrant held by DKR
Soundshore Oasis Holding Fund, Ltd issued on May 3, 2004 in connection
with a private placement. These shares are the subject of a separate
registration statement filed with the SEC that was declared effective
on June 21, 2004, as amended and supplemented from time to time (File #
333-115395).
We have included a description of each selling stockholder's
relationship to Markland Technologies, Inc. and how each selling
stockholder acquired the shares to be sold in this offering in the
table, in the notes to the table and in this registration statement.
Please note that:
o Other than as may be stated in this registration statement or any
supplement and/or amendment, none of the selling stockholders has
had any material relationship with us or our affiliates within the
past three years.
o All of the outstanding shares of our common stock covered by this
registration statement were "restricted securities" under the
Securities Act prior to this registration statement.
24
VOTING AND INVESTMENT CONTROL
The table below sets forth selling stockholders that are entities and
the names of individuals having voting and investment control over the
securities held by these entities on November 9, 2004. We prepared this table
based upon information supplied to us by the selling stockholders. This
information is not necessarily indicative of beneficial ownership for any other
purpose.
ENTITY VOTING AND INVESTMENT CONTROL
- ------ -----------------------------
DKR Soundshore Oasis Holding Fund, Ltd Seth Fisher
DKR Soundshore Strategic Holding Fund, Ltd Seth Fisher
Greenfield Capital Partners LLC Michael James Byl
Verdi Consulting, Inc. Chad A. Verdi
Harborview Master Fund L.P. Richard Rosenblum/David Stefansky
Southridge Partners LP Stephen Hicks
MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF
OPERATIONS
THE FOLLOWING DISCUSSION AND ANALYSIS SHOULD BE READ IN CONJUNCTION
WITH THE OTHER FINANCIAL INFORMATION AND CONSOLIDATED FINANCIAL STATEMENTS AND
RELATED NOTES APPEARING ELSEWHERE IN THIS FORM 10-KSB. THIS DISCUSSION CONTAINS
FORWARD-LOOKING STATEMENTS THAT INVOLVE RISKS AND UNCERTAINTIES. OUR ACTUAL
RESULTS COULD DIFFER MATERIALLY FROM THOSE ANTICIPATED IN THE FORWARD-LOOKING
STATEMENTS AS A RESULT OF A VARIETY OF FACTORS, INCLUDING THOSE DISCUSSED IN
"RISK FACTORS" AND ELSEWHERE IN THIS FORM 10-KSB AND THE DOCUMENTS INCORPORATED
BY REFERENCE. READERS ARE CAUTIONED NOT TO PLACE UNDUE RELIANCE ON ANY
FORWARD-LOOKING STATEMENTS CONTAINED IN THIS ANNUAL REPORT ON FORM 10-KSB. WE
WILL NOT UPDATE THESE FORWARD-LOOKING STATEMENTS UNLESS THE SECURITIES LAWS AND
REGULATIONS REQUIRE US TO DO SO.
OVERVIEW
The following management's discussion and analysis of financial
condition and results of operations is organized as follows:
o OVERVIEW. This section provides a general description of
Markland, its business and recent developments and events that
have occurred since 2002 that we believe are important in
understanding the results of operations and financial
condition and to anticipate future trends. In addition, we
have provided a brief description of our acquisition of EOIR
Technologies, Inc., an event that impacts the comparability of
the results being analyzed.
o RESULTS OF OPERATIONS. This section provides an analysis of
Markland's results of operations for the fiscal years ended
June 30, 2004 and June 30, 2003. This analysis is presented on
a consolidated basis.
o LIQUIDITY AND CAPITAL RESOURCES. This section provides an
analysis of Markland's cash flows for the fiscal years ended
June 30, 2004 and June 30, 2003, as well as a discussion of
recent financing arrangements.
o CRITICAL ACCOUNTING POLICIES. This section discusses certain
critical accounting policies that we consider important to
Markland's financial condition and results of operations, and
that required significant judgment and estimates on the part
of management in application. Markland's significant
accounting policies, including the critical accounting
policies discussed in this section, are summarized in the
notes to the accompanying consolidated financial statements.
25
OVERVIEW
BACKGROUND
GENERAL. We provide to the United States Department of Defense ("DOD")
and to various other United States Intelligence Agencies ("INTEL"); remote
sensing technology products, and services to protect our country's military
personnel and infrastructure assets. We also provide to the Department of
Homeland Security ("Homeland Security"); products, services and emerging
technologies to protect our country's borders, infrastructure assets and
personnel. Our mission is to build world-class integrated solutions for the
Homeland Security ("Homeland Security"), DOD and INTEL marketplaces via
expansion of our existing contracts, development of our emerging technologies
and acquisition of synergistic revenue producing assets.
We have undergone material changes to our business and our financial
structure during the period covered by the financial statements included in this
Form 10-KSB. Our business, as it exists today, consists of four business areas:
remote sensor systems for military and intelligence applications, chemical
detection, border security and advanced technologies.
Our primary sources of future operating revenue are from our wholly
owned subsidiary EOIR, which was acquired by us on June 29, 2004. EOIR offers
products and services which include; (i) design and fabrication of customized
remote sensor systems and platforms for DOD, INTEL and Homeland Security
applications; (ii) remote sensor data collection, data signal processing and
data exploitation; and (iii) training in the use of remote sensor systems and
data. These efforts involve systems engineering, system integration,
prototyping, manufacturing and field data collections as well as data analysis
and processing.
Prior to the acquisition of EOIR Technologies, Inc. ("EOIR"), our
primary sources of operating revenue were sales of our automatic chemical agent
detection and alarm system produced by our wholly owned subsidiary Science and
Technology Research Inc. ("STR"), border security logistics products and
services provided by our wholly owned subsidiary ERGO Systems ("ERGO"), and
Small Business Investment Research ("SBIR") funded research grants for the
development of gas plasma antenna technology.
Our acquisition of EOIR has materially changed our business. To the
extent the following discussion refers to our financial results, you should note
that we have reported our quarterly and annual financial results under
accounting principles generally accepted in the United States of America
("GAAP"). We did not complete our acquisition of EOIR Technologies, Inc. until
June 29, 2004, and therefore, the results of operations of EOIR for the year
ended June 30, 2004, are not included in our Statement of Loss for fiscal year
2004. For comparative purposes, we have included a discussion of certain
financial information concerning EOIR in our discussion and analysis of our
financial condition and results of operations. Information concerning the EOIR
acquisition can be found in our Current Report on Form 8-K/A filed with the SEC
on September 13, 2004 (File # 000-28863) which includes audited financial
statements for EOIR for the years ended December 31, 2003 and December 31, 2002,
and unaudited financial statements for the three months ended March 31, 2004, as
well as unaudited pro forma information for fiscal year ended June 30, 2003 and
the nine months ended March 31, 2004.
MARKLAND BUSINESS
REMOTE SENSOR SYSTEMS FOR MILITARY AND INTELLIGENCE APPLICATIONS
Our acquisition of EOIR on June 29, 2004, a company which provides
remote sensing technology products and services to the United States Department
of Defense and to various other United States Intelligence Agencies, is a very
important part of our ongoing business strategy of creating a world-class
integrated portfolio of solutions for the Homeland Security, DOD and INTEL
marketplaces.
EOIR's most significant source of revenues is an Omnibus Contract with
the United States Army Night Vision and Electronic Sensors Directorate which has
a total potential value of approximately $406 million over its five year period
of performance. Approximately 86% of EOIR revenues for its fiscal year ended
December 31, 2003, were derived from this contract. The Omnibus Contract has an
extensive and varied scope that requires us to provide a very broad range of
products and technical services. For those products and technical services that
EOIR does not possess in-house, we have and continue to subcontract to our team
members and other subcontractors as necessary.
26
CHEMICAL DETECTOR
In October 2003, our subsidiary, Security Technology, Inc., acquired
all of the common stock of Science and Technology Research, Inc. ("STR"), a
chemical detector manufacturer, as part of our ongoing business strategy of
creating an integrated portfolio of homeland security solutions.
STR has a contract with the U.S. Navy to be the sole producer of the
U.S. Navy's shipboard Automatic Chemical Agent Detection and Alarm System used
to detect all classic nerve and blister agents as well as other chemical warfare
agent vapors. STR's sole of revenues is this contract with the United States
Navy which has a total potential value of approximately $37,000,000 over its
period of performance. As of June 30, 2004, we had completed delivery pursuant
to all outstanding orders under this contract. We are experiencing a decline in
demand for our chemical detector unit from the U.S. Navy. We plan to compensate
for this reduced demand by marketing this technology to new customers within the
Homeland Security marketplace and by combining it with other technologies for
sale to customers other than the US Navy.
We are presently working on the design of a next generation "point"
chemical detector product, which will also operate using Ion Mobility
Spectrography (IMS) cell technology and provide networked wireless communication
capability.
On December 23, 2003, the U.S. Navy signed a ten-year non-exclusive
license agreement with us to transfer certain chemical detection technology
intellectual property rights to us. We believe the license will allow us to
further expand the applications for the "point" chemical detection technology
and market the technology to non-defense customers such as foreign governments
and commercial entities. The company is combining "stand off" chemical detection
technologies from EOIR which are based on hyper spectral infra red technology
with the "point" chemical detection technology of STR which is based on Ion
Mobility Spectroscopy. This integrated and combined chemical detection
capability we believe will accelerate penetration into new markets for the
chemical detection products we now offer and will help to increase our revenues
in the next fiscal year for chemical detection products.
BORDER SECURITY
We acquired the assets of Ergo Systems, Inc., in January 2003. This
acquisition provided us with contracts with the Department of Homeland Security
to maintain, integrate, and implement design enhancements to border security
systems installed at U.S. ports of entry for the Dedicated Commuter Lane, which
is part of a larger U.S. Customs and Immigration and Naturalization Service
initiative to reduce wait times, improve data accuracy, and improve overall
efficiencies at all border crossings for both freight and passengers.
During the fiscal year we entered into a teaming agreement with
Accenture, who was recently awarded the US VISIT Contract. The purpose of this
contract is to secure our borders and expedite the entry/exit process while
enhancing the integrity of our immigration system and respecting the privacy of
visitors to the US. We have recently been awarded a subcontract which enables
the company to derive revenues from the US VISIT Contract. Although during
fiscal year 2004, our subsidiary ERGO Systems, Inc. recognized approximately
$955,736 of revenue from these contracts. Management believes that the potential
for increased revenues has been greatly enhanced by this subcontract award.
ADVANCED TECHNOLOGIES
Through research and development as well as intellectual property
acquisitions, we have established a portfolio of advanced and emerging
technologies, which we intend to commercialize and utilize within our own
proprietary products or license out for the purpose of revenue generation. These
advanced technologies and intellectual property are as follows:
o Gas plasma antenna,
o Vehicle stopping system,
o Acoustic Core(TM) signature analysis,
o APTIS(TM) human screening portal, and
o Cryptography software.
Of these five advanced technologies we believe that the nine issued and
pending U.S. patents related to gas plasma antenna technology with demonstrated
applications in the fields of ballistic missile defense, phased array radar, and
forward deployed decontamination have the most demonstrated potential to create
future sustained revenue streams.
27
COMPANY HISTORY
EVENTS PRIOR TO FISCAL 2002. Markland, previously known as Quest Net,
was incorporated in Colorado in November 1995, under the name "A.P. Sales Inc."
In December 1998, A.P. Sales Inc. dissolved as a Colorado corporation,
redomiciled in Florida and changed its name to Quest Net Corp. In 2001, before
the period covered by the financial statements included in this Form 10-KSB, our
only asset was the stock of a subsidiary, CWTel, Inc. ("CWTel"), a company in
the telecommunications business. We acquired this company in March 2000 and
secured our payment obligations with 30,000 shares of our Series A Non-Voting
Redeemable Convertible Preferred Stock. CWTel filed for bankruptcy and was
liquidated on March 11, 2002. After the bankruptcy of our subsidiary, we had no
active business operations. On June 30, 2003, we issued 30,000 shares of our
Series A Non-Voting Redeemable Convertible Preferred Stock in satisfaction of
our remaining obligations to the holder of the security interest.
On March 15, 2001, we acquired all the outstanding capital stock of a
company called Vidikron of America, Inc. ("Vidikron"), a development stage
company in the business of creating digital broadband and wireless networking
solutions for the internet. The sole stockholder of Vidikron was Markland LLC.
To acquire Vidikron we issued 10 shares of our convertible Series B Preferred
Stock to Markland LLC. Markland LLC converted all of its Series B Preferred
Stock in June 2001, which, resulted in Markland LLC owning approximately 85% of
our then outstanding common stock. There is no Series B Preferred Stock
outstanding. At this time we changed our name to Markland Technologies, Inc.
On October 19, 2000 we executed a promissory note for $3,500,000 in
favor of James LLC. In July 2001, after the Vidikron acquisition, James LLC
elected to convert $2,500,000 of the principal amount of its $3,500,000
promissory note, together with $125,000 accrued interest, into shares of our
common stock. In September 2001, we assumed all of Vidikron's rights and
obligations under a $3,500,000 secured revolving credit facility with Market
LLC. These transactions made Market LLC our senior secured lender.
EVENTS DURING FISCAL 2002. In May 2002, we received a notice of default
from Market LLC. In June of 2002, we transferred all the stock of Vidikron to
Market LLC in partial satisfaction of our indebtedness to Market LLC. After this
partial payment, we still owed Market LLC $500,000. Our disposition of the
business of Vidikron was treated as a discontinued operation. As a result, we
recorded a loss of $3,259,421 for the fiscal year ended June 30, 2002 resulting
from discontinued operations. At this point in our history we again had no
active business operations. In fiscal 2003, we recorded a gain of $998,713
resulting from the settlement of certain liabilities and obligations recorded in
previous periods in connection with the discontinued operations.
EVENTS DURING FISCAL 2003. In December 2002, we entered into a
transaction with Eurotech Ltd., ipPartners, Inc., Market LLC, and James LLC.
Pursuant to this transaction, the following took place:
o We formed a subsidiary corporation called Security Technology,
Inc.
o Eurotech transferred certain rights to its Acoustic Core
Technology(TM) to our subsidiary.
o Crypto.com Inc. (a subsidiary of Eurotech) and ipPartners,
Inc. transferred certain rights to their cryptology
technologies to our subsidiary.
o 90% of the shares of our common stock held by Market LLC and
James LLC were retired.
o We issued shares of common stock representing 80% of our then
issued and outstanding common stock to Eurotech, Ltd. and
shares of common stock representing 10% of our then issued and
outstanding shares of common stock to ipPartners, Inc.
o We issued $5,225,000 in stated value of our Series C 5%
Cumulative Convertible Preferred Stock to Market LLC and James
LLC in satisfaction of $5,225,000 of convertible notes held by
Market LLC and James LLC and in exchange for their agreement
to surrender 4,498,638 shares of our common stock.
We are not a majority-owned subsidiary of Eurotech, Ltd. due to the
issuances of additional common stock.
28
In January of 2003, we acquired all of the common stock of Ergo
Systems, Inc. ("Ergo"), a provider of security logistic support and related
product development services. Ergo has a contract with the United States
government to provide border security logistic support at five ports of entry.
In consideration for this acquisition, we agreed to pay $400,000 in cash,
payable at certain milestones related to our research efforts. During the year
ended June 30, 2004, we recognized $955,736 from these services.
In March of 2003, we entered into an agreement to acquire the
intellectual property (including patents), equipment and government contracts
relating to our gas plasma antenna technology from ASI Technology Corporation,
but this transaction did not close until September 30, 2003. In consideration
for this acquisition we issued 283,333 shares of common stock valued at $850,000
and agreed to pay $150,000. During the year ended June 30, 2004, we recognized
revenue of $261,479 from SBIR research grants related to this technology.
EVENTS DURING FISCAL 2004. In October of 2003, we acquired all of the
common stock of Science and Technology Research Corporation, Inc. ("STR"). This
company is the producer of the U.S. Navy's shipboard automatic chemical agent
detection and alarm system. In consideration for this acquisition, we issued
1,539,779 shares of common stock valued at $5,100,000 and paid $900,000 in cash,
and issued a promissory note for $375,000. During the year ended June 30, 2004,
we recognized revenue of $4,796,715 from sales of our automatic chemical agent
detection and alarm system to the U.S. Navy. We also entered into a consulting
agreement with the former principal shareholder and employee.
On June 29, 2004, we acquired all of the outstanding stock of EOIR for
$8,000,000 in cash and $11,000,000 in principal amount of five year notes
secured by the assets and stock of EOIR. EOIR is a provider of technology and
services to the United States Army Night Vision and Electronic Sensors
Directorate and has expertise in wide area remote sensing using both
electro-optic and infrared technologies. Markland intends to continue to use the
assets of EOIR for this purpose. We expect that EOIR will represent a majority
of Markland's revenues going forward. We expect that these sensor science
products will be our most significant revenue producing business.
FINANCING ACTIVITIES. We have financed our business activities through
borrowings and private placements of our securities to institutional investors.
We have engaged in the following financing activities:
o In October 2003, we borrowed $1,400,000 from Bay View Capital,
LLC. This borrowing was repaid in April 2004.
o At various times between April 2003 and March 2004 we have
raised an aggregate of approximately $3,832,000 through
private placements of our Series D Preferred Stock to an
institutional investor.
o On April 2, 2004, we sold 3,333,333 shares of common stock and
warrants to purchase 3,333,333 shares of our common stock for
gross proceeds of $2,000,000 to three investors in a private
placement.
o On April 16, 2004, we sold 2,500,000 shares of our common
stock and warrants to purchase 2,500,000 shares of our common
stock for gross proceeds of $2,000,000 to ten investors in a
private placement.
o On May 3, 2004, we sold 7,098,750 shares of our common stock
and warrants to purchase 7,098,750 shares of our common stock
for gross proceeds of $5,679,000 to 34 investors in a private
placement.
o As of April 2004, all of our Series C Cumulative Convertible
Preferred Stock has been converted into common stock and none
remains outstanding.
o On June 30, 2004, we sold 3,500 shares of Series D Preferred
Stock to an institutional investor for $2,000,000 in
connection with the acquisition of EOIR.
o On September 21, 2004, we sold secured convertible promissory
notes and warrants to purchase shares of common stock to two
institutional investors for approximately $4,000,000.
29
RESULTS OF OPERATIONS COMPARISON OF FISCAL 2003 AND FISCAL 2004
Our acquisition of EOIR has materially changed our business. To the
extent the following discussion refers to our financial results, you should note
that we have reported our quarterly and annual financial results under
accounting principles generally accepted in the United States of America
("GAAP"). We did not complete our acquisition of EOIR Technologies, Inc. until
June 29, 2004, and therefore, the results of operations of EOIR for the year
ended June 30, 2004, are not included in our Statement of Loss for fiscal year
2004. For comparative purposes, we have included a discussion of certain
financial information concerning EOIR in our discussion and analysis of our
financial condition and results of operations. Information concerning the EOIR
acquisition can be found in our Current Report on Form 8-K/A filed with the SEC
on September 13, 2004 which includes audited financial statements for EOIR for
the years ended December 31, 2003 and December 31, 2002, and unaudited financial
statements for the three months ended March 31, 2004, as well as unaudited pro
forma information for fiscal year ended June 30, 2003 and the nine months ended
March 31, 2004.
REVENUE:
Revenue for the fiscal year ended June 30, 2004 was $6,013,930,
compared to $658,651 for the same period in 2003.
For the fiscal year ended June 30, 2004, approximately $4,796,715 was
from our chemical detection business, including sales of the ACADA product,
approximately $955,736 was from sales of our border security products and
services, and approximately $261,479 was from SBIR grants for the development of
our gas plasma antenna technology.
Our revenues in 2003 included approximately $440,276 was from sales of
our border security products and services and approximately $218,375 was from
SBIR grants for the development of our gas plasma antenna technology.
On June 29, 2004 we acquired EOIR. As reported on our current report on
Form 8-K /A filed with the SEC on September 13, 2004, EOIR had revenues of
$42,680,858 and $30,570,936 for the fiscal years ended December 31, 2003 and
December 31, 2002, respectively. EOIR revenues were derived primarily from the
remote sensor system products and services of EOIR. On a pro forma basis
combining Markland (including our STR subsidiary) and EOIR, our revenues for the
period ended June 30, 2004 were $59,920,000.
COST OF REVENUES:
Cost of revenues for the year ended June 30, 2004 was $4,674,593,
compared to $445,218 for fiscal year 2003. Cost of revenues increased year to
year as a result of an increase in sales. The increase in costs was primarily
the result of the change in revenue mix and costs of materials for the
manufacture of the ACADA chemical detector unit.
Gross profits for the year ended June 30, 2004 was $1,339,337 compared
to $213,433 for fiscal year 2003. Gross profits increased as a result of
additional revenue from the acquisition of STR.
We had a gross profit margin of approximately 22% for the fiscal year
ended June 30, 2004, compared to 32% for the year ended June 30, 2003.
We expect the remote sensor system products of EOIR to provide a
significant increase to our total gross profit dollars. As reported on our
current report on Form 8-K/A filed with the SEC on September 13, 2004, EOIR's
gross profit was $8,823,724 and $6,999,370 for the years ended December 31, 2003
and 2002, respectively. For the years ended December 31, 2003 and December 31,
2002, EOIR's gross profit margin has been 20.8% and 23.3% of revenue.
SELLING, GENERAL AND ADMINISTRATIVE EXPENSES:
Selling, general and administrative expense for the year ended June
30, 2004 increased by $4,127,069 to $5,313,448, compared to selling, general and
administrative expense for the year ended June 30, 2003 which was $1,186,379.
Selling, general and administrative expense was primarily composed of
payroll, consultants, legal and accounting fees, and vendors. The increase in
selling, general and administrative expense was primarily due to increases in
staff resulting from the acquisition of STR and increases due to related sales
growth. We expect this expense to increase significantly with the acquisition of
EOIR. As reported on our current report on Form 8-K/A filed with the SEC on
September 13, 2004, EOIR's selling, general and administration expense was
$5,622,521 and $5,188,798, for the fiscal years ended December 31, 2003 and 2002
respectively.
30
RESEARCH AND DEVELOPMENT:
During fiscal year 2004, we spent $49,289 on research and development.
During the fiscal year ended 2003, $522,657 was spent on research and
development activities. During the fiscal year ended June 30, 2004, we reduced
our research and development efforts to concentrate our financial resources on
product marketing activities and as a result of completion of funded SBIR
contracts. Included in research and development costs for the year ended June
30, 2003 is $300,000 payable to SyQwest, a related party, for development costs
related to a vehicle stopping technology designed for use in protecting our
borders.
INTEREST EXPENSE:
Interest expense for the years ended June 30, 2004 and June 30, 2003
was $360,347 and $226,751 respectively. Interest and financing expense was from
notes payable issued for bridge financing, premium financing arrangements and
other financing costs.
Interest expense for EOIR for the years ended December 31, 2003 and
December 31, 2002 was $30,239 and $ 22,291, respectively. Interest expense was
from a revolving line of credit used by EOIR and various equipment loans. In
connection with our acquisition of EOIR, EOIR issued, and we guaranteed,
$11,000,000 in original principal amount of notes due to the former stockholders
of EOIR. These notes bear interest at the rate of six (6%) percent per annum and
must be repaid within the next five years. The carrying value of these notes is
$9,532,044 at June 30, 2004. We expect significant increases in interest expense
as a result of this financing and the convertible debt financing completed on
September 21, 2004.
COMPENSATORY ELEMENT OF STOCK ISSUANCES FOR SELLING, GENERAL AND
ADMINISTRATIVE EXPENSES:
Compensatory element of stock issuances for selling, general and
administrative expenses for the years ended June 30, 2004 and June 30, 2003 was
$5,211,737 and $2,051,822 respectively. In fiscal year 2003, this amount
consisted of charges for the issuance of 6,748,465 shares of restricted stock
issued at market value.
In fiscal year 2004, this amount consisted of charges for the issuance
of 5,867,103 shares of restricted stock at a valuation of 100% of market value
of unrestricted stock at the time of issuance. We use our equity to compensate
management and consultants who provide services to us. We expect to continue to
do so in the future. For this reason we expect to continue to incur such
charges.
LOSS FROM CONTINUING OPERATIONS:
Loss from continuing operations for the year ended June 30, 2004 was
$10,511,213. This loss resulted primarily from non-cash charges for the
compensatory element of stock issuances of $5,211,737 and from selling, general
and administrative expenses, which were offset by gross profit.
Loss from continuing operations for the years ended June 30, 2003 was
$3,835,594. This loss resulted primarily from non-cash charges for the
compensatory element of stock issuances of $2,051,822 and from selling, general
and administrative expenses, which were offset to a small extent by gross
profit.
As reported on our current report on Form 8-K/A filed with the SEC on
September 13, 2004, operating income for EOIR for the years ended December 31,
2003 and December 31, 2002 was $3,201,203 and $1,810,572, respectively. This
income was primarily derived from sales under our Omnibus Contract with the
United States Army Night Vision and Electronic Sensors Directorate. Although
these sales are highly concentrated in a single customer, we expect these sales
to continue and do not anticipate a reduction in orders. On a pro forma basis
combining Markland (including our STR subsidiary) and EOIR, loss from operations
for the period ended June 30, 2004 was $7,796,000.
GAIN FROM DISCONTINUED OPERATIONS.
Gain from discontinued operations for the year ended June 30, 2003 was
$998,713. This resulted from the settlement of certain liabilities and
obligations previously recorded in connection with the discontinued operations.
There was no adjustment due to discontinued operations for the year ended June
30, 2004.
31
NET LOSS:
Net loss for the year ended June 30, 2004 was $10,511,213 ($1.31 per
share). Net loss for the year ended June 30, 2003 was $2,836,881 ($1.72 per
share).
As reported on our current report on Form 8-K/A filed with the SEC on
September 13, 2004, net income for EOIR for the years ended December 31, 2003
and December 31, 2002 was $3,165,346 and $1,791,829, respectively. On a pro
forma basis combining Markland (including our STR subsidiary) and EOIR, net loss
for the period ended June 30, 2004 was $13,465,000.
PREFERRED STOCK DIVIDENDS:
Preferred Stock dividends for the year ended June 30, 2004 were
$4,584,248. This consisted of deemed dividends to the holder of our Series C
Preferred Stock of $844,270, deemed dividends to the holder of our Series D
Preferred Stock of $3,555,500, and actual dividends paid upon conversion to
common stock to the holder of our Series C Preferred Stock of $184,478. Deemed
dividends represent non-cash charges for $4,584,248.
Preferred Stock dividends for the year ended June 30, 2003 were
$4,761,971. This consisted of deemed dividends to the holder of our Series C
Preferred Stock of $501,755, deemed dividends to the holder of our Series D
Preferred Stock of $4,107,500, and actual dividends paid upon conversion to
common stock to the holder of our Series C Preferred Stock of $152,716. Deemed
dividends represent non-cash charges for $4,761,971.
We expect to continue to finance our operations with additional debt
and equity financing including, possibly, additional sales of our Series D
Preferred Stock with beneficial conversion features. Such financing could result
in additional charges for preferred stock dividends.
NET LOSS APPLICABLE TO COMMON STOCKHOLDERS:
Net loss applicable to common stockholders for the year ended June 30,
2004 was $15,095,461 ($1.39 per share). Net loss applicable to common
stockholders for the year ended June 30 2003 was $7,598,852 ($1.52 per share).
On a pro forma basis combining Markland (including our STR subsidiary) and EOIR,
net loss per common share for the year ended June 30, 2004 was $(1.20).
LIQUIDITY AND CAPITAL RESOURCES
During fiscal 2004, we experienced $3,906,900 of negative cash flow
from operating activities. This negative cash flow was the result of a loss of
10,511,213 from continuing operations offset by non-cash charges of $6,377,936
and working capital requirements of $226,377. In addition, we experienced
$8,538,386 of negative cash flow from investing activities. These investment
activities consisted of cash used primarily for the acquisition of EOIR. Cash
flows from financing activities for the year ended June 30, 2004 approximated
$13,540,909.
On June 29, 2004, we acquired all of the outstanding stock of EOIR for
$8,000,000 in cash and $11,000,000 in principal amount of five year notes
secured by the assets and stock of EOIR. These notes bear interest at the rate
of six (6%) percent per annum and must be repaid within the next five years. The
carrying value of these notes is $$9,532,044 at June 30, 2004. We expect
significant increases in interest expense as a result of this financing.
We financed our operations and acquisition activities primarily through
sales of common stock and preferred stock as well as through margins from sales
of our products and services. During fiscal 2004, we raised $8,226,845 from
sales of our common stock, and $5,401,970 from sales of our Series D Preferred
Stock.
During fiscal 2003, we experienced $764,550 of negative cash flow from
operating activities. This negative cash flow was the result of a loss from
continuing operations of approximately $3,836,000 mitigated by non-cash charges
of approximately $2,160,000 and increases in accounts payable and other
liabilities of approximately $940,000. In addition, we experienced $191,900 of
negative cash flow from investing activities. These investment activities
consisted of payments made in connection with our acquisition of Ergo and
technology from ASI Technology Corporation. Cash flows from financing activities
for the year ended June 30, 2003 approximated $957,000. We financed our
operations and acquisition activities primarily through sales of common stock
and preferred stock as well as through margins from sales of our products and
services. During fiscal 2003, we raised $340,000 from sales of our common stock,
$170,000 from sales of our Series C Preferred Stock, and $430,000 from sales of
our Series D Preferred Stock.
32
On September 21, 2004, we sold secured convertible promissory notes for
the aggregate consideration of $4,000,000 and in the aggregate principal amount
of $5,200,000. These notes accrue interest at the rate of eight (8%) per annum
and are due and payable within one year.
We believe that required investment capital will be available to us,
but there can be no assurance that we will be able to raise funds on terms
acceptable to us, or at all. We have the ability to adjust the level of research
and development and selling and administrative expenses to some extent based on
the availability of resources. However, reductions in expenditures could delay
development and adversely affect our ability to generate future revenues.
Any equity-based source of additional funds could be dilutive to
existing equity holders and the dilution could be material. The lack of
sufficient funds from operations or additional capital could force us to curtail
or scale back operations and would therefore have an adverse effect on our
business. Other than cash and cash equivalents, we have no unused sources of
liquidity at this time. We expect to incur additional operating losses as a
result of expenditures for research and development and marketing costs for our
security products and technologies. The timing and amounts of these expenditures
and the extent of our operating losses will depend on many factors, some of
which are beyond our control. Accordingly, there can be no assurance that our
current expectations regarding required financial resources will prove to be
accurate. We anticipate that the commercialization of our technologies may
require increased operating costs; however, we cannot currently estimate the
amounts of these costs.
GOING CONCERN
For the fiscal year ended June 30, 2004, we incurred a loss from
continuing operations of $10,511,213 and had a working capital deficiency of
$2,740,722.
For the fiscal year ended June 30, 2003, we incurred a loss from
continuing operations of $3,835,594 and had a working capital deficiency of
$1,235,306.
We have limited finances and require additional funding in order to
market and license our products. There is no assurance that we can reverse our
operating losses, or that we can raise additional capital to allow us to
continue our planned operations. These factors raise substantial doubt about our
ability to continue as a going concern.
The report of our independent registered public accounting firm for the
fiscal year 2004 included elsewhere in this annual report includes an
explanatory paragraph as to the uncertainty that we will continue as a going
concern. While we have experienced operating losses in the past, due to our
acquisition of EOIR, the operating portion of our business is currently cash
flow positive. Our business plan is to continue to grow our customer base and
our revenues and to control and monitor operating expenses and capital
expenditures. In addition, after the conclusion of the 2004 fiscal year, we
consummated a financing through which we realized net cash of approximately
$4,000,000. We believe that our business as currently constituted will produce
positive cash flow which, together with our current cash levels, will enable us
to meet our existing financial obligations as they come due during the current
fiscal year. However, we can provide no assurance that the performance of our
business will meet our expectations.
OFF-BALANCE SHEET ARRANGEMENTS
We have no significant off-balance sheet arrangements that have or are
reasonably likely to have a current or future effect on our financial condition,
changes in financial condition, revenues or expenses, results of operations,
liquidity, capital expenditures or capital resources that is material to
stockholders.
EFFECT OF INFLATION AND CHANGES IN PRICES
Management does not believe that inflation and changes in price will
have a material effect on operations.
33
CRITICAL ACCOUNTING POLICIES
The preparation of Markland's financial statements and related
disclosures in conformity with accounting principles generally accepted in the
United States of America requires management to make estimates and assumptions
that affect the reported amounts of assets and liabilities, and the disclosure
of contingent assets and liabilities as of the date of the financial statements
and the amounts of revenues and expenses recorded during the reporting periods.
We base our estimates on historical experience, where applicable, and other
assumptions that we believe are reasonable under the circumstances. Actual
results may differ from our estimates under different assumptions or conditions.
The sections below present information about the nature of and
rationale for our critical accounting policies.
PRINCIPLES OF CONSOLIDATION
Our consolidated financial statements include the accounts of Markland
and its wholly-owned subsidiaries, Security Technology, Inc., Ergo Systems,
Inc., Science and Technology Research Corporation, Inc. and E-OIR Technologies,
Inc. We have eliminated all significant inter-company balances and transactions.
CONCENTRATIONS
Statement of Financial Accounting Standards ("SFAS") No. 105,
"Disclosure of Information about Financial Instruments With Off-Balance-Sheet
Risk and Financial Instruments with Concentrations of Credit Risk," requires
that we disclose any significant off-balance-sheet and credit risk
concentrations. We are subject to concentrations of credit risk because the
majority of our revenues and accounts receivable are derived from the US Navy,
Computer Science Corporation and The Department of Homeland Security, none of
whom is required to provide collateral for amounts owed to us. We do not believe
that we are subject to any unusual credit risks, other than the normal level of
risk attendant to operating our business.
As of June 30, 2004, we had cash balances in banks in excess of the
maximum amount insured by the FDIC as of June 30, 2004. In addition, we derive
substantially all of our contract revenue from contracts with Federal government
agencies. Consequently, substantially all of our accounts receivable are due
from Federal government agencies either directly or through other government
contractors.
RESEARCH AND DEVELOPMENT
We charge research and development costs to expense as incurred. We
capitalize costs related to acquired technologies that have achieved
technological feasibility and have alternative uses. We expense as research and
development costs the technologies we acquire if they are in process at the date
of acquisition or have no alternative uses.
IMPAIRMENT OF GOODWILL AND AMORTIZABLE INTANGIBLES
In accordance with SFAS No. 142, "Goodwill and Other Intangible
Assets," we review goodwill for impairment annually, or more frequently if an
event occurs or circumstances change that would more likely than not reduce the
fair value of our business enterprise below its carrying value. The impairment
test requires us to estimate the fair value of our overall business enterprise
down to the reporting unit level. We estimate fair value using both a discounted
cash flows model, as well as an approach using market comparables, both of which
are weighted equally to determine fair value. Under the discounted cash flows
method, we utilize estimated long-term revenue and cash flows forecasts
developed as part of our planning process, as well as assumptions of terminal
value, together with an applicable discount rate, to determine fair value. Under
the market approach, fair value is determined by comparing us to similar
businesses (or guideline companies). Selection of guideline companies and market
ratios require management's judgment. The use of different assumptions within
our discounted cash flows model or within our market approach model when
determining fair value could result in different valuations for goodwill.
ESTIMATED USEFUL LIVES OF AMORTIZABLE INTANGIBLE ASSETS
We amortize our amortizable intangible assets over the shorter of the
contractual/legal life or the estimated economic life. We are amortizing the
intangible assets acquired as of a result of the Ergo and ASI acquisitions over
a three-year life commencing with the date of acquisition. With respect to the
Science & Technology Research, Inc. and EOIR Technologies, Inc. acquisitions,
consistent with independent business valuations, we are amortizing the
intangible assets or ten years and nine years respectively.
34
IMPAIRMENT OF LONG-LIVED ASSETS
Pursuant to SFAS No. 144, we continually monitor events and changes in
circumstances that could indicate carrying amounts of long-lived assets may not
be recoverable. We recognize an impairment loss when the carrying value of an
asset exceeds expected cash flows. Accordingly, when indicators or impairment of
assets are present, we evaluate the carrying value of such assets in relation to
the operating performance and future undiscounted cash flows of the underlying
business. Our policy is to record an impairment loss when we determine that the
carrying amount of the asset may not be recoverable. No impairment charges were
recorded in the years ended June 30, 2004 and 2003.
REVENUE RECOGNITION
We recognize revenue when the following criteria are met: (1) we have
persuasive evidence of an arrangement, such as agreements, purchase orders or
written requests; (2) we have completed delivery and no significant obligations
remain, (3) our price to our customer is fixed or determinable, and (4)
collection is probable. We recognize revenues at the time we perform services
related to border security logistic support. With respect to our revenues from
our chemical detectors, we recognize revenue under the units-of-delivery method.
At the time the units are shipped to the warehouse of the United States Navy,
the Company recognizes as revenues the contract price of each unit and
recognizes the applicable cost of each unit shipped. As of June 30, 2004, we had
completed delivery pursuant to all outstanding orders under this contract.
IMPACT OF RECENTLY ISSUED ACCOUNTING STANDARDS
In December 2003, the FASB issues FASB Interpretation No. 46R ("FIN
46R"), "Consolidation of Variable Interest Entities". FIN 46R expands upon
existing accounting guidance that addresses when a company should include in its
financial statements the assets, liabilities and activities of another entity. A
variable interest entity is a corporation, partnership, trust or any other legal
structure used for business purposes that either (a) does not have equity
investors with voting rights or (b) has equity investors that do not provide
sufficient financial resources for the entity to support its activities. FIN 46R
requires a variable interest entity to be consolidated by a company if that
company is subject to a majority of the risk of loss from the variable interest
entity's activities or is entitled to receive a majority of the entity's
residual returns or both. The adoption of this interpretation did not have any
impact on our financial position or results of operations.
In May 2003, the FASB issued SFAS No. 150, "Accounting for Certain
Financial Instruments with Characteristics of both Liabilities and Equity." This
statement establishes standards for how an issuer classifies and measures
certain financial instruments with characteristics of both liabilities and
equity. It requires that an issuer classify a financial instrument that is
within its scope as a liability. Many of those instruments were previously
classified as equity. SFAS No. 150 is effective for financial instruments
entered into or modified after May 31, 2003, and otherwise is effective at the
beginning of the first interim period beginning after June 15, 2003. The
adoption of this statement did not have any impact on our financial position or
results of operations.
CHANGES IN ACCOUNTANTS
On July 7, 2004, our Board of Directors determined not to retain Marcum
& Kliegman LLP as our independent registered public accounting firm, as reported
in our current report on Form 8-K filed on July 13, 2004 (File # 000-28863), as
amended from time to time. The audit report of Marcum & Kliegman LLP on our
consolidated financial statements for fiscal year ended June 30, 2003 did not
contain any adverse opinion or disclaimer of opinion, and was not qualified or
modified as to uncertainty, audit scope or accounting principles. However, the
report included an explanatory paragraph wherein Marcum & Kliegman LLP expressed
substantial doubt about our ability to continue as a going concern.
In connection with the audits of the year ended June 30, 2003 and
during the subsequent interim period through July 7, 2004, we did not have any
disagreement with Marcum & Kliegman LLP on any matter of accounting principles
or practices, financial statement disclosure or auditing scope or procedure,
which if not resolved to the satisfaction of Marcum & Kliegman LLP, would have
caused them to make reference to the subject matter of the disagreement in
connection with their reports on our consolidated financial statements.
On July 7, 2004, we engaged Wolf & Company, P.C., an independent
registered public accounting firm. During the years ended June 30, 2004 and 2003
and the subsequent interim period through July 7, 2004, we did not consult with
Wolf & Company, P.C. regarding either the application of accounting principles
to a specified transaction, the type of audit opinion that might be rendered on
our consolidated financial statements, or any matter that was the subject of a
disagreement or reportable event with Marcum & Kliegman LLP.
35
BUSINESS
Markland Technologies, Inc. ("Markland", the "Company" or "we") is an
integrated homeland security and defense company incorporated under the laws of
the State of Florida.
WHO WE ARE
We are the successor to a variety of businesses dating back to 1995.
Our business, as it exists today, consists of four business areas:
o sensor systems for military and intelligence applications;
o chemical detectors;
o border security systems; and
o advanced technologies.
We provide to the United States Department of Defense ("DOD") and to
various other United States Intelligence Agencies ("INTEL"); remote sensing
technology products, and services to protect our country's military personnel
and infrastructure assets. We also provide to the Department of Homeland
Security ("Homeland Security"); products, services and emerging technologies to
protect our country's borders, infrastructure assets and personnel. Our mission
is to build world-class integrated solutions for the Homeland Security, DOD and
INTEL marketplaces via expansion of our existing contracts, development of our
emerging technologies and acquisition of synergistic revenue producing assets.
Prior to the acquisition of E-OIR Technologies, Inc. ("EOIR"), our
primary sources of operating revenue were sales of our automatic chemical agent
detection and alarm system, border security logistics products and services, and
Small Business Investment Research ("SBIR") funded research grants for the
development of gas plasma antenna technology.
As result of the acquisition of EOIR, now a wholly-owned subsidiary of
Markland, our primary sources of operating revenues will be the sales of remote
sensing technology products and services to the United States Department of
Defense and to various other United States Intelligence Agencies. We expect that
our remote sensing technology products and services will continue to be our most
significant revenue-producing business areas going forward.
Our strategy is to grow through organic means via increased acceptance
by our customers of our present products and services offerings and also via
synergistic acquisitions of assets that provide products or services to Homeland
Security, DOD, or INTEL.
BUSINESS HISTORY
Markland Technologies, Inc. is the successor to A. P. Sales Inc., a
corporation incorporated in Colorado in 1995. In December 1998, A. P. Sales was
dissolved as a Colorado corporation and re-domiciled in Florida under the name
Quest Net Corporation ("Quest Net"). In March 2000, Quest Net acquired CWTel,
Inc., a Florida corporation ("CWTel"). CWTel filed a voluntary bankruptcy
petition in November 2001 and was issued a final decree in March 2002. In March
2001, Quest Net acquired all of the outstanding stock of Vidikron of America,
Inc., a Delaware corporation ("Vidikron"). As a result, Vidikron's sole
stockholder, Market LLC, a Cayman Islands limited liability company, became
Quest Net's majority stockholder and Vidikron became a wholly-owned subsidiary
of Quest Net. Quest Net subsequently changed its name to Markland Technologies,
Inc. In order to cure a default in our obligations to Market LLC, we transferred
all of our interest in Vidikron to Market LLC in June 2002. As a result, at the
end of fiscal 2002, we had no active business operations.
In December of 2002, we entered into a transaction with Eurotech, Ltd.,
ipPartners, Inc., Market LLC, and James LLC. Pursuant to this transaction the
following took place:
o We formed a subsidiary corporation called Security Technology,
Inc.
o Eurotech transferred certain rights to its acoustic core
technology relating to illicit material detection to our
subsidiary.
o Crypto.com Inc. (a subsidiary of Eurotech) and ipPartners
transferred certain rights to their cryptology technologies to
our subsidiary.
36
o 90% of the shares of our common stock held by Market LLC and
James LLC were retired.
o We issued 80% of our then issued and outstanding common stock
to Eurotech and shares of common stock representing 10% of our
then issued and outstanding shares of common stock to
ipPartners.
o We issued $5,225,000 in stated value of our Series C 5%
Cumulative Convertible Preferred Stock to Market LLC and James
LLC in satisfaction of $5,225,000 of convertible notes held by
Market LLC and James LLC and in exchange for their agreement
to surrender 4,498,638 shares of our common stock.
In January 2003, we acquired all the common stock of Ergo Systems,
Inc., a company in the business of providing border security logistic support
and product development services to the U.S. government. Ergo Systems Inc. has a
contract with the Department of Homeland Security to maintain, integrate and
implement design enhancements to border security systems. In consideration for
this acquisition we agreed to pay $400,000 in cash, payable at certain
milestones which are related to research efforts.
In March 2003, we entered into an agreement to acquire the intellectual
property (including patents), equipment, and government contracts for certain
gas plasma antenna technology from ASI Technology Corporation. We closed this
transaction in September 2003. We paid a purchase price of $150,000 in cash and
283,333 shares of our common stock valued at $850,000.
In October of 2003, we acquired all of the common stock of Science and
Technology Research Corporation, Inc. This company is the producer of the U.S.
Navy's Shipboard Automatic Chemical Agent Detection and Alarm System. In
consideration for this acquisition, we issued 1,539,779 shares of common stock
valued at $5,100,000, paid $900,000 in cash and issued a promissory note for
$375,000. We also entered into a consulting agreement with the former principal
shareholder and employee.
On June 29, 2004, we acquired all of the outstanding stock of EOIR for
$8,000,000 in cash and $11,000,000 in principal amount of five-year notes
secured by the assets and stock of EOIR. EOIR is a provider of technology and
services to the United States Army Night Vision and Electronic Sensors
Directorate, as well as other United States Department of Defense and
Intelligence Agencies. It has significant expertise in wide-area remote sensing
using both electro-optic and infrared technologies. Markland intends to continue
to use the assets of EOIR for this purpose and to also broaden its product base
and offerings to the Department of Homeland Security. Markland will combine
certain EOIR technology assets in the areas of chemical detection with those of
its other operating subsidiary Science and Technology Research Inc. to provide a
more complete integrated product line offering for both "stand off" and "point"
chemical detection systems. EOIR will represents a vast majority of Markland's
revenues as we expect that EOIR will continue to be our most significant revenue
producing business area in the next fiscal year.
GENERAL DESCRIPTION OF OUR BUSINESS
We classify our business into the following areas:
o remote sensor systems for military and intelligence
applications;
o chemical detection;
o border security; and
o advanced technologies.
REMOTE SENSOR SYSTEMS FOR MILITARY AND INTELLIGENCE APPLICATIONS
Our acquisition of EOIR, a company which provides remote sensing
technology products and services to the United States Department of Defense and
to various other United States Intelligence Agencies, is an important part of
our ongoing business strategy of creating a world-class integrated portfolio of
solutions for the Homeland Security, DOD and INTEL marketplaces.
EOIR offers products and services which include; (i) design and
fabrication of customized remote sensor systems and platforms for DOD, INTEL and
Homeland Security applications; (ii) remote sensor data collection, data signal
processing and data exploitation; and (iii) training in the use of remote sensor
systems and data. These efforts involve systems engineering, system integration,
prototyping, manufacturing and field data collections as well as data analysis
and processing.
37
EOIR's most significant source of revenues is an Omnibus Contract with
the United States Army Night Vision and Electronic Sensors Directorate.
Approximately 86% of EOIR revenues for the fiscal year ended December 31, 2003,
were derived from this contract. The Omnibus Contract has an extensive and
varied scope that requires us to provide a very broad range of products and
technical services. For those products and technical services that EOIR does not
possess in-house, we subcontract to our team members and other subcontractors as
necessary.
EOIR intellectual property lies in patents pending, trade secrets and
the experience and capabilities of its technical staff whom support these
research programs. We protect EOIR intellectual property and our competitive
position via patent applications, trade secrets, and non-compete agreements with
our employees.
CHEMICAL DETECTORS
In October 2003, our subsidiary, Security Technology, Inc., acquired
all of the common stock of Science and Technology Research, Inc., a chemical
detector manufacturer, as part of our ongoing business strategy of creating an
integrated portfolio of homeland security solutions.
We have a contract with the U.S. Navy to be the sole producer of the
U.S. Navy's shipboard Automatic Chemical Agent Detection and Alarm System used
to detect all classic nerve and blister agents as well as other chemical warfare
agent vapors. During fiscal year 2004, our subsidiary STR recognized
approximately $4,796,715 of revenue from this contract. As of June 30, 2004, we
had delivered all the units requested to date under this existing contract. At
the option of the US Navy additional units may be purchased by the US Navy or
other government agencies under this contract in the future.
We recently entered into an international distribution agreement with
Tradeways, Ltd, to market and sell Markland's Shipboard ACADA chemical detection
systems to foreign militaries to market our product in Argentina, Australia,
Austria, Bahrain, Canada, Chile, Croatia, Denmark, Egypt, Estonia, Finland,
Greece, Ireland, Israel, Italy, Japan, Jordan, Korea, Kuwait, Malaysia, The
Netherlands, New Zealand, Norway, Oman, Pakistan, Portugal, Qatar, Saudi Arabia,
Spain, Sweden, Taiwan, Turkey, and the United Arab Emirates. To date, we have
not sold any products through this channel.
We are presently working on the design of a next generation "point"
chemical detector product, which will also operate using Ion Mobility
Spectrography ("IMS") cell technology and provide networked wireless
communication capability.
On December 23, 2003, the U.S. Navy signed a ten-year non-exclusive
license agreement with us to transfer certain chemical detection technology
intellectual property rights to us. We believe the license will allow us to
further expand the applications for the "point" chemical detection technology
and market the technology to non-defense customers such as foreign governments
and commercial entities. We expect to continue to manufacture the Automatic
Chemical Agent Detection and Alarm System for the U.S. Navy and simultaneously
pursue opportunities with the Department of Homeland Security as well as foreign
military sales. We are experiencing a decline in demand for our chemical
detector unit from the U.S. Navy. We plan to compensate for this reduced demand
by marketing this technology to new customers within the Homeland Security
marketplace and by combining it with other technologies for sale to existing
customers. In the interim, we are combining "stand off" chemical detection
technologies from EOIR which are based on hyper spectral infra red technology
with the "point" chemical detection technology of STR which is based on Ion
Mobility Spectroscopy. This integrated and combined chemical detection
capability we believe will accelerate penetration into new markets for the
chemical detection products we now offer and help to increase revenues in the
next fiscal year for chemical detection products.
BORDER SECURITY
We acquired the assets of Ergo Systems, Inc., in January 2003. This
acquisition provided us with contracts with the Department of Homeland Security
to maintain, integrate, and implement design enhancements to border security
systems installed at U.S. ports of entry for the Dedicated Commuter Lane, which
is part of a larger U.S. Customs and Immigration and Naturalization Service
initiative to reduce wait times, improve data accuracy, and improve overall
efficiencies at all border crossings for both freight and passengers.
38
The Dedicated Commuter Lane (DCL) integrates several important security
checks. It employs automatic vehicle identification technology, which allows
participants to pass through the border crossing more efficiently than without
automatic screening. Participants run a card through a swipe card reader, which
instantaneously sends patron information, including a photograph, to the
inspector's screen for clearance. The gate rises and allows the patron through.
The whole process takes about 30 seconds. The Dedicated Commuter Lane software
also controls a variety of security subsystems, including video surveillance,
gates, and tire shredders.
In conjunction with the DCL maintenance contract awarded by the
Department of Homeland Security we were also awarded a contract by Computer
Sciences Corporation to perform border maintenance services in multiple ports of
entry in the southern United States. During fiscal year 2004, our subsidiary
Ergo Systems recognized approximately $955,736 of revenue from these contracts.
During the fiscal year we also entered into a teaming agreement with
Accenture, who was recently awarded the US VISIT contract. The purpose of this
contract is to secure our borders and expedite the entry/exit process while
enhancing the integrity of our immigration system and respecting the privacy of
visitors to the United States. We have recently been awarded a subcontract which
enables the company to derive revenues from the USVISIT contract. Potential
revenue amounts from this subcontract are as yet undetermined.
Our subcontract for the US VISIT program is part of a larger Department
of Homeland Security initiative to increase security, reduce wait times, improve
data accuracy, and improve overall efficiencies at all border crossings for both
freight and passengers by creating and implementing a "trusted traveler" concept
of traffic flow. The "trusted traveler" concept is designed for frequent border
crossers who are willing to undergo a background check and travel under certain
restrictions in exchange for the use of a commuter lane. This dedicated commuter
lane substantially decreases the amount of time it takes to drive through the
border. We believe that our experience in integrating solutions will be
attractive to the Department of Homeland Security as it confronts the various
issues of protecting our borders although there can be no assurances that the
trusted traveler concept will result in an increase in sales or revenues.
ADVANCED TECHNOLOGIES
Through research and development as well as intellectual property
acquisitions, we have established a portfolio of advanced and emerging
technologies, which we intend to commercialize and utilize within our own
proprietary products or license out for the purpose of revenue generation. These
advanced technologies and intellectual property are as follows:
o Gas plasma antenna,
o Vehicle stopping system,
o Acoustic Core(TM) signature analysis,
o APTIS(TM) human screening portal, and
o Cryptography software.
GAS PLASMA ANTENNA: We acquired gas plasma antenna technology assets
and a sub-license for plasma sterilization and decontamination from ASI
Technology Corporation in September 2003. The assets at time of purchase
included three ongoing funded SBIR government contracts and nine issued and
pending U.S. patents related to gas plasma antenna technology with demonstrated
applications in the fields of ballistic missile defense, phased array radar, and
forward deployed decontamination.
A plasma antenna's performance equals that of a metal antenna, but the
gas plasma antenna is lighter. These antennae can be used for any purpose for
which a metal antenna is used. A gas plasma antenna weighs substantially less
than metal antennas of comparable performance. When a plasma antenna is turned
off, it is transparent, immune to electronic countermeasures and allows other
adjacent antennas to transmit or receive without interference.
Plasma antenna technology employs ionized gas enclosed in a tube (or
other enclosure) as the conducting element of an antenna. This is a fundamental
change from traditional antenna design that generally employs solid metal wires
as the conducting element. Ionized gas is an efficient conducting element with a
number of important advantages over wire. Since the gas is ionized only for the
time of transmission or reception, "ringing" and associated effects of solid
wire antenna design are eliminated. The design allows for extremely short
pulses, a feature important to many forms of digital communication and radars.
The design further provides the opportunity to construct an antenna that can be
compact and dynamically reconfigured for frequency, direction, bandwidth, gain
and beam width. We believe plasma antenna technology will enable the design of
antennas that are more efficient, lower in weight and smaller in size than
traditional solid wire antennas.
39
We believe our plasma antenna offers numerous advantages over
traditional wire antennas including stealth for military applications and higher
digital performance in commercial applications. We cannot predict when these
products will be ready for commercial or military use.
Our gas plasma research team has been awarded US patent # 6,710,746 for
a gas plasma antenna element demonstrating reconfigurable length. The
development of this technology has been funded to date through grants from the
US Navy and Army.
US patent #6,710,746, which has SBIR origins, relates to plasma
antennas having re-configurable length, beam width, and bandwidth.
Traditionally, antennas have been defined as metallic devices for radiating or
receiving radio waves, or as a conducting wire which is sized to emit radiation
at one or more selected frequencies. As a result, the paradigm for antenna
design has heretofore been focused on antenna geometry and physical dimensions.
We believe that our gas plasma antenna design will result in antennas with
greater flexibility and security than conventional antennas. During fiscal year
2004, funded gas plasma SBIR contracts provided approximately $261,479 in
contract revenues. Presently we do not have any purchase commitments for this
technology.
VEHICLE STOPPING SYSTEM: Under a funded government contract, we
developed a vehicle stopping system to address the increasing risks of
unauthorized and illegal entry into the U.S. Our vehicle stopping system is
designed to safely capture vehicles that are trying to gain entry without
authorization. Our vehicle stopping system consists of a net, buried beneath the
road, which will spring up when a car or truck attempts to speed across the
border illegally. The net is attached to two spindles that unwind with
increasing tension as the illegal car is trapped. Our Vehicle Stopping System is
capable of stopping a vehicle attempting to gain illegal entry at speeds in
excess of 65 miles per hour and without personal injury to occupants or U.S.
government border personnel. The vehicle stopping system was successfully tested
in June 2003 at the San Ysidro, California port of entry. Presently we do not
have any purchase commitments for this system.
ACOUSTIC CORE(TM): We acquired rights to the Acoustic Core(TM)
technology, as it related to illicit material detection, from Eurotech, Ltd. in
December 2002. The Acoustic Core(TM) technology utilizes acoustics sensing and
signature analysis technologies to detect a variety of materials.
Acoustic Core(TM) is a non-intrusive acoustic remote sensing
technology, which exhibits the potential for the automated detection of a large
variety of potentially harmful materials such as C4, plastic flare guns, and
ceramics. This technology is capable of computerized automatic screening of
containers, vehicles and humans. It can detect a broad range of illegal
materials even if the materials are moving at a high rate of speed, with low
false alarm rates, and it utilizes low frequency acoustic energy, which is safe
for humans. This speed and accuracy makes the technology suitable for primary
screening applications where large volumes of containers or humans need to be
screened quickly and accurately, such as in an airport or at a border crossing.
The product of almost a decade of intensive laboratory and field
research, we believe the Acoustic Core(TM) technology has the potential to enter
the security marketplace to fill high-priority homeland security needs. Because
Acoustic Core(TM) technology can utilize the independent acoustic signatures of
various materials, products can be developed and programmed to detect a large
array of harmful substances, including explosives, and bio-hazardous and
radioactive compounds.
We believe that the Acoustic Core(TM) technology can screen large
containers while they are in motion, such as during transport via truck or
railcar. Primary screening of containers in this manner allows for segregation
of suspicious containers for secondary screening by a handheld version of the
remote sensing products.
We completed a project with the U.S. Air Force through a Co-Operative
Research and Development Agreement which used our proprietary Acoustic Core(TM)
technology to inspect cargo. While this contract did not generate revenue for
us, we expect to develop the technology for use in commercially viable products.
However, we cannot predict when these products will be ready for commercial or
military use. Presently we do not have any purchase commitments for this
technology.
40
APTIS(TM): We are involved in the design and testing of APTIS(TM), an
acoustic screening portal intended to facilitate screening of humans for
concealed metallic and non-metallic weapons such as ceramic knives and plastic
guns and explosives. The technology is very flexible and can be incorporated
into existing entry portal systems such as metal detectors, eliminating the need
to replace these systems used to safely screen humans for explosives. Although
we continue to develop this prototype, we cannot predict when it will be ready
for commercial use. Presently we do not have any purchase commitments for this
system.
COMPETITION
The markets for our products and solutions are extremely competitive
and are characterized by rapid technological change as a result of technical
developments exploited by competitors, the changing technical needs of the
customers, and frequent introductions of new features. We expect competition to
increase as other companies introduce products that are competitively priced,
that may have increased performance or functionality, or that incorporate
technological advances not yet developed or implemented by us. Some of our
present and potential competitors may have financial, marketing, and research
resources substantially greater than ours. In order to compete effectively in
this environment, we must continually develop and market new and enhanced
products at competitive prices, and have the resources to invest in significant
research and development activities. There is a risk that we may not be able to
make the technological advances necessary to compete successfully. Existing and
new competitors may enter or expand their efforts in our markets, or develop new
products to compete against ours. Our competitors may develop new technologies
or enhancements to existing products or introduce new products that will offer
superior price or performance features. New products or technologies may render
our products obsolete. Many of our primary competitors are well established
companies that have substantially greater financial, managerial, technical,
marketing, personnel and other resources than we do.
We have certain proprietary technologies, some of which have been
developed, and others that are in development. We will focus on our proprietary
technologies, or leverage our management experience, in order to differentiate
ourselves from these organizations. There are many other technologies being
presented to the Department of Homeland Security that directly compete with our
technologies. The Department of Homeland Security may pursue solutions different
from ours.
INTELLECTUAL PROPERTY
Our ability to compete effectively depends to a significant extent on
our ability to protect our proprietary information. We rely primarily on patents
and trade secret laws, confidentiality procedures and licensing arrangements to
protect our intellectual property rights. We own multiple U.S. and foreign
patents. We enter into confidentiality agreements with our consultants and key
employees, and maintain controls over access to and distribution of our
technology, software and other proprietary information. The steps we have taken
to protect our technology may be inadequate to prevent others from using what we
regard as our technology to compete with us.
We do not generally conduct exhaustive patent searches to determine
whether the technology used in our products infringes patents held by third
parties. In addition, product development is inherently uncertain in a rapidly
evolving technological environment in which there may be numerous patent
applications pending, many of which are confidential when filed, with regard to
similar technologies.
We may face claims by third parties that our products or technology
infringe their patents or other intellectual property rights in the future. Any
claim of infringement could cause us to incur substantial costs defending
against the claim, even if the claim is invalid, and could distract the
attention of our management. If any of our products are found to violate
third-party proprietary rights, we may be required to pay substantial damages.
In addition, we may be required to re-engineer our products or seek to obtain
licenses from third parties to continue to offer our products. Any efforts to
re-engineer our products or obtain licenses on commercially reasonable terms may
not be successful, which would prevent us from selling our products, and, in any
case, could substantially increase our costs and have a material adverse effect
on our business, financial condition and results of operations.
41
EOIR provides engineers and scientists to perform research at
Government research Laboratories. However, research performed in these
Government laboratories is paid for with Government funds and is typically the
property of the US Government. This intellectual property may be utilized via
licensing agreements executed with the US Government, but there are no
guarantees that the US Government will provide such licenses.
RESEARCH AND DEVELOPMENT
During the fiscal years ended June 30, 2003 and June 30, 2004, we spent
$522,657 and $49,289 on research and development respectively. During the fiscal
year ended June 30, 2004, we reduced our research and development efforts to
concentrate our financial resources on product marketing activities and as a
result of completion of funded SBIR contracts.
Our research and development activities consist of projects funded
entirely by us or with the assistance of SBIR grants, and SBIR projects are
generally directed towards the discovery of specific information requested by
the government research sponsor.
In addition, our subsidiary EOIR is permitted to charge and recover a
certain percentage of its administrative budget on Internal Research and
Development programs. These programs are generally short in duration and may
yield new processes or techniques that will advance our technical knowledge on
our Government programs.
We believe that focused investments in research and development are
critical to our future growth and competitive position in the marketplace. Our
research and development efforts are directed to timely development of new and
enhanced products that are central to our business strategy. The industries in
which we compete are subject to rapid technological developments, evolving
industry standards, changes in customer requirements, and new product
introductions and enhancements. As a result, our success depends in part upon
our ability to enhance our existing products, develop and introduce new products
that improve performance on a cost effective and timely basis. We may be unable
to successfully develop products to address new customer requirements or
technological changes, and any products we develop may not achieve market
acceptance.
DEPENDENCE ON U.S. GOVERNMENT CONTRACTS
We offer substantially all of our entire range of our services and
products to agencies of the U.S. Government. In both fiscal years 2004 and 2003,
100% of our revenue came from U.S. Government prime or subcontracts.
Although we are continuously working to diversify our client base, we
will continue to aggressively seek additional work from the US Government. As
with other government contractors, our business is subject to government client
funding decisions and actions that are beyond our control.
Much of our business is won through submission of formal competitive
bids. Commercial bids are frequently negotiated as to terms and conditions for
schedule, specifications, delivery and payment. With respect to bids for
government work, however, in most cases the client specifies the terms and
conditions and form of contract.
Essentially all contracts with the United States Government, and many
contracts with other government entities, permit the government client to
terminate the contract at any time for the convenience of the government or for
default by the contractor. We operate under the risk that such terminations may
occur and have a material impact on operations.
GOVERNMENT REGULATION
Most of our U.S. Government business is subject to unique procurement
and administrative rules based on both laws and regulations, including the U.S.
Federal Acquisition Regulation that provide various profit and cost controls,
rules for allocations of costs, both direct and indirect, to contracts and
non-reimbursement of unallowable costs such as interest expenses and certain
costs related to business acquisitions, including for example the incremental
depreciation and amortization expenses arising from fair value increases to the
historical carrying values of acquired assets.
42
Companies supplying defense-related equipment to the U.S. Government
are subject to certain additional business risks specific to the U.S. defense
industry. Among these risks are the ability of the U.S. Government to
unilaterally suspend a company from new contracts pending resolution of alleged
violations of procurement laws or regulations. In addition, U.S. Government
contracts are conditioned upon the continuing availability of Congressional
appropriations. Congress usually appropriates funds for a given program on a
September 30 fiscal year basis, even though contract performance may take
several years. Consequently, at the outset of a major program, the contract is
usually partially funded, and additional monies are normally committed to the
contract by the procuring agency only as appropriations are made by Congress for
future fiscal years.
U.S. Government contracts are, by their terms, subject to unilateral
termination by the U.S. Government either for its convenience or default by the
contractor if the contractor fails to perform the contracts' scope of work. Upon
termination other than for a contractor's default, the contractor will normally
be entitled to reimbursement for allowable costs and an allowance for profit.
Foreign defense contracts generally contain comparable provisions permitting
termination at the convenience of the government. To date, none of our
significant contracts have been terminated.
As is common in the U.S. defense industry, we are subject to business
risks, including changes in the U.S. Government's procurement policies (such as
greater emphasis on competitive procurement), governmental appropriations,
national defense policies or regulations, service modernization plans, and
availability of funds. A reduction in expenditures by the U.S. Government for
products and services of the type we manufacture and provide, lower margins
resulting from increasingly competitive procurement policies, a reduction in the
volume of contracts or subcontracts awarded to us or the incurrence of
substantial contract cost overruns could materially adversely affect our
business.
Certain of our sales are direct commercial sales to foreign
governments. These sales are subject to U.S. Government approval and licensing
under the Arms Export Control Act. Legal restrictions on sales of sensitive U.S.
technology also limit the extent to which we can sell our products to foreign
governments or private parties. Currently we do not have any sales from overseas
customers.
SALES AND MARKETING
We currently divide the marketing efforts of our products and services
into three areas: (1) directly to federal or local government agencies, (2) to
large partners who may represent an opportunity for us as subcontractors, and
(3) to commercial entities. These marketing duties are divided among upper
management.
MANUFACTURING
Our primary manufacturing facilities are located in Fredericksburg, VA
and Providence, RI .We also utilize our offices in Providence, RI as
manufacturing prototype development facilities.
EMPLOYEES
As of September 2004, we employed approximately 191 full-time
employees. We believe our future success will depend upon the continued service
of our key technical and senior management personnel and upon our continued
ability to attract and retain highly qualified technical and managerial
personnel. None of our employees is represented by a labor union. We have never
experienced a work stoppage and consider our relationship with our employees to
be good.
PROPERTY
We have a three year lease for our executive offices of approximately
1,000 square feet located in Ridgefield, Connecticut and a month-to-month lease
for a manufacturing facility of approximately 5,000 square feet located in
Fredericksburg, Virginia. We also have an administrative office in Providence,
RI which is utilized under a monthly sublease comprising approximately 4,000
square feet.
43
EOIR, our wholly owned subsidiary, holds a four-year lease its
executive and administrative offices of approximately 5,420 square feet in
Woodbridge, Virginia. The lease, which has an option to renew for an additional
three-year term, expires on September 30, 2005. EOIR also leases approximately
5,000 square feet in Spotsylvania, Virginia, where it houses its software
development unit. This lease is currently on a month-to-month basis.
We also have several offices located in Fredericksburg, Va. One office
with approximately 4,722 sq ft., with a 1 year lease, one with 1,200 sq ft.,
with a 5 year lease, one with 10,000 sq ft., with a 5 year lease, and one with
4,200 sq ft., with a five year lease. We believe that our present facilities are
adequate to meet our current needs. If new or additional space is required, we
believe that adequate facilities are available at competitive prices. However,
we may not be able to relocate to a new facility without severely disrupting the
production of our goods.
LEGAL PROCEEDINGS
On June 28, 2004, Charles Wainer filed a civil suit against the Company
in Florida state court alleging breach of a stock purchase agreement and breach
of an employment agreement stemming from Wainer's sale of his business to a
predecessor of the Company and his subsequent employment thereat. In the
complaint, Wainer alleges Markland owes him $300,000 cash, some unspecified
portion of $700,000 in stock, some unspecified portion of $86,000 cash for lease
payments, and approximately $20,000 in back-pay. The Company believes that these
claims are without merit and plans to vigorously defend the action. On August
11, 2004, the Company answered the complaint and denied any liability.
On or about September 16, 2004, Joseph R. Moulton, Sr. initiated a
lawsuit in the Circuit Court of Spotsylvania County, Virginia, against the
Company, EOIR, our wholly owned subsidiary, and our Chief Executive Officer and
Director, Robert Tarini. Mr. Moulton was the largest single shareholder of EOIR
prior to its acquisition by the Company, owning approximately 67% of the EOIR
capital stock. Mr. Moulton received approximately $5,863,000 in cash and a
promissory note of EOIR in the approximate principal amount of $6,967,000 for
his shares of EOIR at the closing of the acquisition of EOIR by the Company.
In his complaint Mr. Moulton asserts, among other things, that the
Company breached its obligations under the Stock Purchase Agreement, dated June
29, 2004, pursuant to which the Company acquired EOIR, by terminating Mr.
Moulton's employment with EOIR and removing him from the EOIR board of
directors.
Mr. Moulton is seeking damages allegedly suffered by his loss of
employment, extreme emotional distress, and costs incurred to enforce his
contractual rights. In addition, he is seeking certain other equitable relief
including, the appointment of a receiver to oversee the management of EOIR until
these promissory notes issued to former EOIR shareholders at the closing of the
acquisition are paid in full and a declaratory judgment that the Company's
actions constitute an event of default under these promissory notes allowing for
the acceleration of all amounts (approximately $11,000,000) due thereunder. The
Company is a guarantor of these notes.
The Company believes that the allegations in this lawsuit are entirely
without merit. The Company has filed an answer denying Mr. Moulton's allegations
and opposing vigorously all equitable relief sought. The Company has also filed
a demurrer seeking to dismiss certain claims. The Company is considering
bringing various claims against Mr. Moulton either by counterclaim or in a
separate action.
In addition, we are subject to legal proceedings, claims, and
litigation arising in the ordinary course of business. While the outcome of
these matters is currently not determinable, we do not expect that the ultimate
costs to resolve these matters will have a material adverse effect on our
consolidated financial position, results of operations, or cash flows.
44
DIRECTORS, EXECUTIVE OFFICERS, PROMOTERS AND CONTROL PERSONS
Each director serves as director until his successor is duly elected
and qualified. Our executive officers are elected by, and serve at the
discretion of, our board of directors. There are no family relationships between
our executive officers and directors. Our executive officers and directors are
as follows:
NAME AGE POSITION YEAR BEGAN
- --------------------- --- --------------------------------- ----------
Robert Tarini 45 Chief Executive Officer, Chairman 2002
of the Board of Directors
Kenneth Ducey, Jr. 39 President, Chief Financial Officer 2002
and Director
Joseph P. Mackin 54 Director 2004
Each director serves for a term beginning on the date they are first
elected or appointed and continuing until the next succeeding annual meeting of
stockholders.
ROBERT TARINI has served as our chief executive officer since November
14, 2003 and as our chairman of the board of directors since December 9, 2002.
In April 2003, Mr. Tarini founded Syqwest Inc., a firm which specializes in the
design and manufacture of acoustic remote sensing devices utilized in marine and
land based applications. In April 2001, Mr. Tarini founded Trylon Metrics Corp.,
a developer of acoustic remote sensing technology, and acted as President of
Trylon from April 2001 to present. In May 2001, Mr. Tarini founded ipPartners
Inc. and has served as its President to present. ipPartners Inc. specializes in
the development of acoustic remote sensing devices. Since 1999, Mr. Tarini has
served as the chief executive officer of Ocean Data Equipment Corporation, where
he oversaw the design and development of a complete line of scientific
instruments targeted for geophysical and hydrographic research, and developed a
remote sensing technique, which is currently being applied to detecting illicit
materials. From June 1982 to July 1990, Mr. Tarini worked at Raytheon, where he
designed active sonar and sonar trainers for US and foreign customers which were
installed onto every 688 class attack submarine and every SQQ-89 surface ship
combat system, in total, over 100 seafaring vessels.
KENNETH P. DUCEY, JR. has served as our president, chief financial
officer and member of our board of directors since December 2002. From 1998 to
2002, Mr. Ducey led three small technology companies while working at the
venture capital firm, Spencer Trask. Mr. Ducey was responsible for developing
new business, typically in segments in which the company was not yet practicing.
In 1988, Mr. Ducey launched Palmtop Utilities, a consulting company that
developed the first link between the Sharp Wizard and ACT! contact management
software. Mr. Ducey led Palmtop Utilities to become the largest dealer of Sharp
Wizards, and secured licensing arrangements with Sharp, Contact Software
International, and Microsoft. After successfully selling the assets of Palmtop
Utilities in 1992, Mr. Ducey helped to develop The Outsourcing Institute, where
he developed and sold multi-million dollar contracts to MCI and
PricewaterhouseCoopers. From 1985 to 1986, Mr. Ducey was a trader at Salomon
Brothers where he was responsible for actively traded technology companies
listed on the NASDAQ National Market. Mr. Ducey was nationally recognized in
September 2000 by Business Week as a leading expert in outsourcing.
DR. JOSEPH P. MACKIN has been a member of our board of directors since
July 13, 2004. Dr. Mackin has been with EOIR for 4 years and is currently an
Executive Vice President and Chief Scientist for EOIR. Dr. Mackin is responsible
for strategic technology development and Homeland Security initiatives as well
as a key participant in corporate day-to-day operations at EOIR. He has served
on numerous government panels and committees, and was most recently appointed as
the Lead Sensor Scientist on the prestigious National Academy of Science study
called "ARMY S&T FOR HOMELAND DEFENSE" published in June 2003. Prior to joining
EOIR, Dr. Mackin was an Assistant Sensor Systems Group Leader at MIT Lincoln
Laboratories where, among other things, he served as the system integration lead
for the Smart Sensor Web program. Dr. Mackin holds a PhD in Physics from the
Massachusetts Institute of Technology and a BS in Engineering from the United
States Military Academy at West Point. He is retired as an officer in the United
States Army.
45
COMPENSATION OF DIRECTORS AND EXECUTIVE OFFICERS
DIRECTOR COMPENSATION
We do not, as a standard practice, compensate our directors for their
service. However, all of our current directors also serve us as either officers
or consultants, and we compensate them for their service in such capacities.
EMPLOYMENT AGREEMENTS
ROBERT TARINI AND KENNETH DUCEY, JR. On May 12, 2004, the Company
entered into five-year compensation agreements with Robert Tarini, our Chairman
and Chief Executive Officer, Kenneth Ducey, Jr., our President and Chief
Financial Officer, and Asset Growth Company. Asset Growth Company is wholly
owned by Kenneth Ducey, Jr., and the following compensation terms of our
agreements with Asset Growth Company and Kenneth Ducey, Jr., are provided on an
aggregated basis. These agreements, as amended on June 14, 2004, provide for the
following remuneration to each of Robert Tarini and Kenneth Ducey, Jr.
(including Asset Growth Company):
o Base annual remuneration of $300,000 payable over the five-year period
ending January 2, 2009;
o Discretionary bonuses over the term of the agreement of up to 300% of
the base remuneration;
o Conditional stock grants over the period commencing April 1, 2004
through January 2, 2008, based on performance criteria. The
stock grants, if all earned, entitle each of Messrs. Tarini and Ducey
(including Asset Growth Company) to receive up to 7.5% of the Company's
common stock on a fully diluted basis. These grants are earned
according to the following schedule:
STOCK PERCENTAGE GRANT DATE
---------------- ---------------
Grant 1 2.5% May 12, 2004
Grant 2 1.0% July 1, 2004
Grant 3 1.0% October 1, 2004
Grant 4 1.0% January 2, 2005
Grant 5 1.0% January 2, 2006
Grant 6 0.5% January 2, 2007
Grant 7 0.5% January 2, 2008
The number of shares of common stock to be granted on each grant date
is equal to the product of (a) the number of fully diluted shares outstanding at
the grant date and (b) the stock percentage associated with that grant date;
o In the event of a change in control of the Company during the period
covered by the agreement, each executive/consultant will automatically
be granted all remaining stock grants and will be due cash and expense
compensation for the shorter of (i) three years from the date of the
change in control, or (ii) until the end of the term of the agreement.
A change in control is defined by the agreements as a change in the
majority ownership of the equity of the company, the resignation or
termination of the majority of the board of directors within a two
month period, or the replacement of the CEO or the President of the
Company; and
o Expense allowance for all reasonable and necessary expenses of $5,000
per month.
The new agreements supersede our prior employment or consulting
arrangements with Messrs. Tarini and Ducey, the terms of which are summarized
below:
Pursuant to our consulting agreement with Mr. Tarini, he served as our
chairman and chief executive officer for an initial term of three years at a
base consulting fee of $10,000 per month. We also agreed to reimburse Mr. Tarini
for all reasonable and necessary out-of-pocket expenses related to the
performance of his duties under this agreement. We issued 430,474 shares of our
common stock in connection with the execution of the agreement and satisfaction
of stated performance criteria. Mr. Tarini was eligible to receive a
performance-based bonus of up to four times his annual base salary upon the
conclusion of the term of the agreement. He was also eligible to participate in
any bonus or incentive compensation program established by our board of
directors.
46
In the event that we terminated Mr. Tarini's engagement without cause,
or he terminated his engagement for "good reason" (defined in the agreement as,
among other things, the assignment of duties inconsistent with Mr. Tarini's
position or any material breach by us of the consulting agreement), we would
have been obligated to continue payments until the earlier of (a) three months
from the date of termination or (b) the date on which Mr. Tarini obtained a
full-time engagement elsewhere. This agreement also subjected Mr. Tarini's to
certain restrictive covenants, including an obligation to maintain confidential
information.
Under our employment agreement with Mr. Ducey, he served as our
president and chief financial officer for an initial term of three years at an
annual base salary of $185,000. The agreement also provided for up to $1,200 a
month for his expenses, including his automobile, health insurance and
reasonable expenses associated with setting up and maintaining a home office.
The remaining terms of his agreement, including provisions for grants of common
stock, bonuses and severance pay, were substantially the same as those of Mr.
Tarini's agreement.
DELMAR R. KINTNER. We entered into an employment agreement with Mr.
Kintner in January 2003 whereby he would serve as our chief executive officer
for an initial term of one year at an annual base salary of $150,000. The
agreement provided for a grant of up to 2.27% of our common stock on a
fully-diluted basis provided certain performance criteria were met. It also
provided for up to $1,200 a month for his expenses, including his automobile,
health insurance and reasonable expenses associated with setting up and
maintaining a home office. This agreement was terminated in November 2003. Prior
to termination, Mr. Kintner was granted 119,303 shares of our common stock, with
a fair market value of $343,097 as of the date of grant. We are not required
under the agreement with Mr. Kintner to provide for any further compensation,
including any additional grants of our common stock.
SUMMARY COMPENSATION TABLE
EXECUTIVE OFFICER COMPENSATION
SUMMARY COMPENSATION TABLE
The following table provides summary information concerning the
compensation earned by our chief executive officer and our other executive
officers for services rendered for the fiscal years ended June 30, 2002, June
30, 2003 and June 30, 2004. Delmar Kintner served as our Chief Executive Officer
until November 2003.
LONG-TERM
ANNUAL COMPENSATION COMPENSATION
------------------- ------------
SECURITIES
UNDERLYING
NAME AND PRINCIPAL POSITION YEAR SALARY ($) BONUS ($) OPTIONS (#)
- ---------------------------------------- ---- ----------- --------------- -----------
Robert Tarini............................. 2004 $ 210,000 $ 3,183,130 (2)
Chief Executive Officer and Chairman 2003 $ 120,000 $ 76,667
of the Board of Directors (1) 2002
Kenneth P. Ducey, Jr. .................... 2004 $ 240,000 $ 3,163,130 (2)
President and Chief Financial Officer 2003 $ 180,000 $ 76,667
2002
Joseph P. Mackin (3) ..................... 2004 $ 190,000 1,250,286
Executive Vice President, EOIR 2003
2002
Gregory A. Williams (3) .................. 2004 $ 135,000 1,250,286
Vice President, EOIR 2003
2002
Delmar R. Kintner......................... 2004 $ 120,000 $ 254,849
Chief Executive Officer 2003 $ 120,000 $ 128,051
2002
- ------------------
(1) Mr. Tarini assumed the rule of Chief Executive Officer upon Mr.
Kintner's resignation in November 2003.
47
(2) Includes 1,930,161 unregistered shares of common stock valued at
$3,033,130 based on the closing market price as of the date of grant.
(3) Mr. Mackin serves as Executive Vice
President of EOIR, our wholly owned subsidiary. In his
capacity as a member of our Board of Directors, he has the ability
to influence our policy.
(4) Mr. Williams resigned from our Board of Directors and his position as
Vice President of EOIR effective November 1, 2004.
AGGREGATED OPTION/SAR EXERCISES IN LAST FISCAL YEAR AND FY-END OPTION/SAR VALUES
NUMBER OF SECURITIES PERCENT OF TOTAL
UNDERLYING OPTIONS/SARS GRANTED
OPTIONS/SARS GRANTED TO EMPLOYEES IN EXERCISE OR BASE
NAME (#) FISCAL YEAR PRICE ($/SH) EXPIRATION DATE
- --------------------- -------------------- -------------------- ---------------- ---------------
Robert Tarini 0 0.0% N/A N/A
Kenneth P. Ducey, Jr. 0 0.0% N/A N/A
Gregory A. Williams 1,250,286 11.8% (1) $ 0.3775 June 29, 2014
Joseph P. Mackin 1,250,286 11.8% (1) $ 0.3775 June 29, 2014
Delmar R. Kintner 0 0.0% N/A N/A
(1) Under our 2004 Stock Incentive Plan, we granted an employee options to
purchase a number of shares to be determined by dividing a stated value
by the fair market value per share at the time of vesting. Solely for
the purposes of determining these percentages, we have assumed that the
number of shares for which such options are exercisable is equal to the
number of shares which would be issuable upon exercise were the options
vested in full on June 30, 2004.
EQUITY COMPENSATION PLAN DISCLOSURE
SECURITIES AUTHORIZED FOR ISSUANCE UNDER MARKLAND'S EQUITY COMPENSATION
PLANS
The following table sets forth certain information as of June 30, 2004,
regarding securities authorized for issuance under our equity compensation
plans, including individual compensation arrangements.
- --------------------------------------- ------------------------- ------------------------ --------------------------
NUMBER OF SECURITIES TO WEIGHTED-AVERAGE NUMBER OF SECURITIES
BE ISSUED UPON EXERCISE EXERCISE PRICE OF REMAINING AVAILABLE FOR
OF OUTSTANDING OPTIONS, OUTSTANDING OPTIONS, FUTURE ISSUANCE UNDER
PLAN CATEGORY WARRANTS AND RIGHTS WARRANTS AND RIGHTS EQUITY COMPENSATION PLANS
- --------------------------------------- ------------------------- ------------------------ --------------------------
Equity compensation plans approved
by security holders 0 N/A 0
- --------------------------------------- ------------------------- ------------------------ --------------------------
Equity compensation plans not
approved by security holders 12,294,159 (1) $0.53 31,356,295 (2)(3)
- --------------------------------------- ------------------------- ------------------------ --------------------------
TOTAL 12,294,159 $0.53 31,356,295
- --------------------------------------- ------------------------- ------------------------ --------------------------
- ----------------------
(1) Includes warrants to purchase 1,698,133 shares of our common stock
issued as finder's fees in connection with the Securities Purchase
Agreements entered into between certain investors and our company dated
April 2, 2004, April 16, 2004 and May 3, 2004, and 10,596,026 shares of
our common stock underlying options issued to certain of our employees.
Included in the number of shares issuable upon the exercise of options
are five future price options issued to one of our employees. Solely
for the purpose of determining the number of shares issuable upon the
exercise of these options, we have assumed full vesting as of June 30,
2004, at which time the options would have been exercisable for up to
1,205,286 shares of our common stock.
48
(2) On June 29, 2004, our board of directors adopted the Markland
Technologies, Inc. 2004 Stock Incentive Plan the We have reserved a
total of 25,000,000 shares of Common Stock for issuance under the 2004
Stock Incentive Plan, of which 14,403,974 remained available for future
issuance as of June 30, 2004. The 2004 Stock Incentive Plan authorizes
the grant of incentive options, non-statutory options, and restricted
and unrestricted stock. For a complete description of the 2004 Stock
Incentive Plan, please refer to footnote 9 to the Financial Statements.
(3) Included in this figure are 17,436,271 shares of our common stock are
potentially issuable under our four-year employment agreements with
each of Robert Tarini, Kenneth P. Ducey, Jr., and Verdi Consulting,
effective January 1, 2004. Under each of these agreements, we are
required to issue shares upon the achievement of performance
objectives. The number of shares to be granted is determined as a
percentage of our outstanding common stock, calculated on a fully
diluted basis (i.e., the number of shares of common stock which would
be outstanding were all outstanding instruments convertible or
exercisable for shares of common stock converted or exercised in full).
The 17,436,271 shares consist of 6,637,143 shares of our common stock
which we issued subsequent to the completion of our 2004 fiscal year
and an additional 10,315,179 shares of common stock, representing an
estimate of the maximum number of shares which may become issuable in
the event all performance criteria are met. Solely for the purposes of
this estimate, we have assumed that the outstanding fully diluted
common stock at the time of the first such future grant will be equal
to the number outstanding as of June 30, 2004. We can provide no
assurance that the actual number of shares ultimately granted under
these agreements will not exceed this estimate. For a complete
description of each of these agreements, please refer to footnote 12 to
the Financial Statements.
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
At the close of business on November 5, 2004, there were issued and
outstanding 51,564,458 shares of our common stock. The following table provides
information regarding beneficial ownership of our common stock as of November 5,
2004 by:
o each person known by us to be the beneficial owner of more
than five percent of our common stock;
o each of our directors;
o each executive officer named in the summary compensation table
(including three former executive officers); and
o all of our current directors and executive officers as a
group.
The persons named in this table have sole voting and investment power
with respect to the shares listed, except as otherwise indicated. The inclusion
of shares listed as beneficially owned does not constitute an admission of
beneficial ownership. Shares included in the "Right to Acquire" column consist
of shares that may be purchased through the exercise of options that vest within
60 days of November 5, 2004.
SHARES BENEFICIALLY OWNED
------------------------------------------------------------
RIGHT TO
NAME AND ADDRESS OF BENEFICIAL OWNER OUTSTANDING ACQUIRE TOTAL PERCENT
- -------------------------------------------------- ----------- ------------ ------------ ---------
James LLC ........................................ 1,671,950 3,871,046 5,542,996 9.999%
Harbour House, 2nd Floor
Waterfront Drive
PO Box 972
Road Town
Tortola, British Virgin Islands
Robert Tarini(1).................................. 4,803,952 0 4,803,952 9.316%
54 Danbury Road #207
Ridgefield, Connecticut 06877
Kenneth P. Ducey, Jr.(2).......................... 4,118,105 0 4,118,105 7.986%
54 Danbury Road #207
Ridgefield, Connecticut 06877
49
Gregory A. Williams(3)............................ 0 0 0 *
5 English Hills Drive
Fredricksburg, Virginia 22406
Joseph P. Mackin.................................. 0 0 0 *
15 Maypole Road
Quincy, Massachusetts 02169
Delmar Kintner (4) ............................... 122,116 0 122,116 *
3153 Skyline Drive
Oceanside, California 92056
All directors and executive officers as a group
(3 persons)..................................... 8,922,057 0 8,922,057 17.303%
- ----------------------
* Represents beneficial ownership of less than 1.0%.
(1) Mr. Tarini is the beneficial owner of 499,849 shares of common stock
issued to ipPartners and 136,000 shares of common stock issued to
Syqwest, Inc.
(2) Mr. Ducey is the beneficial owner of 2,879,485 shares of common stock
issued to Asset Growth Company.
(3) Mr. Williams resigned from our company on November 1, 2004.
(4) Mr. Kintner resigned from our company in November 2003.
DISCLOSURE OF COMMISSION POSITION ON INDEMNIFICATION FOR SECURITIES ACT
LIABILITIES
Article X of our charter provides that, subject to Section 607.0850 of
the Florida Business Corporation Act, we will indemnify our current and former
officers and directors against expenses (including attorneys fees), judgments,
fines and amounts paid in settlement arising out of his services as our officer
or director.
Section 607.0850 of the Florida Business Corporation Act states that we
have the power to indemnify any person made a party to any lawsuit by reason of
being our director or officer against expenses (including attorneys' fees),
judgments, fines and amounts paid in settlement actually and reasonably incurred
by him in connection with such action, suit or proceeding if he acted in good
faith and in a manner he reasonably believed to be in, or not opposed to, the
best interests of the corporation, and, with respect to any criminal action or
proceeding, had no reasonable cause to believe his conduct was unlawful.
Our employment agreements with our directors and officers contain
provisions requiring us to indemnify them to the fullest extent permitted by
Florida law. The indemnification agreements require us to indemnify our
directors and officers to the extent permitted by our charter and to advance
their expenses incurred in connection with a proceeding with respect to which
they are entitled to indemnification.
Insofar as indemnification for liabilities arising under the Securities
Act of 1933 (the "Act") may be permitted to directors, officers and controlling
persons of the small business issuer pursuant to the foregoing provisions, or
otherwise, the small business issuer has been advised that in the opinion of the
Securities and Exchange Commission such indemnification is against public policy
as expressed in the Act and is, therefore, unenforceable.
CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS
On December 9, 2002, our subsidiary, Security Technology, Inc.,
acquired intellectual property rights and assets relating the Acoustic Core(TM)
technology for detecting illicit material from Crypto.com, Inc., a subsidiary of
Eurotech, Ltd. pursuant to the Exchange Agreement dated December 9, 2002. In
exchange for the purchased technology, we agreed to issue for 4,498,638 shares
of our common stock to Eurotech, Ltd. and ipPartners, Inc. Of the shares issued,
3,998,789 were transferred to Eurotech as payment for causing Crypto.com to
deliver to us the purchased technology, and 499,849 were transferred to
ipPartners in exchange for their forgiveness and discharge of certain
obligations owed to them by Crypto in connection to the property transferred.
50
ipPartners, Inc. is controlled by Robert Tarini. Our chief executive
officer, however, at the time of this transaction, Mr. Tarini was an unrelated
third party. After the transaction, Eurotech, Ltd. owned eighty percent (80%) of
our outstanding common stock, making us their majority-owned subsidiary. In
order to accomplish this transaction, Market LLC and James LLC, our controlling
shareholders at the time, agreed to a recapitalization of the Company whereby
Market LLC and James LLC collectively surrendered 4,498,638 shares of our common
stock, and $5,225,000 of convertible promissory notes, in exchange for
$5,225,000 in stated value Series C Cumulative Convertible Preferred Stock.
During January 2003, we completed our acquisition of Ergo Systems, Inc. from
Ocean Data Equipment Corporation, now called SyQwest, Inc. Robert Tarini, our
chief executive officer, is also the chief executive officer of SyQwest, Inc.
Ergo's main asset is an annually renewable U.S. Government General Services
Administration contract to provide logistic support and product development for
five U.S. ports of entry. In exchange for Ergo we agreed to pay SyQwest $400,000
in cash, due in installments that are triggered with the completion of research
milestones. As of April 30, 2004, we have paid SyQwest $176,900 of which
$126,900 is an advance representing partial payment for monies that will be due
upon the completion of the first milestone.
On March 27, 2003, we entered into an exchange agreement with Eurotech
whereby Eurotech exchanged 1,666,666 shares of our common stock for 16,000
shares of our Series D Cumulative Convertible Preferred Stock. Our Series D
Cumulative Convertible Preferred Stock has a stated value of $1,000 per share
and has a beneficial conversion feature where each share is immediately
convertible into common stock at a discount to market prices. During the past
six months we have also issued shares of our Series D Cumulative Convertible
Preferred Stock to James LLC. James LLC has invested a total of $3,832,000 in
our Series D Cumulative Convertible Preferred Stock. As of September 24, 2004,
the Series D Cumulative Convertible Preferred Stock held by James LLC was
convertible into 4,287,964 shares of our common stock.
On July 24, 2003, we entered into an agreement with SyQwest, Inc., in
which we issued 750,000 shares of our common stock in exchange for the
forgiveness of $450,000 for unpaid services performed by SyQwest in connection
with research conducted in relation to our vehicle stopping technology. Robert
Tarini, our chief executive officer, is also the chief executive officer of
SyQwest. We have the right at any time by written notice to repurchase these
shares from SyQwest at a price equal to $.60 per share.
In September 30, 2003 we acquired one hundred percent (100%) of the
outstanding stock of Science and Technology Research, Inc., which produces our
U.S. Navy shipboard automatic chemical agent detection and alarm system product.
We paid the stockholder of Science and Technology Research a total of $6,475,000
consisting of $900,000 in cash, common stock valued at $5,100,000, a promissory
note of $375,000, and acquisition costs of $100,000. To finance this acquisition
we executed a two year, twelve percent (12%), secured Promissory Note with Bay
View Capital, LLC for $1,400,000. Bay View Capital, LLC is controlled by Robert
Tarini, our chief executive officer, and Chad Verdi, whom we have engaged as a
consultant. The outstanding balance and accrued interest of this note were
repaid in full in April 2004.
Also on May 12, 2004, the we entered into five-year employment
agreements with our Chief Executive Officer and Chairman of our Board of
Directors, Robert Tarini, and our Chief Financial Officer and Director, Kenneth
P. Ducey, Jr. The agreements provide for salary and bonus compensation, as well
as performance based equity grants. The terms of the agreements are set forth in
detail in this report in the section entitled Compensation of Directors and
Executive Officers under heading "Employment Agreements." We have also executed
amendments to these agreements with each of Mr. Tarini and Mr. Ducey which
provided for a higher initial grant of shares in exchange for the omission of
antidilution protection in the agreements, a concession granted prior to
execution of the agreements.
On June 29, 2004, we acquired all of the outstanding stock of EOIR for
$8 million in cash and $11 million in principal amount of five year notes issued
to the former shareholders of EOIR, including two of our current directors,
Gregory A. Williams and Joseph P. Mackin. Neither Mr. Williams nor Mr. Mackin
had any affiliation with us prior to the transaction. In connection with their
continued employment at EOIR, and as a condition of the acquisition, we granted
each of Mr. Williams and Mr. Mackin options to purchase 1,250,286 shares of our
common stock at an exercise price of $0.3775 per share. The options vest in five
equal annual installments.
51
Also in connection with this acquisition, we issued to James LLC 3,500
shares of Series D Preferred Stock in exchange for $2,000,000 cash. The Series D
preferred stock is convertible at the option of the stockholder at any time. The
number of shares of our common stock into which each share of Series D preferred
is convertible is determined by dividing $1,000 by the discounted bid price. The
"discounted" bid price is the average closing bid price of our common stock
during the five business days immediately preceding the conversion date
multiplied by the applicable discount factor, as set forth below.
AVERAGE CLOSING BID PRICE (1) DISCOUNT FACTOR
- -------------------------------------------------- ---------------
$15.00 or less 80%
more than $15.00, but less than or equal to $30.00 75%
more than $30.00, but less than or equal to $45.00 70%
more than $45.00 65%
- --------------------
(1) After an adjustment for a 1-for-60 reverse stock split effective October 27,
2003.
The Series D preferred stock can be converted only to the extent that
the Series D stockholder will not, as a result of the conversion, hold in excess
of 9.999% of the total outstanding shares of our common stock. For a complete
description of the terms and conditions of the Series D Preferred Stock please
refer to our annual report on Form 10-KSB for the fiscal year ended June 30,
2003.
On September 21, 2004, we sold secured convertible promissory notes and
common stock purchase warrants to two institutional investors. As a condition to
this sale, the investors required our Chief Executive Officer, Robert Tarini,
and our Chief Financial Officer, Kenneth Ducey, Jr., to enter into a lock-up
agreement pursuant to which Mr. Tarini and Mr. Ducey agreed not to sell any
shares of our common stock until 60 days after the effective date of a
registration statement covering the resale of the underlying shares of common
stock of those securities sold in the September 21, 2004 private placement. For
more information on the September 21, 2004 private placement, please see
footnote 16 to our financial statements.
As part of our private placement of secured convertible promissory
notes and common stock purchase warrants completed on September 21, 2004, James
LLC, the largest holder of our Series D Preferred Stock, agreed not to sell any
of its holdings of Series D Preferred Stock until the earlier to occur of: (1)
notice from the us and the investors that the transactions contemplated had been
completed had been terminated, or (2) March 15, 2005. However, pursuant to the
terms of the lock-up agreement, James, LLC may still convert their Series D
shares and sell the underlying shares of common stock in accordance with Rule
144 of the Securities Act of 1933, as amended. In exchange, we agreed that under
certain conditions, if we did not redeem the Series D stock by January 15, 2005,
we would issue to James LLC a warrant to purchase 1,088,160 shares of our common
stock at $.80 per share.
The Company believes that all transactions described above were made on
terms no less favorable to it than those obtainable from unaffiliated third
parties. All future transactions, if any, with its executive officers, directors
and affiliates will be on terms no less favorable to it than those that will be
obtainable from unrelated third parties at the time such transactions are made.
OTHER RELATIONSHIP AND TRANSACTIONS: TRANSACTIONS WITH VERDI CONSULTING
The transactions described below are not related party transactions
within the meaning of Item 404 of Regulation S-B.
On May 12, 2004, the Company entered into a five-year consulting
agreement with Verdi Consulting. Verdi Consulting has assisted us with a variety
of tasks including strategic planning; identifying, structuring and closing on
acquisitions; finding financing; investor relations; and general business
advice. This agreement provides for the following remuneration:
o Base annual remuneration of $300,000 payable over the
five-year period ending January 2, 2009;
o Discretionary bonuses over the term of the agreement of up to
300% of the base remuneration; and
o Conditional stock grants over the period commencing April 1,
2004 through January 2, 2008, based on defined performance
criteria.
52
The stock grants, if all earned, entitle Verdi Consulting to receive up
to 7.5% of the Company's common stock on a fully diluted basis. These grants are
earned according to the following schedule:
STOCK PERCENTAGE GRANT DATE
---------------- ----------
Grant 1 2.5% April 1, 2004
Grant 2 1.0% July 1, 2004
Grant 3 1.0% October 1, 2004
Grant 4 1.0% January 2, 2005
Grant 5 1.0% January 2, 2006
Grant 6 0.5% January 2, 2007
Grant 7 0.5% January 2, 2008
The number of shares of common stock to be granted on each grant date
is equal to the product of (a) the number of fully diluted shares outstanding at
the grant date and (b) the stock percentage associated with that grant date.
o In the event of a change in control of the Company during the
period covered by the agreement, each executive/consultant
will automatically be granted all remaining stock grants and
will be due cash and expense compensation for the shorter of
(i) three years from the date of the change in control, or
(ii) until the end of the term of the agreement. A change in
control is defined by the agreements as a change in the
majority ownership of the equity of the company, the
resignation or termination of the majority of the board of
directors within a two month period, or the replacement of the
CEO or the President of the Company.
We have also executed an amendment to this agreement which provided for
a higher initial grant of shares in exchange for the omission of antidilution
protection in the agreement, a concession granted prior to execution of the
agreement.
This agreement supersedes the prior agreement we had with Verdi
Consulting, which was executed on January 1, 2003. Under this three-year
agreement, we paid Verdi Consulting $12,500 per month as base compensation and
provided a $1,000 per month expense allowance. In addition, as incentive
compensation, we issued 315,375 shares of common stock to Verdi Consulting which
vested in four installments during calendar 2003 and 115,097 shares which vested
on January 1, 2004. Finally, Verdi Consulting was eligible to receive a bonus of
up to $1,200,000 if it was instrumental in assisting us to obtain contracts with
a total value in excess of $1,000,000 during the life of the contract. We had
agreed to pay Verdi Consulting three month's base compensation if we terminated
this contract without cause.
DESCRIPTION OF SECURITIES
Our authorized capital stock consists of 500,000,000 shares of common
stock, $0.0001 par value per share, and 5,000,000 shares of preferred stock,
$0.0001 par value per share. As of November 5, 2004, we had 51,564,458 shares of
our common stock issued and outstanding.
COMMON STOCK
VOTING RIGHTS. Holders of our common stock are entitled to one vote per
share held of record on all matters to be voted upon by our stockholders. Our
common stock does not have cumulative voting rights. Persons who hold a majority
of the outstanding common stock entitled to vote on the election of directors
can elect all of the directors who are eligible for election.
DIVIDENDS. Subject to preferences that may be applicable to the holders
of any outstanding shares of our preferred stock, the holders of our common
stock are entitled to receive such lawful dividends as may be declared by our
board of directors.
Notwithstanding the rights of the holders of our common stock set forth
in our charter, we are subject to the following contractual restrictions
regarding the payment of dividends:
o Pursuant to the Exchange Agreement dated December 9, 2002, with
Eurotech, Ltd., and the other parties named therein, any and all
cash and other liquid assets held by our Company or its
subsidiaries shall be exclusively used for working capital or
investment purposes, and we shall not, and shall not permit our
subsidiaries to, directly or indirectly divert or upstream cash or
other current assets whether in the form of a loan, contract for
services, declaration of dividend, or other arrangement in
contravention of such restriction until the second anniversary of
the closing date of the exchange transaction.
53
o Pursuant to the Securities Purchase Agreement with DKR Soundshore
Oasis Holding Fund, Ltd, and DKR Soundshore Strategic Holding
Fund, Ltd. dated September 21, 2004, we have covenanted that so
long as any of the notes issued pursuant to such agreement are
outstanding, we will not declare, pay or make any provision for
any cash dividend or cash distribution with respect to our common
stock or preferred stock, without first obtaining the approval of
the investors party the agreement.
LIQUIDATION AND DISSOLUTION. In the event of our liquidation,
dissolution or winding up, and subject to the rights of the holders of any
outstanding shares of our preferred stock, the holders of shares of our common
stock will be entitled to receive pro rata all of our remaining assets available
for distribution to our stockholders.
OTHER RIGHTS AND RESTRICTIONS. Our charter prohibits us from granting
preemptive rights to any of our stockholders. All outstanding shares are fully
paid and nonassessable.
Our common stock is quoted on the OTC Bulletin Board by the National
Association of Securities Dealers, Inc. under the symbol "MRKL.OB.
PREFERRED STOCK
Our articles of incorporation authorize us to issue shares of our
preferred stock from time to time in one or more series without stockholder
approval.
As of November 5, 2004, we had designated 30,000 shares as Series A
preferred stock, all of which were outstanding on that date, and 40,000 shares
of our preferred stock as Series D Preferred Stock, 17,725 of which were
outstanding on that date.
The following is a summary description of the principal terms of each
series of our preferred stock. For a complete statement of all the terms of each
series of preferred stock, please review the applicable certificate of
designation that we have previously filed with the SEC on October 13, 2003 as
exhibits to our annual report on Form 10-KSB for the year ended June 30, 2003.
SERIES A NON-VOTING REDEEMABLE CONVERTIBLE PREFERRED STOCK
VOTING RIGHTS: Except as otherwise provided under Florida law, the
Series A preferred stock has no voting rights.
DIVIDENDS: The Series A preferred stock does not accrue dividends.
CONVERSION: Each share of the Series A preferred stock is convertible
at our option into one-third of one share of our common stock.
ANTIDILUTION: Upon the occurrence of a stock split or stock dividend,
the conversion rate shall be adjusted so that the conversion rights of the
Series A preferred stock stockholders shall be nearly equivalent as practicable
to the conversion rights of the Series A preferred stock stockholders prior to
such event.
REDEMPTION: We may redeem all or any portion of the outstanding shares
of the Series A preferred stock upon cash payment of $10.00 per share.
DISSOLUTION: In the event of any voluntary or involuntary liquidation,
dissolution or winding up of our affairs, the Series A preferred stock will be
treated as senior only to our common stock. If, upon any winding up of our
affairs, and after the Series D preferred stockholders are paid in full, our
assets available to pay the holders of Series A preferred stock are not
sufficient to permit the payment in full, then our remaining assets will be
distributed to those holders on a pro rata basis.
SERIES D CONVERTIBLE PREFERRED STOCK
VOTING RIGHTS: Except as otherwise provided under Florida law, the
Series D preferred stockholders have no right to vote with the holders of our
common stock. However, our charter requires that the Series D preferred
stockholders approve any amendment to the rights and preferences of the Series D
preferred stock. Where the Series D preferred stockholders do have the right to
vote as a series, whether under our charter or pursuant to Florida law, the
affirmative vote of the holders of at least 67% of the outstanding shares of
Series D preferred stock is necessary to constitute approval.
54
DIVIDENDS: The Series D preferred stock does not accrue dividends.
CONVERSION: The Series D preferred stock is convertible at the option
of the stockholder at any time. The number of shares of our common stock into
which each share of Series D preferred is convertible is determined by dividing
$1,000 by the discounted bid price. The "discounted" bid price is the average
closing bid price of our common stock during the five business days immediately
preceding the conversion date multiplied by the applicable discount factor, as
set forth below.
AVERAGE CLOSING BID PRICE (1) DISCOUNT FACTOR
- --------------------------------------------------- ---------------
$15.00 or less 80%
more than $15.00, but less than or equal to $30.00 75%
more than $30.00, but less than or equal to $45.00 70%
more than $45.00 65%
- ---------------
(1)After an adjustment for a 1-for-60 reverse stock split effective October 27,
2003.
The Series D preferred stock can be converted only to the extent that
the Series D stockholder will not, as a result of the conversion, hold in excess
of 9.999% of the total outstanding shares of our common stock.
ANTIDILUTION: Upon the occurrence of a transaction that results in a
change of control, or a split off of the company assets, a stock split or a
stock dividend, the price at which the Series D preferred stock is convertible
shall be adjusted so that the conversion rights of the Series D preferred stock
stockholders shall be nearly equivalent as practicable to the conversion rights
of the Series D preferred stock stockholders prior to the transaction.
REDEMPTION: We have the right to redeem any outstanding shares of our
Series D preferred stock at any time. The redemption price per share is equal to
$1,000 multiplied by 135%. Our Series D preferred stock is convertible, even
after we have provided a notice of redemption, until the Series D stockholder
has received full cash payment for the shares we are redeeming.
DISSOLUTION: In the event of any voluntary or involuntary liquidation,
dissolution or winding up of our affairs, the Series D preferred stock will be
treated as senior to all preferred stock and our common stock. If, upon any
winding up of our affairs, our assets available to pay the holders of Series D
preferred stock are not sufficient to permit the payment in full, then all our
assets will be distributed to those holders on a pro rata basis.
WARRANTS
COMMON STOCK PURCHASE WARRANTS ISSUED IN APRIL 2, 2004, PRIVATE
PLACEMENT.
In our private placement transaction completed on April 2, 2004, we
issued common stock purchase warrants to purchase an aggregate of 3,333,333
shares of common stock with an exercise price of $1.00 per share to the
investors. In addition, we issued a common stock purchase warrant to purchase
333,333 shares of our common stock with an exercise price of $1.40 per share to
West Hastings Ltd. as a finder's fee.
These warrants have a so-called "most favored nation" provision
pursuant to which the exercise price of the warrants and the terms of the
warrants will automatically be changed if we issue warrants with a lower
exercise price or with terms more favorable to the holder at any time prior to
180 days after the effective date of a registration statement providing for the
resale of shares issuable upon exercise of the warrant. If we issue warrants
with a lower exercise price than the warrants we issued on April 2, 2004 during
this period, the exercise price of the warrants we issued on April 2, 2004 will
be reduced to that new lower price. If we issue warrants with terms more
favorable to the warrant holder than the terms set forth in the warrants we
issued on April 2, 2004, such new more favorable terms will automatically be
incorporated into the April 2 warrants.
The shares underlying these warrants have been registered in a separate
registration statement filed with the SEC, as amended and supplemented from time
to time (File # 333-115395).
55
The holder of a warrant will not possess any rights as a stockholder
until the holder exercises the warrant.
COMMON STOCK PURCHASE WARRANTS ISSUED IN APRIL 16, 2004, PRIVATE
PLACEMENT.
In our private placement transaction completed on April 16, 2004, we
issued common stock purchase warrants to purchase an aggregate of 2,500,000
shares of common stock with an exercise price of $1.50 per share to the
investors. In addition, we issued a common stock purchase warrant to purchase
25,000 shares of our common stock with an exercise price of $2.00 per share to
Baker Consulting as a finder's fee.
These warrants have a "most favored nation" provision pursuant to which
the exercise price of the warrants will automatically be changed (but only to
the extent that such change does not itself cause a change to the warrants we
issued on April 2, 2004, on account of the most favored nation clause contained
in the April 2 warrants), if we issue warrants with a lower exercise price at
any time prior to 180 days after the effective date of a registration statement
providing for the resale of shares issuable upon exercise of the warrant. If we
issue warrants with a lower exercise price than the warrants we issued on April
16, 2004 during this period, the exercise price of the warrants we issued on
April 16, 2004, will be reduced to that new lower price.
The shares underlying these warrants have been registered in a separate
registration statement filed with the SEC, as amended and supplemented from time
to time (File # 333-115395).
The holder of a warrant will not possess any rights as a stockholder
until the holder exercises the warrant.
COMMON STOCK PURCHASE WARRANTS ISSUED IN MAY 3, 2004 PRIVATE PLACEMENT.
In our private placement transaction completed on May 3, 2004, we
issued redeemable common stock purchase warrants to purchase an aggregate of
7,098,750 shares of common stock with an exercise price of $1.50 per share to
the investors.
These common stock purchase warrants are redeemable by us, at any time,
after our common stock has a closing bid price of not less than $2.25 per share
for 20 consecutive trading days after such effective date for $0.0001 per share.
These warrants do not have a "most favored nation" provision.
All the warrants are exercisable for a period of three (3) years. All
of the warrants contain provisions that protect holders against dilution by
adjusting of the exercise price in certain events such as stock dividends and
distributions, stock splits, recapitalizations, mergers, consolidations, and
issuances of common stock below their respective exercise price per share.
The terms of the common stock purchase warrants provide that the number
of shares to be obtained by each of the holders of the warrants upon exercise of
our common stock purchase warrants cannot exceed the number of shares that, when
combined with all other shares of common stock and securities then owned by each
of them, would result in any one of them owning more than 4.99% (or, in some
cases, 9.99%) of our outstanding common stock at any point in time.
The shares underlying these warrants have been registered in a separate
registration statement filed with the SEC, as amended and supplemented from time
to time (File # 333-115395).
The holder of a warrant will not possess any rights as a stockholder
until the holder exercises the warrant.
WARRANTS ISSUED ON SEPTEMBER 21, 2004 AND NOVEMBER 9, 2004
On September 21, 2004 and November 9, 2004, we issued warrants
initially exercisable for shares of our common stock at an initial exercise
price of $1.50 per share. These warrants are subject to the following
adjustments provisions:
o Under the terms of the warrants, if we do not make a prepayment of
an aggregate of $4,000,000 in principal, plus any interest having
accrued thereon, on the notes issued to the Initial Investors in
this private placement by March 15, 2005, the exercise price of
the warrant will be reduced from $1.50 to the lesser of (i) $0.792
and (ii) 80% of the average closing price per share of our common
stock on the date the adjustment is made.
56
o Adjustments are also required in the event that we issue common
stock or common stock equivalents at a price per share below the
then effective exercise price of the warrants.
o In the event any of the foregoing adjustments are made, the
warrants will become exercisable for a number of shares equal to
the aggregate exercise price (i.e., the exercise price per share
multiplied by the number of underlying shares) prior to the
adjustment divided by the adjusted exercise price per share.
The warrants are exercisable for a period of five years from the date
of issuance.
All of the warrants contain provisions that protect holders against
dilution by adjusting of the exercise price in certain events such as stock
dividends and distributions, stock splits, recapitalizations, mergers,
consolidations, and issuances of common stock below their respective exercise
price per share.
The terms of the warrants provide that the number of shares to be
acquired by each of the holders of the warrants upon exercise of these warrants
cannot exceed the number of shares that, when combined with all other shares of
common stock and securities then owned by each holder and its affiliates, would
result in any one of them owning more than 4.999% of our outstanding common
stock at any point in time. By written notice to the Company, the holder of the
warrant may waive this contractual limitation, effective 61 days after delivery
of such notice.
The terms of the warrants also provide that the number of shares to be
acquired by each of the holders of the warrants upon exercise of these warrants
cannot exceed the number of shares that, when combined with all other shares of
common stock and securities then owned by each holder and its affiliates, would
result in any one of them owning more than 9.99% of our outstanding common stock
at any point in time.
We have registered in this registration statement the resale of the
shares underlying these warrants by the selling stockholders identified in this
prospectus.
The holder of a warrant will not possess any rights as a stockholder
until the holder exercises the warrant.
NOTES
CONVERTIBLE NOTES ISSUED ON SEPTEMBER 21, 2004 AND NOVEMBER 9, 2004
On September 21, 2004 and November 9, 2004, we issued convertible
promissory notes with a one-year maturity in aggregate principal amounts of
$5,200,000 and $1,755,000 respectively.
These notes accrue interest at an annual rate of 8%. All accrued
interest will become immediately payable on March 15, 2005, after which time
interest will be payable on a monthly basis, in arrears.
At any time, and at the option of the holder of the note, the
outstanding principal and accrued interest of the notes may be converted into
shares of our common stock at an initial conversion price per share of $0.80.
If we do not make the prepayments discussed below, the conversion price
will be adjusted from $0.80 per share to the lower of (i) $0.80 and (ii) a
floating rate equal to 80% of average closing price per share of our common
stock for the five trading days preceding conversion:
o Under the terms of these notes issued on September 21, 2004 we are
required to pay to the Initial Investors $4,000,000 of the
outstanding principal and interest by March 15, 2005, and the
remaining outstanding balance by September 21, 2005.
o Under the terms of the notes issued on November 9, 2004, we are
required to pay each Additional Investor a principal amount on
each note equal to the consideration paid by the Additional
Investor holding such note plus any accrued interest by March 15,
2005, and the remaining outstanding balance by November 9, 2005.
We have registered in this registration statement the resale of the
shares underlying these notes by the selling stockholders identified in this
prospectus.
57
The holder of a note will not possess any rights as a stockholder until
the holder convert the notes into shares of our common stock.
FLORIDA LAW AND CERTAIN CHARTER AND BYLAW PROVISIONS
Provisions of Florida law, our charter and bylaws could make it more
difficult to acquire us by means of a merger, tender offer, proxy contest, open
market purchases and otherwise. These provisions, which are summarized below,
are expected to discourage types of coercive takeover practices and inadequate
takeover bids and to encourage persons seeking to acquire control of us to first
negotiate with us. We believe that the benefits of increased protection of our
potential ability to negotiate with the proponent of an unfriendly or
unsolicited proposal to acquire or restructure us outweigh the disadvantages of
discouraging takeover or acquisition proposals because negotiation of these
proposals could result in an improvement of their terms.
AUTHORIZED BUT UNISSUED STOCK. We have shares of common stock and
preferred stock available for future issuance, in some cases, without
stockholder approval. We may issue these additional shares for a variety of
corporate purposes, including public offerings to raise additional capital,
corporate acquisitions, stock dividends on our capital stock or equity
compensation plans.
The existence of unissued and unreserved common stock and preferred
stock may enable our board of directors to issue shares to persons friendly to
current management or to issue preferred stock with terms that could render more
difficult or discourage a third-party attempt to obtain control of us, thereby
protecting the continuity of our management. In addition, if we issue preferred
stock, the issuance could adversely affect the voting power of holders of common
stock and the likelihood that such holders will receive dividend payments and
payments upon liquidation.
SPECIAL MEETING OF STOCKHOLDERS. Our bylaws provide that special
meetings may be called only by our board of directors or by holders of not less
than 10% of all the votes entitled to be cast on any issue proposed to be
considered at the proposed special meeting. This provision may make it more
difficult for stockholders to take action opposed by our board of directors.
AMENDMENT TO OUR BYLAWS. Section 607.1004 of the Florida Business
Corporation Act provides that preferred stockholders have the right to vote as a
class on amendments to our charter that would negatively impact their rights or
preferences as preferred stockholders of such class. Our charter, however,
provides that our board of directors has the exclusive authority to alter, amend
or repeal them. This provision of our charter may also make it more difficult
for stockholders to take action opposed by our board of directors.
TRANSFER AGENT
The transfer agent and registrar for our common stock is Florida
Atlantic Stock Transfer, Inc.
PLAN OF DISTRIBUTION
The Selling Stockholders and any of their pledgees, donees,
transferees, assignees and successors-in-interest may, from time to time, sell
any or all of their shares of Common Stock on any stock exchange, market or
trading facility on which the shares are traded or in private transactions.
These sales may be at fixed or negotiated prices. The Selling Stockholders may
use any one or more of the following methods when selling shares:
o ordinary brokerage transactions and transactions in which the
broker-dealer solicits Investors;
o block trades in which the broker-dealer will attempt to sell the
shares as agent but may position and resell a portion of the block
as principal to facilitate the transaction;
o purchases by a broker-dealer as principal and resale by the
broker-dealer for its account;
o an exchange distribution in accordance with the rules of the
applicable exchange;
o privately negotiated transactions;
o to cover short sales made after the date that this Registration
Statement is declared effective by the Commission;
58
o broker-dealers may agree with the Selling Stockholders to sell a
specified number of such shares at a stipulated price per share;
o a combination of any such methods of sale; and
o any other method permitted pursuant to applicable law.
The Selling Stockholders may also sell shares under Rule 144 under the
Securities Act, if available, rather than under this prospectus.
Broker-dealers engaged by the Selling Stockholders may arrange for
other brokers-dealers to participate in sales.
Broker-dealers may receive commissions or discounts from the Selling
Stockholders (or, if any broker-dealer acts as agent for the purchaser of
shares, from the purchaser) in amounts to be negotiated. The Selling
Stockholders do not expect these commissions and discounts to exceed what is
customary in the types of transactions involved.
The Selling Stockholders may from time to time pledge or grant a
security interest in some or all of the Shares owned by them and, if they
default in the performance of their secured obligations, the pledgees or secured
parties may offer and sell shares of Common Stock from time to time under this
prospectus, or under an amendment to this prospectus under Rule 424(b)(3) or
other applicable provision of the Securities Act of 1933 amending the list of
selling stockholders to include the pledgee, transferee or other successors in
interest as selling stockholders under this prospectus.
Upon the Company being notified in writing by a Selling Stockholder
that any material arrangement has been entered into with a broker-dealer for the
sale of Common Stock through a block trade, special offering, exchange
distribution or secondary distribution or a purchase by a broker or dealer, a
supplement to this prospectus will be filed, if required, pursuant to Rule
424(b) under the Securities Act, disclosing
(i) the name of each such Selling Stockholder and of the
participating broker-dealer(s),
(ii) the number of shares involved,
(iii) the price at which such the shares of Common Stock were
sold,
(iv) the commissions paid or discounts or concessions allowed
to such broker-dealer(s), where applicable,
(v) that such broker-dealer(s) did not conduct any
investigation to verify the information set out or incorporated by
reference in this prospectus, and
(vi) other facts material to the transaction.
In addition, upon the Company being notified in writing by a Selling
Stockholder that a donee or pledge intends to sell more than 500 shares of
Common Stock, a supplement to this prospectus will be filed if then required in
accordance with applicable securities law.
The Selling Stockholders also may transfer the shares of Common Stock
in other circumstances, in which case the transferees, pledgees or other
successors in interest will be the selling beneficial owners for purposes of
this prospectus. The Selling Stockholders and any broker-dealers or agents that
are involved in selling the shares may be deemed to be "underwriters" within the
meaning of the Securities Act in connection with such sales. In such event, any
commissions received by such broker-dealers or agents and any profit on the
resale of the shares purchased by them may be deemed to be underwriting
commissions or discounts under the Securities Act. Discounts, concessions,
commissions and similar selling expenses, if any, that can be attributed to the
sale of Securities will be paid by the Selling Stockholder and/or the
purchasers.
59
Each Selling Stockholder who is an affiliate of a broker-dealer has
represented and warranted to the Company that he acquired the securities subject
to this registration statement in the ordinary course of such Selling
Stockholder's business and, at the time of his purchase of such securities such
Selling Stockholder had no agreements or understandings, directly or indirectly,
with any person to distribute any such securities. As such, they are not
underwriters within the meaning of Section 2(11) of the Securities Act. The
Company has advised each Selling Stockholder that it may not use shares
registered on this Registration Statement to cover short sales of Common Stock
made prior to the date on which this Registration Statement shall have been
declared effective by the Commission.
The selling stockholders have acknowledged that they understand their
obligations to comply with these provisions of the Exchange Act and the rules
thereunder and have agreed that they will not engage in any transaction in
violation of such provisions.
If a selling stockholder uses this prospectus for any sale of the
Common Stock, it will be subject to the prospectus delivery requirements of the
Securities Act. The Selling Stockholders will be responsible to comply with the
applicable provisions of the Securities Act and Exchange Act, and the rules and
regulations thereunder promulgated, including, without limitation, Regulation M,
as applicable to such Selling Stockholders in connection with resales of their
respective shares under this Registration Statement.
The selling stockholders have acknowledged that they understand their
obligations to comply with the provisions of the Exchange Act and the rules
thereunder relating to stock manipulation, particularly Regulation M, and have
agreed that they will not engage in any transaction in violation of such
provisions.
The Company is required to pay all fees and expenses incident to the
registration of the shares, but the Company will not receive any proceeds from
the sale of the Common Stock. The Company has agreed to indemnify the Selling
Stockholders against certain losses, claims, damages and liabilities, including
liabilities under the Securities Act.
AVAILABLE INFORMATION
We are a public company and file annual, quarterly and special reports,
proxy statements and other information with the Securities and Exchange
Commission. Copies of the reports, proxy statements and other information may be
read and copied at the SEC's Public Reference Room at 450 Fifth Street, N.W.,
Washington, D.C. 20549. You can request copies of such documents by writing to
the SEC and paying a fee for the copying cost. You may obtain information on the
operation of the Public Reference Room by calling the SEC at 1-800-SEC-0330. The
SEC maintains a web site at (http://www.sec.gov) that contains reports, proxy
and information statements and other information regarding registrants that file
electronically with the SEC.
This prospectus is part of a registration statement on Form SB-2 that
we filed with the SEC. Certain information in the registration statement has
been omitted from this prospectus in accordance with the rules and regulations
of the SEC. We have also filed exhibits and schedules with the registration
statement that are excluded from this prospectus. For further information you
may:
o read a copy of the registration statement, including the exhibits
and schedules, without charge at the SEC's Public Reference Room;
or
o obtain a copy from the SEC upon payment of the fees prescribed by
the SEC.
LEGAL MATTERS
Foley Hoag LLP of 155 Seaport Boulevard, Boston, Massachusetts 02210
has advised us about the legality and validity of the shares. We know of no
members of Foley Hoag who are beneficial owners of our common stock or preferred
stock.
60
EXPERTS
Our consolidated financial statements as of June 30, 2004, included in
this prospectus have been audited by Wolf & Company, P.C., registered
independent public accounting firm, as stated in their report appearing herein,
and have been so included in reliance upon the report of such firm given upon
their authority as experts in accounting and auditing.
Our consolidated financial statements as of June 30, 2003, included in
this prospectus have been audited by Marcum & Kliegman, LLP, registered
independent public accounting firm, as stated in their report appearing herein,
and have been so included in reliance upon the report of such firm given upon
their authority as experts in accounting and auditing.
61
INDEX TO FINANCIAL STATEMENTS
Page
----
REPORTS OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM AND CONSOLIDATED FINANCIAL
STATEMENTS FOR MARKLAND TECHNOLOGIES, INC. AND SUBSIDIARIES
FOR THE YEARS ENDED JUNE 30, 2004 AND 2003
Report of Independent Registered Public Accounting Firm of Wolf & Company, P.C................ F-2
Report of Independent Registered Public Accounting Firm of Marcum & Kliegman LLP............... F-3
Consolidated Balance Sheet at June 30, 2004.................................................... F-4
Consolidated Statements of Loss for the Years Ended June 30, 2004 and 2003..................... F-5
Consolidated Statements of Stockholders' (Deficiency) Equity for the Years Ended
June 30, 2004 and 2003....................................................................... F-6
Consolidated Statements of Cash Flows for the Years Ended June 30, 2004 and 2003............... F-12
Notes to Consolidated Financial Statements..................................................... F-15
F-1
REPORTS OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the Board of Directors
Markland Technologies, Inc. and Subsidiaries
Ridgefield, Connecticut
We have audited the consolidated balance sheet of Markland Technologies and
subsidiaries as of June 30, 2004, and the related consolidated statements of
loss, stockholders' equity and cash flows for the year then ended. These
financial statements are the responsibility of the Company's management. Our
responsibility is to express an opinion on these financial statements based on
our audits.
We conducted our audit in accordance with the standards of the Public Company
Accounting Oversight Board (United States). Those standards require that we plan
and perform the audit to obtain reasonable assurance about whether the financial
statements are free of material misstatement. An audit includes examining, on a
test basis, evidence supporting the amounts and disclosures in the financial
statements. An audit also includes assessing the accounting principles used and
significant estimates made by management, as well as evaluating the overall
financial statement presentation. We believe that our audit provided a
reasonable basis for our opinion.
In our opinion, the consolidated financial statements referred to above present
fairly, in all material respects, the financial position of Markland
Technologies, Inc. and subsidiaries as of June 30, 2004 and the results of their
operations and their cash flows for the year then ended, in conformity with
accounting principles generally accepted in the United States of America.
The accompanying consolidate financial statements have been prepared assuming
that the Company will continue as a going concern. As discussed in Note 1 to the
consolidated financial statements, the Company has suffered recurring losses
from operations and its current liabilities exceed its current assets. The
Company has limited finances and may require additional funding in order to
market and license its products. There are no assurances that the Company can
reverse its operating losses or that it can raise additional capital to allow it
to continue its planned operations. This raises substantial doubt about the
Company's ability to continue as a going concern. Management's plans in regard
to these matters are also described in Note 1. The financial statements do not
include any adjustments that might result from the outcome of this uncertainty.
/S/ WOLF & COMPANY, P.C.
- ------------------------
Boston, Massachusetts
October 13, 2004
F-2
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
Board of Directors and Stockholders
Markland Technologies, Inc. and Subsidiaries
We have audited the accompanying consolidated statements of operations,
stockholders' (deficiency) equity, and cash flows of Markland Technologies,
Inc. and Subsidiaries ("the Company") for the year ended June 30, 2003.
These consolidated financial statements are the responsibility of the
Company's management. Our responsibility is to express an opinion on these
consolidated financial statements based on our audit.
We conducted our audit in accordance with the standards of the Public
Company Accounting Oversight Board (United States). Those standards require
that we plan and perform the audit to obtain reasonable assurance about
whether the consolidated financial statements are free of material
misstatement. An audit includes examining, on a test basis, evidence
supporting the amounts and disclosures in the consolidated financial
statements. An audit also includes assessing the accounting principles used
and significant estimates made by management, as well as evaluating the
overall consolidated financial statement presentation. We believe that our
audit provides a reasonable basis for our opinion.
In our opinion, the consolidated financial statements of Markland Technologies,
Inc. and Subsidiaries referred to above present fairly, in all material
respects, the results of their operations and their cash flows for the year
ended June 30, 2003, in conformity with accounting principles generally accepted
in the United States of America.
The accompanying consolidated financial statements have been prepared assuming
that the Company will continue as a going concern. As shown in the consolidated
financial statements, the Company incurred a net loss of approximately
$2,837,000 during the year ended June 30, 2003. As of June 30, 2003, the Company
also had a working capital deficiency of approximately $1,235,000. These
conditions raised substantial doubt about the Company's ability to continue as a
going concern. Management's plans in regard to these matters are described in
Note 1. The consolidated financial statements do not include any adjustments
that might result from the outcome of this uncertainty.
/s/ MARCUM & KLIEGMAN LLP
-------------------------
NEW YORK, NEW YORK
SEPTEMBER 15, 2003
F-3
MARKLAND TECHNOLOGIES, INC. AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEET
AT JUNE 30, 2004
ASSETS
CURRENT ASSETS:
Cash $ 1,101,088
Accounts receivable 5,354,267
Other current assets 285,070
-------------
TOTAL CURRENT ASSETS 6,740,425
-------------
PROPERTY AND EQUIPMENT, net of accumulated depreciation of $11,306 1,076,657
-------------
OTHER ASSETS
Amortizable intangible assets, net of accumulated amortization 14,140,548
Technology rights - Acoustic Core 1,300,000
Goodwill 9,706,333
-------------
TOTAL OTHER ASSETS 25,146,881
-------------
TOTAL ASSETS $ 32,963,963
=============
LIABILITIES AND STOCKHOLDERS' EQUITY
CURRENT LIABILITIES:
Accounts payable $ 4,225,701
Accrued expenses and other current liabilities 1,837,836
Unearned contract revenue 324,140
Bank line of credit 600,000
Current portion of long term debt 2,493,470
-------------
TOTAL CURRENT LIABILITIES 9,481,147
NON CURRENT LIABILITIES:
Long term debt, less current portion 7,774,980
-------------
TOTAL LIABILITIES 17,256,127
-------------
COMMITMENTS AND CONTINGENCIES
STOCKHOLDERS' EQUITY:
Series A redeemable convertible preferred stock - no par value;
30,000 authorized, issued and outstanding; liquidation preference 300,000
of $300,000
Series C 5% cumulative convertible preferred stock -
.0001 par value; 8,000 authorized; none issued and outstanding --
Series D convertible preferred stock - $.0001 par value;
40,000 authorized; 22,786 issued and outstanding;
liquidation preference of $22,786,000 2
Common stock - $.0001 par value; 500,000,000 authorized;
31,856,793 shares issued and outstanding 3,180
Additional paid-in capital 50,864,718
Unearned compensation (15,176,116)
Accumulated deficit (20,283,948)
-------------
TOTAL STOCKHOLDERS' EQUITY 15,707,836
-------------
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 32,963,963
=============
The accompanying notes are an integral part of these consolidated financial statements.
F-4
MARKLAND TECHNOLOGIES, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF LOSS
FOR THE YEARS ENDED
JUNE 30,
-------------------------------
2004 2003
------------- -------------
REVENUES $ 6,013,930 $ 658,651
COST OF REVENUES 4,674,593 445,218
------------- -------------
GROSS PROFIT 1,339,337 213,433
------------- -------------
OPERATING EXPENSES:
Selling, general and administrative 5,313,448 1,186,379
Research & development 49,289 522,657
Amortization of compensatory element
of stock issuances for selling,
general and administrative expenses 5,211,737 2,051,822
Amortization of intangible assets 915,729 66,668
------------- -------------
TOTAL OPERATING EXPENSES 11,490,203 3,827,526
------------- -------------
OPERATING LOSS FROM CONTINUING OPERATIONS (10,150,866) (3,614,093)
------------- -------------
OTHER EXPENSES (INCOME), NET:
Interest expense 360,347 226,751
Other income, net -- (5,250)
------------- -------------
TOTAL OTHER EXPENSES (INCOME), NET 360,347 221,501
------------- -------------
LOSS FROM CONTINUING OPERATIONS (10,511,213) (3,835,594)
GAIN FROM DISCONTINUED OPERATIONS:
Gain from discontinued operations -- 998,713
------------- -------------
NET LOSS (10,511,213) (2,836,881)
DEEMED DIVIDEND TO PREFERRED STOCKHOLDERS - Series C 844,270 501,755
DEEMED DIVIDEND TO PREFERRED STOCKHOLDERS - Series D 3,555,500 4,107,500
PREFERRED STOCK DIVIDEND - Series C 184,478 152,716
------------- -------------
NET LOSS APPLICABLE TO COMMON STOCKHOLDERS $(15,095,461) $ (7,598,852)
============= =============
BASIC AND DILUTED LOSS PER COMMON SHARE:
Loss from continuing operations $ (1.39) $ (1.72)
Gain from discontinued operations $ -- $ 0.20
------------- -------------
Net loss $ (1.39) $ (1.52)
============= =============
WEIGHTED AVERAGE NUMBER OF COMMON SHARES
OUTSTANDING (AFTER 1 for 60 REVERSE SPLIT) 10,872,049 5,002,724
============= =============
The accompanying notes are an integral part of these consolidated financial statements.
F-5
MARKLAND TECHNOLOGIES, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY
FOR THE YEARS ENDED JUNE 30, 2004 AND 2003
SERIES A SERIES C
CONVERTIBLE CONVERTIBLE
COMMON STOCK PREFERRED STOCK PREFERRED STOCK
------------------------- ------------------------ -----------------------
SHARES (1) AMOUNT SHARES AMOUNT SHARES AMOUNT
----------- ----------- ----------- ---------- ---------- ----------
Balance - June 30, 2002 4,998,486 500 -- -- -- --
Stock canceled in connection with December 9, 2002
exchange agreement (4,998,486) (450) -- -- -- --
Stock issued in connection with December 9, 2002
exchange agreement 4,498,638 450 -- -- -- --
Conversion of promissory notes and interest into
Series C convertible preferred stock -- -- -- -- 5,225 1
Stock issued for directors' compensation, net 5,000 1 -- -- -- --
Stock issued in connection with private placement 113,333 11 -- -- -- --
Value assigned to beneficial conversion feature of
convertible debt -- -- -- -- -- --
Preferred stock dividend - Series C -- -- -- -- -- --
Preferred stock dividend - beneficial conversion
feature - Series C -- -- -- -- -- --
Value allocated to Series C preferred stock -
beneficial conversion feature dividend -- -- -- -- -- --
Stock issued in connection with consulting agreement 2,333 -- -- -- -- --
Stock issued in connection with consulting agreements 132,528 13 -- -- -- --
Stock issued in connection with employment agreements 86,559 9 -- -- -- --
Amortization of consulting agreements -- -- -- -- -- --
Amortization of employment agreements -- -- -- -- -- --
Sale of 170 shares of Series C convertible
preferred stock -- -- -- -- 170 --
Conversion of liabilities from discontinued
operations into Series A convertible
preferred stock -- -- 30,000 300,000 -- --
Conversion of common stock into Series D convertible
preferred stock (1,666,666) (167) -- -- -- --
Sale of Series D convertible preferred stock -- -- -- -- -- --
Preferred stock dividend - beneficial conversion
feature - Series D -- -- -- -- -- --
Value allocated to Series D preferred stock -
beneficial conversion feature dividend -- -- -- -- -- --
Net loss -- -- -- -- -- --
Balance - June 30, 2003 3,671,573 367 30,000 300,000 5,395 1
- -------------------
(1) Share amounts have been restated to reflect the 1-60 reverse stock split effected on October 27, 2003.
The accompanying notes are an integral part of these consolidated financial statements.
F-6
MARKLAND TECHNOLOGIES, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY
FOR THE YEARS ENDED JUNE 30, 2004 AND 2003
SERIES D
CONVERTIBLE
PREFERRED STOCK UNEARNED
-------------------------- COMPENSATION
SHARES AMOUNT AMOUNT
----------- ----------- ------------
Balance - June 30, 2002 -- -- --
Stock canceled in connection with December 9, 2002 exchange
agreement -- -- --
Stock issued in connection with December 9, 2002 exchange agreement -- -- --
Conversion of promissory notes and interest into Series C
convertible preferred stock -- -- --
Stock issued for directors' compensation, net -- -- --
Stock issued in connection with private placement -- -- --
Value assigned to beneficial conversion feature of convertible debt -- -- --
Preferred stock dividend - Series C -- -- --
Preferred stock dividend - beneficial conversion feature - Series C -- -- --
Value allocated to Series C preferred stock - beneficial
conversion feature dividend -- -- --
Stock issued in connection with consulting agreement -- -- --
Stock issued in connection with consulting agreements -- -- (4,037,237)
Stock issued in connection with employment agreements -- -- --
Amortization of consulting agreements -- -- (3,573,966)
Amortization of employment agreements -- -- 1,178,002
Sale of 170 shares of Series C convertible preferred stock -- -- 2,051,822
Conversion of liabilities from discontinued operations into Series A
convertible preferred stock -- -- --
Conversion of common stock into Series D convertible preferred stock 16,000 2 --
Sale of Series D convertible preferred stock 430 -- --
Preferred stock dividend - beneficial conversion feature - Series D -- -- --
Value allocated to Series D preferred stock - beneficial conversion
feature dividend -- -- --
Net loss -- -- --
Balance - June 30, 2003 16,430 2 (4,381,379)
- ----------------------
(1) Share amounts have been restated to reflect the 1-60 reverse stock split effected on October 27, 2003.
The accompanying notes are an integral part of these consolidated financial statements.
F-7
MARKLAND TECHNOLOGIES, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY
FOR THE YEARS ENDED JUNE 30, 2004 AND 2003
TOTAL
ADDITIONAL STOCKHOLDERS'
PAID-IN ACCUMULATED (DEFICIENCY)
CAPITAL DEFICIT EQUITY
------------- ------------- -------------
AMOUNT AMOUNT AMOUNT
------------- ------------- -------------
Balance - June 30, 2002 29,490 (6,935,854) (6,905,864)
Stock canceled in connection with December 9, 2002 exchange agreement 450 -- --
Stock issued in connection with December 9, 2002 exchange agreement 1,299,500 -- 1,300,000
Conversion of promissory notes and interest into Series C convertible
preferred stock 5,224,999 -- 5,225,000
Stock issued for directors' compensation, net 2,999 -- 3,000
Stock issued in connection with private placement 339,989 -- 340,000
Value assigned to beneficial conversion feature of convertible debt 125,000 -- 125,000
Preferred stock dividend - Series C (152,716) -- (152,716)
Preferred stock dividend - beneficial conversion feature - Series C (501,755) -- (501,755)
Value allocated to Series C preferred stock - beneficial conversion
feature dividend 501,755 -- 501,755
Stock issued in connection with consulting agreement 30,400 -- 30,400
Stock issued in connection with consulting agreements 5,215,706 -- 1,178,482
Stock issued in connection with employment agreements 4,413,896 -- 839,939
Amortization of consulting agreements (1,178,002) -- --
Amortization of employment agreements (2,051,822) -- --
Sale of 170 shares of Series C convertible preferred stock 170,000 -- 170,000
Conversion of liabilities from discontinued operations into Series A
convertible preferred stock -- -- 300,000
Conversion of common stock into Series D convertible preferred stock 165 -- --
Sale of Series D convertible preferred stock 430,000 -- 430,000
Preferred stock dividend - beneficial conversion feature - Series D (4,107,500) -- (4,107,500)
Value allocated to Series D preferred stock - beneficial conversion
feature dividend 4,107,500 -- 4,107,500
Net loss -- (2,836,881) (2,836,881)
Balance - June 30, 2003 13,900,104 (9,772,735) 46,360
The accompanying notes are an integral part of these consolidated financial statements.
F-8
MARKLAND TECHNOLOGIES, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY
FOR THE YEARS ENDED JUNE 30, 2004 AND 2003
SERIES A CONVERTIBLE SERIES C CONVERTIBLE
COMMON STOCK PREFERRED STOCK PREFERRED STOCK
------------------------ ------------------------ ------------------------
SHARES (1) AMOUNT SHARES AMOUNT SHARES AMOUNT
----------- ----------- ----------- ----------- ----------- -----------
Balance - July 1, 2003 3,671,573 367 30,000 300,000 5,395 1
Issuance of Series D convertible preferred
stock -- -- -- -- -- --
Conversion of Series C convertible preferred
stock and accrued dividends into common stock 5,156,412 516 -- -- (5,395) (1)
Conversion of promissory note into common stock 404,266 40 -- -- -- --
Conversion of Series D convertible preferred
stock into common stock 604,839 60 -- -- -- --
Stock issued in connection with settlement of
liabilities to a related party 750,000 75 -- -- -- --
Stock issued in connection with consulting and
employment agreements 6,122,008 612 -- -- -- --
Common stock issued in conjunction with
acquisition of ASI assets 325,833 33 -- -- -- --
Common stock issued in conjunction with
acquisition of Science and Technology Research
Corporation, Inc. 1,589,779 154 -- -- -- --
Amortization of employment and consulting
agreements -- -- -- -- -- --
Common stock and warrant issuances in private
placements 13,232,083 1,323 -- -- -- --
Intrinsic value of options issued in
connection with EOIR acquisition -- -- -- -- -- --
Net loss -- -- -- -- -- --
Balance - June 30, 2004 31,856,793 3,180 30,000 300,000 -- --
- -----------------------------
(1) Share amounts have been restated to reflect the 1-60 reverse stock split effected on October 27, 1003.
The accompanying notes are an integral part of these consolidated financial statements.
F-9
MARKLAND TECHNOLOGIES, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY
FOR THE YEARS ENDED JUNE 30, 2004 AND 2003
SERIES D CONVERTIBLE UNEARNED
PREFERRED STOCK COMPENSATION
-------------------------------- -------------
SHARES AMOUNT AMOUNT
------------- ------------- -------------
Balance - July 1, 2003 16,430 2 (4,381,379)
Issuance of Series D convertible preferred stock 7,166 -- --
Conversion of Series C convertible preferred stock and
accrued dividends into common stock -- -- --
Conversion of promissory note into common stock -- -- --
Conversion of Series D convertible preferred stock into
common stock (810) -- --
Stock issued in connection with settlement of liabilities
to a related party -- -- --
Stock issued in connection with consulting and
employment agreements -- -- (12,006,474)
Common stock issued in conjunction with
acquisition of ASI assets -- -- --
Common stock issued in conjunction with
acquisition of Science and Technology Research
Corporation, Inc. -- -- --
Amortization of employment and consulting agreements -- -- 5,211,737
Common stock and warrant issuances in private placements -- -- --
Intrinsic value of options issued in
connection with EOIR acquisition -- -- (4,000,000)
Net loss -- -- --
Balance - June 30, 2004 22,786 2 (15,176,116)
- -----------------------
(1) Share amounts have been restated to reflect the 1-60 reverse stock split effected on October 27, 1003.
The accompanying notes are an integral part of these consolidated financial statements.
F-10
MARKLAND TECHNOLOGIES, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY
FOR THE YEARS ENDED JUNE 30, 2004 AND 2003
ADDITIONAL TOTAL
PAID-IN ACCUMULATED STOCKHOLDERS'
CAPITAL DEFICIT EQUITY
------------ ------------ ------------
AMOUNT AMOUNT AMOUNT
------------ ------------ ------------
Balance - June 30, 2003 13,900,104 (9,772,735) 46,360
Issuance of Series D convertible preferred stock 5,401,970 -- 5,401,970
Conversion of Series C convertible preferred stock and accrued
dividends into common stock (515) -- --
Conversion of promissory note into common stock 518,419 -- 518,459
Conversion of Series D convertible preferred stock into common
stock (60) -- --
Stock issued in connection with settlement of liabilities to a
related party 449,925 -- 450,000
Stock issued in connection with consulting and employment agreements 12,286,331 -- 280,469
Common stock issued in conjunction with acquisition of ASI assets 916,692 -- 916,725
Common stock issued in conjunction with acquisition of
Science and Technology Research Corporation, Inc. 5,166,346 -- 5,166,500
Amortization of employment and consulting agreements -- -- 5,211,737
Common stock and warrant issuances in private placements 8,225,506 -- 8,226,829
Intrinsic value of options issued in connection with EOIR acquisition 4,000,000 -- --
Net loss -- (10,511,213) (10,511,213)
Balance - June 30, 2004 50,864,718 (20,283,948) 15,707,836
- ---------------------
(1) Share amounts have been restated to reflect the 1-60 reverse stock split effected on October 27, 2003.
The accompanying notes are an integral part of these consolidated financial statements.
F-11
MARKLAND TECHNOLOGIES, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
FOR THE YEARS ENDED
JUNE 30,
-------------------------------
2004 2003
------------- -------------
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss $(10,511,213) $ (2,836,881)
Gain from discontinued operations -- (998,713)
------------- -------------
Loss from continuing operations (10,511,213) (3,835,594)
Adjustment to reconcile net loss to net
cash used in operating activities:
Depreciation 11,306 --
Amortization of intangible assets 915,729 66,668
Amortization of debt discount and non-cash interest 239,164 41,666
Amortization of compensatory stock compensation 5,211,737 2,051,822
Changes in operating assets and liabilities:
Accounts receivable 350,760 (314,223)
Prepaid expenses and other assets 137,362 (1,167)
Accounts payable (444,295) 939,774
Accrued expenses and other current
liabilities 182,550 328,170
------------- -------------
NET CASH USED IN OPERATING ACTIVITIES (3,906,900) (764,550)
------------- -------------
CASH FLOWS FROM INVESTING ACTIVITIES:
Cash used for acquisitions, net of cash acquired (8,536,533) (191,900)
Purchase of property and equipment (1,853) --
------------- -------------
NET CASH USED IN INVESTING ACTIVITIES (8,538,386) (191,900)
------------- -------------
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds in connection with premium financing agreement -- 44,000
Principal payments relating to premium financing agreement (12,906) (26,996)
Repayments of note payable - STR (75,000) --
Proceeds from note payable - Bay View 1,400,000 --
Repayments of note payable - Bay View (1,400,000) --
Proceeds from sale of common stock in private placement 8,226,845 340,000
Proceeds from sale of Series C 5% cumulative
convertible preferred stock -- 170,000
Proceeds from sale of Series D convertible preferred stock 5,401,970 430,000
------------- -------------
NET CASH PROVIDED BY FINANCING ACTIVITIES 13,540,909 957,004
------------- -------------
NET INCREASE IN CASH 1,095,623 554
CASH - BEGINNING OF YEAR 5,465 4,911
------------- -------------
CASH - END OF YEAR $ 1,101,088 $ 5,465
============= =============
The accompanying notes are an integral part of these consolidated financial statements.
F-12
MARKLAND TECHNOLOGIES, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
(CONTINUED)
FOR THE YEARS ENDED
JUNE 30,
------------------------------
2004 2003
------------- -------------
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION:
Cash paid during the years for:
Interest $ 100,769 $ --
============= =============
Taxes $ -- $ --
============= =============
Non-cash investing and financing activities:
Conversion of notes payable and accrued interest into
preferred stock $ 518,459 $ 5,225,000
============= =============
Conversion of liabilities from discontinued operations into
Series A convertible preferred stock $ -- $ 300,000
============= =============
Acquisition of technology rights by issuance of common stock $ -- $ 1,300,000
============= =============
Acquisition of ASI by issuance of common stock $ 916,725 $ --
============= =============
Acquisition of STR by issuance of common stock $ 5,166,500 $ --
============= =============
Conversion of accounts payable into Common Stock $ 450,000 $ --
============= =============
Conversion of common stock into Series D convertible preferred
stock $ -- $ 10,000
============= =============
Deemed dividend preferred stock - beneficial conversion
Feature - Series C $ 844,270 $ 501,755
============= =============
Deemed dividend preferred stock - beneficial conversion
Feature - Series D $ 3,555,500 $ 4,107,500
============= =============
Accrued Dividends on preferred stock $ 184,478 $ 152,716
============= =============
Payable on purchase of Ergo $ -- $ 273,100
============= =============
Secured convertible promissory note debt discount $ -- $ 125,000
============= =============
The accompanying notes are an integral part of these consolidated financial statements.
F-13
MARKLAND TECHNOLOGIES, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
YEARS ENDED JUNE 30, 2004 AND 2003
During years ended June 30, 2004 and 2003, the Company acquired the assets and assumed the
liabilities of various entities. The transactions had the following non-cash impact on the
balance sheet:
2004 2003
------------- -------------
Accounts receivable $ 5,390,805 $ --
Equipment 1,083,467 --
Other current assets 317,851 --
Intangibles 25,029,277 400,000
Accounts payable (3,678,360) --
Accrued liabilities (1,860,156) --
Notes payable to sellers (10,339,351) (273,100)
Line of credit (600,000) --
Transaction costs (792,000) --
Equity (5,950,000) --
------------- -------------
Net Cash Used for Acquisitions, net
of cash acquired of $538,467 $ 8,601,533 $ 126,900
============= =============
The accompanying notes are an integral part of these consolidated financial statements.
F-14
MARKLAND TECHNOLOGIES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
YEARS ENDED JUNE 30, 2004 AND 2003
1. NATURE OF OPERATIONS
BUSINESS HISTORY AND OPERATIONS
Markland Technologies, Inc. ("Markland"), previously known as Quest Net
Corporation, was incorporated in Colorado in November 1995, under the name "A.P.
Sales Inc." In December 1998, A.P. Sales Inc. dissolved as a Colorado
corporation, redomiciled in Florida and changed its name to Quest Net
Corporation.
In March 2000, Markland acquired CWTel, Inc. ("CWTel"), a Florida-based
telecommunication corporation. In November 2001, CWTel filed a voluntary
bankruptcy petition in the State of Florida. In March 2002, a final decree was
issued, the trustee discharged and the case closed.
On March 15, 2001, Markland acquired all of the outstanding stock of Vidikron of
America, Inc. ("Vidikron"). As a result of this acquisition, the sole
stockholder of Vidikron, Market LLC, controlled a majority of the common stock
of Markland and, accordingly, the transaction was accounted for as a reverse
acquisition and as a recapitalization of Vidikron, pursuant to which Vidikron
was treated as the accounting acquirer. Accordingly the historical financial
statements are those of Vidikron. Vidikron became a wholly-owned subsidiary of
Markland. Subsequently, Quest Net changed its name to Markland Technologies,
Inc. and Vidikron adopted the year-end of Quest Net.
On May 28, 2002, Markland received a notice of default from Market LLC relating
to a loan and security agreement and a related secured convertible revolving
credit note due to Markland's failure to make payments of principal and interest
due under the note. In addition, as a result of the defaults under the note,
Market LLC declared all outstanding principal and interest under the note,
totaling $4,213,300, to be immediately due and payable. In June of 2002, all of
the shares of the Vidikron subsidiary, including all of its operating assets and
liabilities, were transferred to Market LLC in partial satisfaction of the
indebtedness due Market LLC of $50,000. As a result, Markland had no active
business following such event. The assets and liabilities and operating results
of Vidikron have been treated as a discontinued operation in the accompanying
consolidated financial statements (see Note 11).
On November 21, 2002, Security Technology, Inc. ("STI") was incorporated as a
Delaware C corporation and became a wholly-owned subsidiary of Markland.
In December 2002, Markland, Eurotech Ltd. ("Eurotech"), ipPartners, Inc.
("ipPartners"), a related party, Market LLC and James LLC, entered into an
exchange agreement ("Exchange Agreement"). On December 19, 2002, the
transactions contemplated by the Exchange Agreement were consummated. Pursuant
to the Exchange Agreement, Eurotech transferred to Markland certain rights to
Eurotech's Acoustic Core technology, relating to illicit materials detection,
and certain cryptology technology. Market LLC and James LLC, the holders of 100%
of the issued and outstanding common stock of Markland, exchanged 4,498,638
shares of Markland's common stock (90% of their total holdings) and certain
convertible notes owed by Markland in exchange for $5,225,000 in stated value of
Series C 5% Cumulative Convertible Preferred Stock. Markland issued 3,998,789
shares of common stock, representing approximately eighty percent (80%) of its
outstanding common stock, to Eurotech, and 499,849 shares of common stock,
representing approximately ten percent (10%) of its outstanding common stock, to
ipPartners. As a result of this transaction, a change of control occurred and
Markland became an 80%-owned subsidiary of Eurotech.
F-15
MARKLAND TECHNOLOGIES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
YEARS ENDED JUNE 30, 2004 AND 2003
In January 2003, Markland purchased the common stock of Ergo Systems, Inc.
("Ergo"). In September 2003, Markland purchased certain technology from ASI
Technology Corporation ("ASI"). In October 2003, Markland purchased the common
stock of Science and Technology Research Corporation, Inc. ("STR").
We acquired from ASI gas plasma antenna technology assets and a sub-license for
plasma sterilization and decontamination. The assets at time of purchase
included three ongoing funded SBIR government contracts and nine issued and
pending U.S. patents related to gas plasma antenna technology with demonstrated
applications in the fields of ballistic missile defense, phased array radar, and
forward deployed decontamination.
STR provides a full range of electrical and mechanical engineering support as
well as fabrication and assembly of electrical and mechanical systems. STR is a
producer of the United States Navy's Shipboard Automatic Chemical Agent
Detection and Alarm System (ACADA). The Navy deploys the "man-portable" point
detection system to detect all classic nerve and blister agents as well as other
chemical warfare agent (CWA) vapors.
Markland acquired 100% of E-OIR Technologies, Inc.'s ("EOIR") outstanding common
stock in conjunction with a Stock Purchase Agreement dated June 29, 2004. EOIR
provides research and engineering services to Defense and Intelligence Community
customers. EOIR's technical services include design and fabrication of sensor
systems for military and intelligence community applications. These efforts
involve systems, engineering, system integration, prototyping, field collections
as well as data analysis and processing. Substantially all of EOIR's revenues
are derived from approximately twenty Government contracts with ten different
U.S. Government agencies.
These transactions are in support of Markland's objective to provide end-to-end
solutions to the Department of Homeland Security ("DHS") and Department of
Defense ("DOD"). Markland's principal end customer is the United States
Government. Markland operates in one principal business segment of providing
primarily Government Agencies with products to protect the United States'
borders, military personnel and infrastructure assets. All of the Markland's
operating units have similar products and services, production processes,
customers and regulatory environment. During 2004, sales of remote sensing
products, border security products and services and SBIR funded research grants
comprised 80%, 16% and 4% of our revenue, respectively. During 2003, revenue was
comprised of sales of border security products and services and SBIR funded
research grants of 67% and 33%, respectively. The Company's revenues from the
acquisition of EOIR will be derived from the sales of remote sensor system
products and services.
Markland is subject to risks common to companies in the Homeland Defense
Technology industry, including, but not limited to, development by its
competitors of new technological innovations, dependence on key personnel,
protection of proprietary technology and loss of significant customers. Since
the United States Government represents substantially all of Markland's current
revenue, the loss of this customer would have a material adverse effect on
Markland's future operations.
BASIS OF PRESENTATION
The accompanying consolidated financial statements have been prepared in
conformity with accounting principles generally accepted in the United States of
America, which contemplate continuation of Markland as a going concern. Markland
has incurred net losses of $10,511,213 and $2,836,881 for the years ended June
F-16
MARKLAND TECHNOLOGIES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
YEARS ENDED JUNE 30, 2004 AND 2003
30, 2004 and 2003, respectively. Additionally, Markland had a working capital
deficiency of $2,740,722 at June 30, 2004. Markland has limited finances and may
require additional funding in order to market and license its products.
Subsequent to June 30, 2004, Markland issued secured convertible promissory
notes and warrants to purchase shares of common stock and received net proceeds
of approximately $4,000,000 (see Note 16). There is no assurance that Markland
can reverse its operating losses, or that it can raise additional capital to
allow it to continue its planned operations. These factors raise substantial
doubt about Markland's ability to continue as a going concern.
Markland's ability to continue as a going concern remains dependent upon the
ability to obtain additional financing or through the generation of positive
cash flows from continuing operations. These financial statements do not include
any adjustments relating to the recoverability of recorded asset amounts that
might be necessary as a result of the above uncertainty. While Markland has
experienced operating losses in the past, due to the acquisition of EOIR,
management believes the operating portion of the business will be cash flow
positive in fiscal 2005. Management's business plan is to continue to grow the
customer base and revenues and to control and monitor operating expenses and
capital expenditures. In addition, subsequent to year end, Markland consummated
a financing through which we realized net cash of approximately $4,000,000.
Management believes that the business as currently constituted will produce
positive cash flow which, together with the current cash levels, will enable
Markland to meet existing financial obligations as they come due during the
current fiscal year. However, management can provide no assurance that the
performance of the business will meet these expectations.
2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Principles of Consolidation
- ---------------------------
The consolidated financial statements include the accounts of Markland and its
wholly-owned subsidiaries, Security Technology, Inc. ("STI"), Ergo Systems, Inc.
("Ergo"), Science and Technology Research Corporation, Inc. ("STR") and E-OIR
Technologies, Inc. ("EOIR"). All significant inter-company balances and
transactions have been eliminated in consolidation.
Use of Estimates in Preparation of Financial Statements
- -------------------------------------------------------
The preparation of the accompanying consolidated financial statements in
conformity with accounting principles generally accepted in the United States of
America requires management to make certain estimates and assumptions that
affect the reported amounts of assets and liabilities and disclosures of
contingent assets and liabilities at the date of the financial statements and
the reported amounts of revenue and expenses during the reporting period. Actual
results could differ from those estimates. Significant estimates that are
particularly susceptible to change are the determination of the fair value of
assets acquired and liabilities assumed in business combinations, impairment of
identified intangible assets, goodwill and long lived assets, the fair value of
equity instruments issued, valuation reserves on deferred tax assets and revenue
and costs recognized on long-term, fixed-price contracts.
Concentrations
- --------------
Markland has cash balances in banks in excess of the maximum amount insured by
the FDIC as of June 30, 2004.
F-17
MARKLAND TECHNOLOGIES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
YEARS ENDED JUNE 30, 2004 AND 2003
Substantially all revenue is generated from contracts with Federal government
agencies. Consequently, substantially all accounts receivable are due from
Federal government agencies either directly or through other government
contractors.
Cash and Cash Equivalents
- -------------------------
Cash equivalents include interest-bearing deposits with original maturities of
three months or less.
Allowance for Doubtful Accounts
- -------------------------------
The allowance for doubtful accounts reflects management's best estimate of
probable losses inherent in the accounts receivable balance. Management
determines the allowance based on known trouble accounts, historical experience
and other currently available evidence. Markland's receivables are from
government contracts. Markland has not experienced any losses in accounts
receivable and has provided no allowance at June 30, 2004 or 2003.
Property and Equipment
- ----------------------
Property and equipment are valued at cost and are being depreciated over their
useful lives using the straight-line method for financial reporting. Routine
maintenance and repairs are charged to expense as incurred. Expenditures which
materially increase the value or extend useful lives are capitalized.
Property and equipment are depreciated using straight-line methods over the
estimated useful lives of assets as follows:
Computers and equipment 3 years
Furniture and fixtures 5-7 years
Vehicles 5 years
Software 3 years
Property and equipment consisted of the following at June 30, 2004:
Software $ 63,830
Computer equipment 512,236
Vehicles 405,258
Furniture and fixtures 106,639
--------------
$ 1,087,963
Less accumulated depreciation (11,306)
--------------
$ 1,076,657
==============
Depreciation expense for the years ended June 30, 2004 and 2003 was $11,306 and
$0, respectively.
Income Taxes
- ------------
The Company accounts for income taxes using the asset and liability method.
Deferred tax assets and liabilities are recognized for the future tax
consequences attributable to differences between the financial statement
carrying amounts of existing assets and liabilities and their respective tax
bases, and operating loss and tax credit carry forwards. Deferred tax assets and
liabilities are measured using enacted tax rates expected to apply to taxable
F-18
MARKLAND TECHNOLOGIES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
YEARS ENDED JUNE 30, 2004 AND 2003
income in the years in which these temporary differences are expected to be
recovered or settled. A deferred tax asset is recorded for net operating loss
and tax credit carry forwards to the extent that their realization is more
likely than not. The deferred tax benefit or expense for the period represents
the change in the deferred tax asset or liability from the beginning to the end
of the period.
Revenue Recognition
- -------------------
We recognize revenue when the following criteria are met: (1) we have persuasive
evidence of an arrangement, such as contracts, purchase orders or written
requests; (2) we have completed delivery and no significant obligations remain,
(3) our price to our customer is fixed or determinable, and (4) collection is
probable. We recognize revenues at the time we perform services related to
border security logistic support. With respect to our revenues from our chemical
detectors, we recognize revenue under the units-of-delivery method. At the time
the units are shipped to the United States Navy, the Company recognizes as
revenues the contract price of each unit and recognizes the applicable cost of
each unit shipped. As of June 30, 2004, the Company had completed delivery of
all outstanding orders under the contract.
Unearned Revenue
- ----------------
Unearned revenue represents cash collection in excess of revenue earned from
fixed price contracts.
Fair Value of Financial Instruments
- -----------------------------------
The financial statements include various estimated fair value information at
June 30, 2004, as required by Statement of Financial Accounting Standards No.
107, "Disclosures about Fair Value of Financial Instruments." Financial
instruments are initially recorded at historical cost. If subsequent
circumstances indicate that a decline in the fair value of a financial asset is
other than temporary, the financial asset is written down to its fair value.
Unless otherwise indicated, the fair values of financial instruments approximate
their carrying amounts. By their nature, all financial instruments involve risk,
including credit risk for non-performance by counterparties. The maximum
potential loss may exceed any amounts recognized in the consolidated balance
sheets.
The fair value of cash, accounts receivable, bank line of credit and long-term
debt approximate their recorded amounts because of their relative market and
settlement terms. The fair value of the notes payable issued to the former
owners of EOIR (see Note 3) have been recorded at their fair value, as
determined by an independent valuation, which is less than the face value due to
a below market interest rate.
Advertising Costs
- -----------------
Advertising costs are expensed as incurred. For the years ended June 30, 2004
and 2003, advertising and promotion expenses were approximately $19,504 and
$-0-, respectively.
Shipping Costs
- --------------
Delivery and shipping costs are included in cost of revenue in the accompanying
consolidated statements of loss.
F-19
MARKLAND TECHNOLOGIES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
YEARS ENDED JUNE 30, 2004 AND 2003
Research and Development
- ------------------------
Research and development costs are charged to expense as incurred. Markland
capitalizes costs related to acquired technologies that have achieved
technological feasibility and have alternative uses. Acquired technologies which
do not meet this criteria are expensed as research and development costs.
Reverse Stock Split/Loss Per Share
- ----------------------------------
Share amounts and per share data have been restated to reflect a 1 for 60
reverse stock split effective as of October 27, 2003.
Basic and diluted net loss per common share has been computed based on the
weighted average number of shares of common stock outstanding during the periods
presented.
Common stock equivalents, consisting of Series A and D Convertible preferred
stock, options and warrants were not included in the calculation of the diluted
loss per share because their inclusion would have had the effect of decreasing
the loss per share otherwise computed.
Impairment of Intangible Assets
- -------------------------------
The Company records as goodwill the excess of purchase price over the fair value
of the identifiable net assets acquired. Statements of Financial Accounting
Standards (SFAS ) No. 142, "Goodwill and Other Intangible Assets", prescribes a
two-step process for impairment testing of goodwill, which is performed
annually, as well as when an event triggering impairment may have occurred. The
first step tests for impairment, while the second step, if necessary, measures
the impairment. The Company has elected to perform its annual analysis during
the fourth quarter of each fiscal year. No indicators of impairment were
identified in the fiscal year ended June 30, 2004.
Impairment of Long-Lived Assets
- -------------------------------
Pursuant to SFAS No. 144, "Accounting for the Impairment or Disposal of
Long-lived Assets", Markland continually monitors events and changes in
circumstances that could indicate carrying amounts of long-lived assets may not
be recoverable. An impairment loss is recognized when expected cash flows are
less than the asset's carrying value. Accordingly, when indicators or impairment
are present, Markland evaluates the carrying value of such assets in relation to
the operating performance and future undiscounted cash flows of the underlying
assets. Markland's policy is to record an impairment loss when it is determined
that the carrying amount of the asset may not be recoverable. No impairment
charges were recorded in the years ended June 30, 2004 and 2003.
Stock-Based Compensation
- ------------------------
At June 30, 2004, as permitted under SFAS No. 148, "Accounting for Stock-Based
Compensation - Transition and Disclosure", which amended SFAS No. 123,
"Accounting for Stock-Based Compensation", Markland has elected to continue to
follow the intrinsic value method in accounting for its stock-based employee
compensation arrangements as defined by Accounting Principles Board Opinion
("APB") No. 25, "Accounting for Stock Issued to Employees", and related
interpretation including Financial Accounting Standards Board ("FASB")
Interpretation No. 44, "Accounting for Certain Transactions Involving Stock
Compensation", an interpretation of APB No. 25. Since the only options issued by
the Company were issued in conjunction with a business combination on June 29,
2004, had the Company recorded compensation costs related to these options based
on fair value at the grant date consistent with SFAS No. 123, there would have
been no effect on the Company's net loss in any period presented.
Impact of Recently Issued Accounting Standards
- ----------------------------------------------
In May 2003, the FASB issued SFAS No. 150, "Accounting for Certain Financial
Instruments with Characteristics of both Liabilities and Equity." This statement
establishes standards for how an issuer classifies and measures certain
financial instruments with characteristics of both liabilities and equity. It
requires that an issuer classify a financial instrument that is within its scope
as a liability. Many of those instruments were previously classified as equity.
SFAS No. 150 is effective for financial instruments entered into or modified
after May 31, 2003, and otherwise is effective at the beginning of the first
interim period beginning after June 15, 2003. The adoption of this statement did
not have any impact on our financial position or results of operations.
F-20
MARKLAND TECHNOLOGIES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
YEARS ENDED JUNE 30, 2004 AND 2003
In December 2003, the FASB issues FASB Interpretation No. 46R ("FIN 46R"),
"Consolidation of Variable Interest Entities". FIN 46R expands upon existing
accounting guidance that addresses when a company should include in its
financial statements the assets, liabilities and activities of another entity. A
variable interest entity is a corporation, partnership, trust or any other legal
structure used for business purposes that either (a) does not have equity
investors with voting rights or (b) has equity investors that do not provide
sufficient financial resources for the entity to support its activities. FIN 46R
requires a variable interest entity to be consolidated by a company if that
company is subject to a majority of the risk of loss from the variable interest
entity's activities or is entitled to receive a majority of the entity's
residual returns or both. The adoption of this interpretation did not have any
impact on our financial position or results of operations.
3. ACQUISITIONS
Acoustic Core(TM) Technology
- ----------------------------
On December 9, 2002, in connection with the Exchange Agreement dated as of
December 9, 2002, by and among Eurotech, the Company, Crypto.com, Inc.,
("Crypto" - a wholly-owned subsidiary of Eurotech), Secured Technology, Inc.
("STI"), ipPartners, Inc., Market LLC and James LLC (the "Exchange"), Eurotech
and Crypto agreed to license and transfer certain intellectual property to a
newly-formed subsidiary of the Company, STI, in exchange for 3,998,789 shares of
the Company's newly issued common stock (the "Exchange Shares"). The Exchange
Shares constituted 80% of the Company's outstanding common stock making the
Company a majority-owned subsidiary of Eurotech. In addition, as part of the
agreement, ipPartners was issued 499,849 shares of common stock in exchange for
their forgiveness and discharge of certain obligations owed to ipPartners with
respect to the property transferred to STI. Eurotech is a development-stage,
Washington, D.C.-based, technology company, whose common stock is registered
under the Exchange Act. Prior to the Exchange, Market LLC and James LLC
controlled the Company.
In connection with the Exchange, on December 9, 2002, the Company, Market LLC
and James LLC agreed to a recapitalization of the Company, whereby $5,225,000 in
stated value of a new series of preferred stock, designated Series C 5%
Cumulative Convertible Preferred Stock (the "Series C Preferred Stock") was
issued by the Company, in exchange for $5,225,000 of convertible promissory
notes, inclusive of accrued interest, as well as, for the agreement by James LLC
F-21
MARKLAND TECHNOLOGIES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
YEARS ENDED JUNE 30, 2004 AND 2003
and Market LLC to collectively surrender 4,498,638 shares of the Company's
common stock prior to the consummation of the above Exchange agreement between
the Company and Eurotech, among others.
The rights licensed from Eurotech in the Exchange consist of certain proprietary
technology known as Acoustic Core used to detect illicit substances, and certain
cryptology technology held by Eurotech's subsidiary, Crypto. Since Eurotech
owned 80% of the common stock of the Company on December 9, 2002, the technology
acquired from Eurotech was recorded by the Company at Eurotech's carrying value
of $1,300,000. Eurotech had purchased the rights to such technologies in 2001.
The Company's technical employees and advisors concluded that as of December
2002, the Company has established technological feasibility for its ultimate
security product to be marketed. Additional development services and testing are
necessary to complete the product development. The Company will begin to
amortize this asset over the economic useful life of five years when the
technology is available for general release to its customers. The Company is
engaged in a project with the U.S. Air Force to evaluate the Acoustic Core(TM)
technology for use in the inspection of cargo. The technology utilizes acoustic
waves to detect illicit materials and density changes. In addition, the Company
is in the process of adapting such technology for use in the detection of
concealed weapons on persons that cannot be detected by traditional metallic
screeners.
Purchase of Intangible Assets of ASI Technology Corporation
- -----------------------------------------------------------
On March 19, 2003, Markland and ASI Technology Corporation, a Nevada
corporation, ("ASI") closed its Technology Purchase Agreement (the "Agreement").
Under the Agreement, ASI agreed to sell and Markland agreed to purchase certain
assets relating to ASI's gas plasma antenna technology, including patents,
patent applications, equipment, government contract rights and other
intellectual property rights. Under an interim arrangement, Markland had
received revenues from these contracts billed for periods after April 1, 2003
and was obligated for all related costs. Markland had agreed to use its best
efforts to manage and administer the contracts during this period prior to
closing and to pay ASI a fee of $2,500 per month for administrative support.
These fees amounted to $15,000. The closing of this transaction occurred on
September 30, 2003.
The purchase price of the ASI assets amounted to $1,000,000. This consisted of
$150,000 in cash, of which $65,000 was paid by June 30, 2003 and $85,000 was
paid by December 31, 2003 and 283,333 shares of common stock valued at $850,000.
These assets are being amortized over 3 years.
In connection with the Agreement, ASI and Markland entered into a registration
rights agreement entitling ASI to include its shares of Markland's common stock
in future registration statements filed by Markland under the Securities Act of
1933 in connection with public offerings of Markland's common stock. In the
event that Markland fails to register such stock on behalf of ASI, or if a
registration statement for the shares is delayed, Markland will have to issue an
additional $150,000 worth of common stock to ASI.
Also in connection with the Agreement, ASI and Markland entered into a
sublicense agreement pursuant to which ASI has sublicensed to Markland the right
to develop and sell products to certain government, military and homeland
security customers in the United States and Canada using Markland's plasma
sterilization and decontamination technology. Markland has agreed to pay ASI
$5,000 per month for these rights for a period of 24 months, of which $5,000 has
been paid to ASI under this agreement and $35,000 is included in selling,
general and administrative expenses for the year ended June 30, 2004.
F-22
MARKLAND TECHNOLOGIES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
YEARS ENDED JUNE 30, 2004 AND 2003
During March of 2004, Markland issued 42,500 shares of common stock valued at
$66,725 to ASI as a penalty for not having an effective registration statement
for the shares issued to ASI. This amount was charged to selling, general and
administrative expense in the statement of loss for the year ended June 30,
2004.
Purchase of Science and Technology Research, Inc.
- -------------------------------------------------
In October 2003, Markland completed the acquisition of 100% of the common stock
of Science and Technology Research, Inc., a Maryland corporation ("STR"), by its
subsidiary, Security Technology, Inc., a Delaware Corporation ("STI"), through a
merger of STI with newly formed STR Acquisition Corporation, a Maryland
Corporation. STR is a producer of the U.S. Navy's Shipboard Automatic Chemical
Agent Detection and Alarm System (ACADA). The Navy deploys the "man-portable"
point detection system to detect all classic nerve and blister agents as well as
other chemical warfare agent (CWA) vapors.
The purchase price for the STR aggregated $6,475,000 and consisted of $900,000
in cash, which was paid in October 2003, 1,539,779 shares of common stock valued
at $5,100,000, a promissory note of $375,000 and acquisition costs of $100,000.
The promissory note bears no interest and, under amended terms, is due in full
on October 15, 2004. Holders of the shares of common stock were granted
piggy-back registration rights. The promissory note is collateralized by all of
the assets of STR and 40% of the common stock of STR held by Markland. In June
2004, the Company made the first principal payment in the amount of $75,000. The
remaining promissory note, as amended, is payable as follows:
July 15, 2004 $ 75,000
August 15, 2004 75,000
September 15, 2004 75,000
October 15, 2004 75,000
---------
$300,000
=========
On March 15, 2004, Markland agreed to pay $40,000 of cash and issue an
additional 50,000 shares of common stock valued at $66,500 in exchange for his
agreement to extend the due date of the promissory note to October 15, 2004.
These amounts were charged to interest expense in the statement of loss for the
year ended June 30, 2004.
A summary of the allocation, as determined by an independent valuation, of the
aggregate consideration for the acquisition to the fair value of the assets
acquired and liabilities assumed is as follows:
Fair value of net assets acquired:
Fair value of assets acquired -
Current assets, including cash of $115,830 $ 783,657
Property and equipment 53,467
Fair value of liabilities assumed -
Accounts payable and accrued expenses (368,932)
------------
Fair value of identifiable net tangible assets acquired 468,192
Existing contracts 416,000
Customer relationships 1,551,944
Goodwill 4,038,864
------------
Total Purchase Price $ 6,475,000
============
F-23
MARKLAND TECHNOLOGIES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
YEARS ENDED JUNE 30, 2004 AND 2003
Markland also entered into a consulting agreement with the principal shareholder
and employee of STR (see Note 12).
Markland funded the cash portion of the acquisition from a loan provided by Bay
View Capital, LLC, ("Bay View"). Robert Tarini, Markland's Chairman is
affiliated with Bay View. The entire amount of the loan provided by Bay View was
$1,400,000 (see Note 6).
The results of operations of STR have been included in Markland's consolidated
statements of operations commencing October 1, 2003.
Purchase of E-OIR Technologies, Inc.
- ------------------------------------
On June 29, 2004, Markland acquired all of the outstanding stock of E-OIR
Technologies, Inc. ("EOIR") for $8,000,000 in cash and $11,000,000 in principal
amount of five year notes secured by the assets and stock of EOIR. EOIR is a
provider of technology and services to the US Army Night Vision Laboratories and
has expertise in wide area remote sensing using both electro-optic and infrared
technologies. The acquisition was consummated in furtherance of Markland's
stated strategy of making synergistic acquisitions in order to provide products
and services to Homeland Defense, the Department of Defense and U.S.
Intelligence Agencies.
In connection with this acquisition, Markland has also adopted a Stock Incentive
Plan (see Note 9).
A summary of the allocation, as determined by an independent valuation, of the
aggregate consideration for the merger to the fair value of the assets acquired
and liabilities assumed is as follows:
Cash $ 8,000,000
Promissory note (net of $1,467,956
below market interest rate discount) 9,532,044
Transaction costs 792,000
------------
Total Purchase Price $18,324,044
============
Fair value of net assets acquired:
Fair value of assets acquired -
Current assets, including cash of $332,637 $ 6,073,467
Property and equipment 1,030,000
Fair value of liabilities assumed:
Accounts payable & accrued expenses (5,169,584)
Bank loans and overdrafts (1,032,308)
------------
Fair value of identifiable net tangible assets acquired 901,575
Customer relationships 11,755,000
Goodwill 5,667,469
------------
Total Purchase Price $18,324,044
============
The goodwill in this transaction, as determined by the independent valuation,
arose as a result of anticipated synergies, cost savings and other items not
related to tangible net assets or identifiable intangible assets.
As a result of the transaction being structured as a stock acquisition, Markland
does not expect the goodwill to be deductible for tax purposes.
In connection with the EOIR acquisition, Markland also raised gross proceeds of
$2,000,000 through a private placement of an additional 3,500 shares of its
Series D Preferred Stock to a single institutional investor (see Note 8).
Between March 31, 2004 and June 30, 2004 Markland completed three private
placements, issuing a total of 13,232,083 shares of common stock plus additional
warrants for total proceeds of $9,679,000 ($8,226,845 net of issuance costs).
Cash raised in these financings were used, in part, to fund the acquisition of
EOIR.
F-24
MARKLAND TECHNOLOGIES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
YEARS ENDED JUNE 30, 2004 AND 2003
Unaudited pro forma financial information for the years ended June 30, 2004, had
the acquisitions of STR and EOIR been completed as of July 1, 2002, is as
follows:
Unaudited Pro Forma Information
- -------------------------------
Unaudited pro forma information for Markland's acquisition of STR is as follows:
- --------------------------------------------------------------------------------
MARKLAND-STR 2004 2003
- --------------------------------------------------------------------------------
Revenues $ 6,518,000 $ 6,713,000
============== ==============
Loss from operations $ (10,245,000) $ (3,349,000)
============== ==============
Net loss applicable to common
stockholders $ (15,227,000) $ (8,488,000)
============== ==============
Net loss applicable to common
stockholders per common share $ (1.35) $ (1.30)
============== ==============
Unaudited pro forma information for Markland's acquisition of EOIR is as
follows:
MARKLAND-EOIR 2004 2003
- --------------------------------------------------------------------------------
Revenues $ 59,416,000 $ 34,315,000
============== ==============
Loss from operations $ (7,702,000) $ (2,973,000)
============== ==============
Net loss applicable to common
stockholders $ (13,333,000) $ (8,743,000)
============== ==============
Net loss applicable to common
stockholders per common share $ (1.23) $ (1.75)
============== ==============
Unaudited pro forma information for Markland's acquisition of both STR and EOIR
is as follows:
MARKLAND-STR-EOIR 2004 2003
- --------------------------------------------------------------------------------
Revenues $ 59,920,000 $ 40,369,000
============== ==============
Loss from operations $ (7,796,000) $ (2,708,000)
============== ==============
Net loss applicable to common
stockholders $ (13,465,000) $ (8,633,000)
============== ==============
Net loss applicable to common
stockholders per common share $ (1.20) $ (1.32)
============== ==============
F-25
MARKLAND TECHNOLOGIES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
YEARS ENDED JUNE 30, 2004 AND 2003
4. AMORTIZATION OF INTANGIBLE ASSETS
Amortizable intangible assets consist of the following at June 30, 2004:
Amortizable intangibles - EOIR $ 11,755,000
Amortizable intangibles - Ergo 400,000
Amortizable intangibles - ASI 1,000,000
Amortizable intangibles - STR 1,967,944
--------------
Total amortizable intangibles $ 15,122,944
Accumulated amortization (982,396)
--------------
Net amortizable intangibles $ 14,140,548
==============
The purchase price of $400,000 related to the January 2003 acquisition of Ergo
was allocated entirely to a contract with the United States Government. The
contract is being amortized over a three-year period commencing with the date of
the acquisition, January 14, 2003. Amortization expense related to the contract
for the years ended June 30, 2004 and 2003 was $133,332 and $66,668,
respectively.
The intangible assets acquired from ASI on September 30, 2003 totaled
$1,000,000. These assets are being amortized over a three-year period commencing
October 1, 2003. Amortization expense related to this contract for the year
ended June 30, 2004 was $250,000.
The excess of the purchase price of STR over the fair value of assets acquired
was $6,006,808. Of this amount, $4,038,864 was allocated to goodwill and
$1,967,944 to amortizable intangible assets. $416,000 was allocated to existing
contracts with a twenty-six month estimated economic life and the remaining
$1,551,944 was allocated to customer relationships with an estimated economic
useful life of ten years. Markland has recorded amortization expense of $532,396
for year ended June 30, 2004.
The excess of the purchase price of EOIR over the fair value of assets acquired
is $18,022,469. Of this amount, $6,267,469 was allocated to goodwill and
$11,755,000 to amortizable intangible assets comprising contracts and customer
relationships. This asset has an estimated useful life of nine years. Markland
has not recorded amortization expense for year ended June 30, 2004 as the
acquisition was completed on June 29, 2004.
Future amortization expense related to the above-acquired intangible assets over
the next five years is as follows:
Years Ending
June 30, Amount
------------ -----------
2005 $2,119,972
2006 1,941,305
2007 1,544,639
2008 1,461,306
2009 1,461,306
-----------
$8,528,527
===========
The intangible assets entitled "Acoustic Core" which has a carrying value of
$1,300,000 are not available for commercial sale as of June 30, 2004.
Accordingly, no amortization expense has been recorded through June 30, 2004.
F-26
MARKLAND TECHNOLOGIES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
YEARS ENDED JUNE 30, 2004 AND 2003
5. LINES OF CREDIT
Secured Convertible Revolving Credit Notes
- ------------------------------------------
On December 9, 2002, as part of the Company's recapitalization, in accordance
with the Exchange Agreement entered between the Company and Market LLC,
$3,812,000 representing principal and accrued interest under this line of credit
was converted into 3,812 shares of the Company's newly issued Series C 5%
Cumulative Convertible Preferred Stock (see Note 8).
On December 10, 2002, Markland entered into a Restated and Amended Secured
Convertible Revolving Credit Note Agreement for $500,000.
Interest under this note accrued at the interest rate of 6% per annum.
The note was convertible at any time, in whole or in part, into shares of the
Company's common stock. The total number of shares of common stock issuable upon
conversion will be determined by dividing the principal amount of this note
being converted by 80% of the closing bid price of the common stock based on the
average of the five trading days immediately preceding the date of conversion.
The value of the beneficial conversion feature of $125,000 was being amortized
as interest expense over the term of the debt.
The principal on the note and accrued interest totaling $518,459 was converted
into 404,266 shares of Markland's common stock on April 12, 2004. All
unamortized discount related to the beneficial conversion feature was charged to
interest expense at that time. Amortization of the beneficial conversion feature
for the years ended June 30, 2004 and 2003 was $60,126 and $41,666,
respectively.
Bank Line of Credit
- -------------------
EOIR established a $500,000 line of credit with Virginia Community Bank in
October 1999. It is secured by current accounts receivable with variable
interest at the prime lending rate (4% at June 30, 2004) plus 1%. The line of
credit was extended in 2004, increased to $600,000 and expires in April, 2005.
The balance due under this credit line was $600,000 as of June 30, 2004.
There is no interest expense associated with this line in the statements of loss
because EOIR was acquired on June 29, 2004.
6. LONG-TERM DEBT
Note Payable - AI
- -----------------
In December 2003, Markland signed a note to finance an insurance premium. The
unpaid balance of this note on June 30,2004 was $4,098.
Note Payable - Bay View Capital
- -------------------------------
On September 4, 2003, Markland signed a term sheet with Bay View Capital, LLC, a
related party, and received in October, 2003 a $1,400,000 bridge-financing loan
of which Markland immediately repaid $211,000. The proceeds from this loan were
used by Markland to fund the acquisition of STR (see Note 3). The loan agreement
provides for Markland to make 24 monthly payments of principal and interest.
F-27
MARKLAND TECHNOLOGIES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
YEARS ENDED JUNE 30, 2004 AND 2003
Principal is calculated on a monthly basis using a "Cash Flow Recapture
Mechanism" as defined in the agreement. Interest is payable monthly in arrears
at a rate of 12% per annum payable. The note requires monthly payments in the
amount equal to twenty five percent of the gross revenue of STR for the
immediately preceding calendar month. The remaining principal balance together
with any unpaid interest is due on October 27, 2005. The note was secured by a
security interest in substantially all assets of Markland. The balance of the
note, plus accrued interest, was paid in full in April 2004. Interest expense
related to this note was $100,769 for the year ended June 30, 2004.
Note Payable - STR Acquisition
- ------------------------------
On October 1, 2003, Markland issued a note in the amount of $375,000 in
connection with the acquisition of STR (see Note 3). This note is payable in
full by October 15, 2004. The outstanding balance at June 30, 2004 was $300,000.
On March 15, 2004, Markland agreed to issue to George Yang $40,000 of cash and
an additional 50,000 shares of common stock valued at $66,500 in exchange for
his agreement to extend the note to October 15, 2004. These amounts were charged
to interest expense in the statement of loss for the year ended June 30, 2004.
Accrued expenses include $40,000 related to this agreement.
Notes Payable - EOIR Acquisition
- --------------------------------
On June 29, 2004, EOIR issued notes guaranteed by Markland in the face amount of
$11,000,000 in connection with the acquisition of EOIR's common stock. These
notes accrue interest at 6% compounded monthly and are payable in quarterly
installments over 60 months. The fair market value of these notes is $9,532,044
as determined by an independent valuation. The discount of $1,467,956 will be
amortized to interest expense over the life of the note.
Other Long-Term Bank Debt
- -------------------------
Markland's long-term bank debt consists of the following as of June 30, 2004:
Wachovia Bank, secured by a vehicle, dated November,
2001 with monthly payments of $877 including
interest of 6.1% $ 23,563
First Market Bank, secured by research equipment,
dated October, 2002 with monthly payments of $3,715
including interest of LIBOR plus 2.75% (4.1082% at
June 30, 2004) 141,685
First Market Bank, dated July, 2002 with monthly payments
of $15,278 plus interest of
LIBOR plus 2.75%, (4.1082% at June 30, 2004) 185,363
First Market Bank, secured by leasehold improvements,
dated March 19, 2003 with monthly
payments of $3,514 including interest of 5.05% 64,294
American Honda Finance, secured by vehicle, dated
March 24, 2003 with monthly payments
of $406 including interest of 4.70% 17,403
----------
$ 432,308
==========
F-28
MARKLAND TECHNOLOGIES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
YEARS ENDED JUNE 30, 2004 AND 2003
Future debt maturities for all notes payable and long-term debt are as follows
for the years ending:
June 30
-------
2005 $2,787,061
2006 2,280,294
2007 2,249,763
2008 2,219,288
2009 2,200,000
-------------
Total 11,736,406
Less: debt discount (1,467,956)
-------------
$ 10,268,450
=============
7. NEW EQUITY LINE
On September 10, 2003, Markland entered into a Private Equity Credit Agreement
with Brittany Capital Management, Ltd. ("Brittany"). Markland agreed to issue
and sell to Brittany up to $10,000,000 worth of its common stock over the next
three years. Prior to any sales, Markland is required to file a registration
statement with the Securities and Exchange Commission, relating to the shares to
be issued, and to have such registration statement declared effective.
After the registration statement is declared effective, Markland would be able
to put shares to Brittany according to the terms outlined in the agreement (the
"Put"). The minimum Put amount is $1,000,000 over the life of the agreement and
$25,000 per Put. Failure to satisfy the minimum Put requirement over the life of
the Private Equity Credit Agreement will result in a charge to Markland.
Shares will be issued to Brittany, in connection with each Put, at 92% of the
average of the closing bid prices for the lowest three (3) (not necessarily
consecutive) trading days during the ten (10) trading day period immediately
following the Put date. Under certain conditions, Markland will be required to
issue additional shares and/or accrue financial penalties.
There can be no assurances that Markland will receive any proceeds from this
agreement. As of June 30, 2004, Markland has not drawn down on this equity line.
As of June 30, 2004, no shares have been registered by Markland related to this
agreement. For all periods presented, Markland has determined that the fair
value of this Put was not material.
8. STOCKHOLDERS' EQUITY
Preferred Stock:
- ----------------
The Company is authorized to issue 5,000,000 shares of preferred stock which may
be issued in series with such designations, preferences, stated values, rights,
qualifications, or limitations as determined by the Board of Directors.
Series A Redeemable Convertible Preferred Stock
-----------------------------------------------
On June 30, 2003, Markland issued 30,000 shares of our Series A Non-Voting
Redeemable Convertible Preferred Stock in satisfaction of our remaining
obligations under a promissory note. The Series A Preferred Stock has no par
value, is non-voting and has a stated value of $10 per share. The Preferred
Stock is convertible at any time at the option of the Company, and cannot be
converted by the holder. This stock is convertible at the rate of three shares
of Series A Preferred Stock for each share of common stock. This conversion rate
may be adjusted at any time by the Company as a result of either the sale of the
F-29
MARKLAND TECHNOLOGIES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
YEARS ENDED JUNE 30, 2004 AND 2003
Company or as a result of a stock split or stock dividend that is issued by the
Company while these shares remain outstanding.
The Company shall have the right, but not the obligation to, at any time after
the issuance of these shares to redeem all or any portion of the outstanding
shares of Series A Preferred Stock from the holder in cash at the stated value
of $10 per share by sending notice to the holder. The Series A Preferred Stock
has a liquidation preference of $10 per share. This stock does not accrue
dividends.
Series B Convertible Preferred Stock
------------------------------------
On September 4, 2003, Markland's board of directors approved a resolution to
cancel its Series B convertible preferred stock.
Series C 5% Cumulative Convertible Preferred Stock
--------------------------------------------------
On December 9, 2002, the Company entered into an Exchange Agreement, among the
Company and Market LLC and James LLC who agreed to exchange their convertible
notes payable in the amount of $3,812,000 and $1,413,000, respectively
($5,225,000 in value), inclusive of accrued interest for 5,225 shares ($1,000
stated value per share) of the Company's newly issued Series C Preferred Stock.
The Series C Preferred Stock is non-voting and has a liquidation preference of
$1,000 per share.
The holders of the Series C Preferred Stock are entitled to receive dividends on
each share of preferred stock, which shall accrue on a daily basis at the rate
of 5% per annum on the sum of the liquidation preference plus all accumulated
and unpaid dividends thereon. These dividends shall accrue whether or not they
have been declared or there are legally available funds with which to pay them,
and at the option of the holders are payable either in cash or in unrestricted
common stock.
The Series C Preferred Stock is redeemable at any time by Markland, and cannot
be converted by the holders without written permission for a period of 6 months
following the issuance of the shares and then only 10% may be converted per
month thereafter. The Series C Preferred Stock is convertible at the option of
the holder at a conversion price ranging from 65% to 80% of the common stock's
market price at the time of the conversion.
During the year ended June 30, 2003, Markland sold 170 shares of Series C
Preferred Stock for proceeds of $170,000.
On the dates these shares were issued, Markland calculated a beneficial
conversion feature related to the conversion discount of $1,386,025. This
beneficial conversion feature was accreted to deemed dividends over the
conversion period of the Series C Preferred Stock which is 16 months. Deemed
dividends related to this beneficial conversion feature were $884,270 and
$501,755 for the years ended June 30, 2004 and 2003, respectively.
During the years ended June 30, 2004 and 2003, the Company accreted dividends of
$184,478 and $152,716, respectively.
During the years ended June 30, 2004, all outstanding Series C Preferred Stock
and dividends of $337,194 were converted into 6,029,844 shares of common stock.
F-30
MARKLAND TECHNOLOGIES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
YEARS ENDED JUNE 30, 2004 AND 2003
Series D Convertible Preferred Stock
------------------------------------
Shares of the Series D Convertible Preferred Stock have a liquidation preference
of $1,000 per share, are non-voting, do not accrue dividends, are redeemable by
Markland anytime and are convertible into shares of Markland's common stock at a
conversion price ranging from 65% to 80% of the common stock's market price at
the time of the conversion.
The Series D preferred stock is convertible at the option of the stockholder at
any time. The number of shares of our common stock into which each share of
Series D preferred is convertible is determined by dividing $1,000 by the
discounted bid price. The "discounted" bid price is the average closing bid
price of our common stock during the five business days immediately preceding
the conversion date multiplied by the applicable discount factor, as set forth
below.
-------------------------------------------------------- ---------------------
AVERAGE CLOSING BID PRICE (1) DISCOUNT FACTOR
-------------------------------------------------------- ---------------------
$15.00 or less 80%
-------------------------------------------------------- ---------------------
more than $15.00, but less than or equal to $30.00 75%
-------------------------------------------------------- ---------------------
more than $30.00, but less than or equal to $45.00 70%
-------------------------------------------------------- ---------------------
more than $45.00 65%
-------------------------------------------------------- ---------------------
----------------------
(1) After an adjustment for a 1-for-60 reverse stock split effective
October 27, 2003.
The Series D preferred stock can be converted only to the extent that the Series
D stockholder will not, as a result of the conversion, hold in excess of 9.999%
of the total outstanding shares of our common stock.
On June 17, 2003, the Company issued to Eurotech 16,000 shares of Series D
Redeemable Convertible Preferred Stock in exchange for 1,666,666 shares of the
Company's common stock. The Company also sold an additional 430 shares of Series
D Preferred Stock to James LLC for net proceeds of $430,000.
During the year ended June 30, 2004, Markland sold to a third party 7,166 shares
of Series D Preferred Stock for gross proceeds of $5,402,000.
Markland has determined that as of the date of issuance there was a beneficial
conversion feature in the aggregate amount of $3,555,500 and $4,107,500 for the
years ended June 30, 2004 and 2003, respectively. The accretion of these
beneficial conversion features on the Series D Preferred Stock has been recorded
as a deemed dividend. The deemed dividends increases the loss applicable to
common shareholders in the calculation of basic and diluted net loss per common
share.
Reverse Stock Split
- -------------------
On September 4, 2003, Markland's board of directors approved a resolution to
effect a one-for-sixty reverse stock split. This action was subsequently
approved by shareholder action which was approved by written consent of the
Markland shareholders who held at least a majority of the voting power of the
common stock, at least 67% of the voting power of the Series C Cumulative
Convertible Preferred Stock, and at least 67% of the voting power of the Series
D Cumulative Convertible Preferred Stock. As a result, each sixty shares of
common stock was converted automatically into one share of common stock. To
avoid the issuance of fractional shares of common stock, each fractional share
F-31
MARKLAND TECHNOLOGIES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
YEARS ENDED JUNE 30, 2004 AND 2003
resulting from the reverse split was rounded up to a whole share. The reverse
stock split did not reduce the 500,000,000 shares of common stock that Markland
is authorized to issue. The resolution, which impacts shareholders of record as
of September 5, 2003 became effective on October 27, 2003. All share amounts and
per share data have been restated to reflect this reverse stock split.
Common Stock Issuances
- ----------------------
In December 2002, the Company entered into a private equity-financing agreement
with two investors in order to raise $340,000 of new capital to finance
operations. In exchange for the capital, the investors received an aggregate of
113,333 shares of the Company's common stock.
In December 2002, the Company issued an aggregate of 6,667 shares of its common
stock to two of its former directors as compensation for services rendered while
employed with the Company. In February 2003, the Company agreed to pay one of
the aforementioned directors $5,000 in lieu of 1,667 shares of previously issued
common stock. For the year ended June 30, 2003, a charge to compensation expense
related to the above transactions amounted to $8,000.
During the months of February and March 2003, the Company entered into four new
one-year consulting agreements, which provide for aggregate monthly remuneration
of $3,000. In connection with those agreements, the Company issued 63,333 shares
of restricted common stock. The shares were valued at $890,000, of which
approximately $605,000 and $285,000 were charged to operations during the years
ended June 30, 2004 and 2003, respectively.
On July 3, 2003, Markland entered into a consulting agreement with Emerging
Concepts Inc. for program management and project engineering services for Ergo
Systems related border security activities. In conjunction with this agreement,
Markland issued Emerging Concepts 25,000 fully vested shares of common stock
valued at $102,000. This amount was charged to operations in the year ended June
30, 2004.
On July 24, 2003, Markland entered into an Agreement (the "Agreement") with
Syqwest, Inc., a Rhode Island corporation, and related party, formerly known as
Ocean Data Equipment Corporation ("Syqwest"). Under this Agreement, Syqwest
agreed to receive 750,000 shares of Markland's restricted common stock as full
consideration for $450,000 of unpaid services, which were performed by Syqwest
in connection with the research efforts as it relates to the Vehicle Stopping
Technology. Pursuant to the Agreement, Markland has the right at any time by
written notice to repurchase from Syqwest these 750,000 shares of restricted
common stock at a purchase price of $0.60 per share. Based on this redemption
right and the restriction on the sale of such securities, Markland has valued
these shares at the redemption price of $450,000.
During the year ended June 30, 2004, Markland issued to ECON Investor Relations,
Inc., a consultant, a 13,790 shares of common stock valued at $44,486. These
fully vested shares were issued for enhanced media and corporate communications
programs. This amount was charged to operations in the year ended June 30, 2004.
In November 2003, Markland entered into a one year agreement with MarketShare
Recovery, Stuart Siller, and George Martin to perform certain services with
regard to investor relations for Markland. In consideration for these services,
Markland agreed to issue a cumulative total of 90,908 shares of its common stock
in quarterly installments of 22,727 shares. Since these shares are earned over
the term of the agreement and are subject to forfeiture, the Company has
accounted for these under variable accounting. Accordingly, the Company records
F-32
MARKLAND TECHNOLOGIES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
YEARS ENDED JUNE 30, 2004 AND 2003
at fair value the unearned shares each period through the term of the agreement.
As of June 30, 2004, the Company has recognized unearned compensation,
additional paid in capital and stock compensation of $91,005, $273,012 and
$182,011, respectively. Subsequent to year end, the Company issued these
consultants 160,000 shares of common stock valued at $106,000 in order to settle
a dispute.
In November 2003, Markland entered into an agreement with Research Works to
prepare an equity research report. In consideration for these services, Markland
issued Research Works a total of 37,099 shares valued at $105,732. This amount
was charged to operations in the year ended June 30, 2004.
During the year ended June 30, 2004, Markland awarded three non-officer
employees of Markland a total of 19,445 shares valued at $48,036. This amount
was charged to operations in the year ended June 30, 2004.
During March of 2004, Markland issued 42,500 shares of common stock valued at
$66,725 to ASI as a penalty for not having an effective registration statement
for the shares issued to ASI. This amount was charged to operations for the year
ended June 30, 2004.
On March 15, 2004, in conjunction with the acquisition of STR, Markland agreed
to issue to George Yang 50,000 shares of common stock valued at $66,500 in
exchange for his agreement to amend a note payable. This amount was charged to
interest expense in the statement of loss for the year ended June 30, 2004.
On February 12, 2004, Markland entered into a one year agreement with Tameraq
Partner for investment banking services. This agreement calls for quarterly
payments of $25,000 payable in stock. As of June 30, 2004, the Company has
recognized unearned compensation, additional paid in capital and stock
compensation of $50,000, $100,000 and $50,000, respectively.
Pursuant to a private placement transaction completed on April 2, 2004, Markland
issued the following:
o 3,333,333 shares of Markland common stock at $0.60 per share;
o 300,000 shares of Markland common stock in order to get the
investors' consent to the private placement on April 16, 2004
(see below)
o warrants to purchase 3,333,333 shares of Markland common stock
at $1.00 per share with a three year term;
o warrants to purchase 333,333 shares of Markland common stock
at $1.40 per share with a three year term that were issued as
finders' fees;
o warrants to purchase 50,000 shares of Markland common stock at
$1.00 per share with a three year term that were issued in
order to get the investors' consent to the private placement
on April 16, 2004 (see below).
Markland agreed to register for resale 150% of the 3,333,333 shares of its
common stock in this offering and 110% of the 3,333,333 shares of its common
stock that are issuable to certain stockholders upon exercise of the warrants to
cover the shares of its common stock, if any, issuable to certain selling
stockholders as liquidated damages for breach of certain covenants contained in
or as a result of adjustments contemplated by certain provisions of the
Securities Purchase Agreement dated as of April 2, 2004 or the Registration
Rights Agreement dated as of April 2, 2004. Markland also agreed to register
F-33
MARKLAND TECHNOLOGIES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
YEARS ENDED JUNE 30, 2004 AND 2003
110% of the 383,333 shares of its common stock that are issuable to certain
stockholders upon exercise of the warrants issued as finders' fee and in order
to obtain the investors' consent.
Pursuant to a private placement transaction completed on April 16, 2004,
Markland issued the following:
o 2,500,000 shares of Markland common stock;
o warrants to purchase 3,333,333 shares of Markland common stock
at $1.50 per share with a three year term;
o warrants to purchase 25,000 shares of Markland common stock at
$2.00 per shares with a three year term that were issued as
finders' fees.
Markland agreed to register for sale 150% of the 2,500,000 shares of its common
stock sold to certain selling stockholders pursuant to the Securities Purchase
Agreement dated April 16, 2004 and 110% of the 3,333,333 shares of its common
stock that are issuable to certain stockholders upon exercise of the warrants
sold in this private placement, to cover the shares of its common stock, if any,
issuable to certain selling stockholders as liquidated damages for breach of
certain covenants contained in or as a result of adjustments contemplated by
certain provisions of the Securities Purchase Agreement dated as of April 16,
2004 or the Registration Rights Agreement dated as of April 2, 2004.
Pursuant to a private placement transaction completed on May 3, 2004, Markland
issued the following:
o 7,098,750 shares of its common stock;
o warrants to purchase 7,098,750 shares of its common stock at
$1.50 per shares with a three year term;
o warrants to purchase 529,800 shares of its common stock at
$1.50 per share with a three year term that were issued as
finders' fees.
In conjunction with these three private placements, Markland received gross
proceeds of $9,679,000 and net proceeds of $8,226,845 (after deducting finders'
fees and transaction costs). Under certain conditions, Markland can redeem the
warrants issued in the May 3, 2004 private placement at a price of $.0001 per
warrant.
Markland has entered into compensation agreements with certain officers and a
consultant (see Note 12) which provide for, among other things, certain
performance-based stock grants. Due to the indeterminate number of shares to be
issued under these agreements, Markland accounts for these stock compensation
plans under variable accounting. Accordingly, for the year ended June 30, 2004,
Markland recognized unearned compensation, additional paid in capital and stock
compensation expense of $11,035,110, $15,414,419 and $4,379,309, respectively.
For the year ended June 30, 2003, the Company recognized unearned compensation,
additional paid in capital and stock compensation expense of $3,781,000,
$5,518,000 and $1,737,000, respectively. In connection with these agreements,
Markland issued 5,830,713 and 155,754 shares of common stock during the years
ended June 30, 2004 and 2003, respectively.
F-34
MARKLAND TECHNOLOGIES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
YEARS ENDED JUNE 30, 2004 AND 2003
During December 2002 and amended on January 18, 2003, the Company entered into a
consulting agreement for six months with an option to renew for an additional
six months for services relating to corporate communications. The agreement
provides for monthly fees of $7,000, plus expenses, and 333 shares of the
Company's common stock. For the year ended June 30, 2003, the Company issued
this consultant 2,333 shares of restricted common stock total and has charged
approximately $30,000 to operations related to these stock issuances.
Markland has established the following reserves for the future issuance of
common stock as follows:
Reserve for the exercise of warrants 14,703,549
Reserve for stock option plan 25,000,000
Reserve for conversion of Series A Preferred Stock 10,000
Reserve for conversion of Series D Preferred Stock 37,734,756
-------------
Total reserves 77,448,305
=============
The Company is also obligated to issue certain shares under employment and
consulting agreements (see Note 12).
9. OPTIONS AND WARRANTS
In conjunction with the Company's acquisition of EOIR (see Note 3), the Company
adopted the 2004 Stock Incentive Plan ("the Plan"). The Plan authorizes the
Company to issue up to 25,000,000 of common shares in the form of options, stock
awards, performance share awards or stock appreciation rights.
On June 29, 2004, the Company issued options to eleven former minority owners of
EOIR who have continued employment with the Company. These options have a ten
year term and vest ratably over a five year period. Ten of these employees
received options to purchase 9,345,737 shares of common stock at a price of
$.3775. On the date of grant, the intrinsic value of these options, $3,528,016,
was recorded as unearned stock-based compensation and additional paid in
capital. This intrinsic value will be amortized to stock compensation over the
five year vesting period.
One employee received five options, each of which allows for the purchase of a
number of shares equal to .11799575 times a fraction of $1,600,000 divided by
the fair value of the stock on the vesting date. One of these options vests each
year for the next five years. The exercise price of these options will be
one-half the fair value of the stock on the vesting date. The intrinsic value of
these options based on the fair value of the stock on June 30, 2004 is $471,983.
This intrinsic value has been recorded as unearned stock-based compensation and
additional paid in capital. Due to the variable nature of the exercise price and
number of shares to be issued under these options, the intrinsic value will be
remeasured each period until the terms are fixed. The intrinsic value of each
option will be amortized over the vesting periods. As of September 30, 2004, the
maximum number of shares issuable under these options is 1,210,213.
Markland has also agreed to grant options to purchase an additional 5,000,000
shares of common stock to employees of EOIR in the future. Markland expects that
these options will vest over five years after the date of grant and will have an
exercise price equal to the fair market value of the common stock on the date of
grant.
No options were vested at June 30, 2004.
F-35
MARKLAND TECHNOLOGIES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
YEARS ENDED JUNE 30, 2004 AND 2003
SFAS No. 123 requires the measurement of the fair value of stock options, to be
included in the statement of loss or disclosed in the notes to financial
statements (see Note 2). The Company has determined that it will continue to
account for stock-based compensation for employees under Accounting Principles
Board Opinion No. 25, Accounting for Stock Issued to Employees, and has elected
the disclosure-only alternative under SFAS Nos. 123 and 148 using the
Black-Scholes option pricing model prescribed by SFAS No. 123. The assumptions
used and weighted average information for the year ended June 30, 2004 is as
follows:
Risk-free interest rate 3.05%
Expected dividend yield -
Expected lives 3 years
Expected volatility 149.4%
Weighted average fair value per share
of options granted $0.71
In connection with private placements of common stock in April and May 2004, the
Company issued warrants to purchase a total of 14,703,549 shares of common stock
at exercise prices between $1.00 and $1.50. Included in these are warrants to
purchase 13,765,416 shares of common stock issued to investors in the private
placement. The value of these warrants was recorded as additional paid in
capital. The Company has estimated the fair value of these warrants on the grant
date as $19,391,359. The remaining warrants to purchase a total of 938,133
shares of common stock were issued as finders' fees. Since these warrants are
considered stock issuance costs, there is no net impact on equity. The Company
has estimated the fair value of these warrants on the grant date as $1,116,945.
At June 30, 2004, the Company had the following outstanding warrants:
Number of
Shares Exercise Date of
Exercisable Price Expiration
---------------- ----------------- ------------------
Issued in conjunction with April 2,
2004 private placement 3,333,333 $1.25 April 2, 2007
333,333 $1.40 April 2, 2007
Issued in conjunction with April 16,
2004 private placement 3,333,333 $1.50 April 16, 2007
25,000 $2.00 April 16, 2007
50,000 $1.00 April 21, 2004
Issued in conjunction with May 3,
2004 private placement 7,098,750 $1.50 May 3, 2007
529,800 $1.50 May 3, 2007
----------------
Total 14,703,549
================
Weighted average exercise price $1.44
================
Weighted average remaining life 2.81 years
================
F-36
MARKLAND TECHNOLOGIES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
YEARS ENDED JUNE 30, 2004 AND 2003
10. NET LOSS PER SHARE
Securities that could potentially dilute basic earnings per share ("EPS") in the
future, and that were not included in the computation of diluted EPS because to
do so would have been anti-dilutive for the periods presented, consists of the
following:
Shares Potentially
Issuable
------------------
Series A Redeemable Convertible Preferred Stock 10,000
Series D Convertible Preferred Stock (convertible at 80% of market value) 34,734,756
Stock options 10,496,915
Warrants 14,703,549
Employment and consulting agreements 17,436,271
-------------
Total as of June 30, 2004 77,381,491
=============
Subsequent to year end, Markland issued more than 20,000,000 shares of common
stock in conjunction with conversions of Series D Convertible Preferred Stock,
employment and consulting agreements and financings (see Note 16).
11. DISCONTINUED OPERATIONS
The Company has treated the disposition of CWTel in March 2002 and Vidikron in
May 2002 as discontinued operations. The following information summarizes the
operating results of the discontinued operations included in the consolidated
financial statements:
Year Ended Year Ended
June 30, 2004 June 30, 2003
------------- -------------
Revenues $ -- $ --
============= =============
Income from operations $ -- $ 998,713
============= =============
Income from discontinued operations $ -- $ 998,713
============= =============
The income from discontinued operations for the year ended June 30, 2003 of
$998,713 is a result of management of the Company completing an analysis of
various obligations related to the discontinued operations. Management
determined that $297,404 of liabilities related to the discontinued operations
were either three years old (past the statute of limitations) or represented an
overestimate of an accrual. In addition, a real estate lease obligation, which
had been recorded in previous years at $706,309, was settled for $5,000.
During the year ended June 30, 2003, the Company converted a $300,000 promissory
note related to the discontinued operations into 30,000 shares of Series A
redeemable convertible preferred stock (see Note 8).
As of June 30, 2004 and 2003, there were no assets or liabilities remaining from
discontinued operations.
F-37
MARKLAND TECHNOLOGIES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
YEARS ENDED JUNE 30, 2004 AND 2003
12. COMMITMENTS AND CONTINGENCIES
Compensation Agreements
- -----------------------
Effective January 2003, Markland entered into a one-year compensation agreement
with the former chief executive officer and three three-year agreements with an
officer, the president and chief financial officer, and two consultants to
Markland, Robert Tarini and Verdi Consulting, which provided for aggregate
remuneration of $47,500 per month. During the year ended June 30, 2004, Markland
accrued $600,000 of bonus compensation under these agreements.
One of these agreements provided for the issuance of 1.67% of Markland's
outstanding common stock in three installments, 50% of the shares were issued on
or about March 21, 2003, 25% of the shares on or about July 1, 2003 and 25% of
the shares on or about October 1, 2003. A final issuance occurred as of December
31, 2003, so that the total amount of shares issued up to December 31, 2003 will
equal 1.67% of the outstanding common stock as of December 31, 2003.
In addition, these three agreements, provide in total for the issuance of 5.01%
of the Company's outstanding common stock in four installments on a fully
diluted basis based upon certain performance criteria being met. Upon contract
signing, the Company issued a number of shares of Common Stock then equivalent
to 0.5% of the total number of shares of Common Stock then outstanding,
inclusive of such Employee's/Consultant's Shares; on or about July 1, 2003,
Company will issue to these Employee/Consultants a number of shares of Common
Stock then equivalent to 0.5% of the total number of shares of Common Stock then
outstanding, inclusive of such Employee's/Consultant's Shares if the Second
Quarter gross revenue target has been met; and on or about October 1, 2003
Company will issue to these Employee/Consultants a number of shares of Common
Stock then equivalent to 0.67% of the total number of shares of Common Stock
then outstanding, inclusive of such Employee's/Consultant's Shares, minus the
aggregate number of Shares issued to these parties in the first two installments
if the Third Quarter gross revenue target has been met. If necessary, an
additional issuance will occur in January 2004, so that the total amount of
shares issued will equal 5.01% of the outstanding common stock calculated on a
fully-diluted basis assuming the conversion of all convertible securities as of
December 31, 2003.
All of the shares issuable under these four agreements were earned as of January
1, 2004. Accordingly, a total of 1,410,719 shares were issued, of which 119,360
were issued during the year ended June 30, 2003 and 1,291,359 were issued during
the year ended June 30, 2004.
On May 12, 2004, Markland entered into five-year compensation agreements with
two executives, the chairman and chief executive officer and the president and
chief financial officer, and a consultant, Verdi Consulting. These agreements,
which are effective on January 1, 2004, provide for the following remuneration:
Base annual remuneration of $300,000 each (an aggregate of $900,000)
payable over the five-year period ending January 2, 2009;
Discretionary bonuses over the term of the agreement of up to 300% of
the base remuneration; and
F-38
MARKLAND TECHNOLOGIES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
YEARS ENDED JUNE 30, 2004 AND 2003
Conditional stock grants over the period commencing April 1, 2004
through January 2, 2008, based on defined performance criteria. The
stock grants, if all earned, entitle each of the three parties to
receive up to 7.5% of Markland's common stock on a fully diluted basis.
These grants are earned according to the following schedule:
Grant 1 2.5% April 1, 2004
Grant 2 1.0% July 1, 2004
Grant 3 1.0% October 1, 2004
Grant 4 1.0% January 2, 2005
Grant 5 1.0% January 2, 2006
Grant 6 0.5% January 2, 2007
Grant 7 0.5% January 2, 2008
The number of shares of common stock to be granted on each grant date is
equal to the product of (a) the number of fully diluted shares
outstanding at the grant date and (b) the stock percentage associated
with that grant date.
In the event of a change in control of Markland during the period covered
by the agreement, each executive/consultant will automatically be granted
all remaining stock grants and will be due cash and expense compensation
for the shorter of (i) three years from the date of the change in
control, or (ii) until the end of the term of the agreement. A change in
control is defined by the agreements as a change in the majority
ownership of the equity of Markland, or the resignation or termination of
the majority of the board of directors within a two month period, or the
replacement of the CEO or the President of Markland.
In June 2004, these agreements were modified to remove the anti-dilution
provision. During the year ended June 30, 2004, a total of 4,575,744 shares of
common stock were issued under these new agreements.
In connection with the STR acquisition, Markland entered into a one year
consulting agreement, as amended on March 17, 2004, with the former President
and principal of STR ("Consultant"). In consideration for the consulting
services to be rendered by Consultant, Markland shall pay to Consultant the sum
of $285,000 (the "fee"). The fee shall be payable as follows: $25,000 is payable
on July 15, 2004, a second payment in the amount of $35,000, is payable on
August 15, 2004, a third payment in the amount of $60,000 is payable on
September 15, 2004, a fourth payment in the amount of $60,000 is payable on
October 15, 2004, a fifth payment in the amount of $60,000 is payable on
November 15, 2004 and the sixth and final payment in the amount of $45,000 is
payable on December 15, 2004. For the year ended June 30, 2004, Markland charged
to operations $225,000 related to this agreement. At June 30, 2004, there is
$225,000 included in Accrued Expenses related to this agreement.
Facility Rental
- ---------------
STR leases its location in Fredericksburg, VA, on a month-to-month basis without
a formal agreement. Rent expense relating to this location for year ended June
30, 2004 was $70,066.
We have a three year lease for our executive offices of approximately 1,000
square feet located in Ridgefield, Connecticut and a month-to-month lease for a
manufacturing facility of approximately 5,000 square feet located in
Fredericksburg, Virginia. We also have an administrative office in Providence,
RI which is utilized under a monthly sublease comprising approximately 4,000
square feet.
F-39
MARKLAND TECHNOLOGIES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
YEARS ENDED JUNE 30, 2004 AND 2003
EOIR, our wholly owned subsidiary, holds a four-year lease for its executive and
administrative offices of approximately 5,420 square feet in Woodbridge,
Virginia. The lease, which has an option to renew for an additional three-year
term, expires on September 30, 2005. EOIR also leases approximately 5,000 square
feet in Spotsylvania, Virginia, where it houses its software development unit.
This lease is currently on a month-to-month basis.
We also have several offices located in Fredericksburg, VA. One office with
approximately 4,722 sq ft., with a 1 year lease, one with 1,200 sq ft. with a 5
year lease, one with 10,000 sq ft., with a 5 year lease, and one with 4,200 sq
ft., with a five year lease. Monthly lease amounts for these facilities total
approximately $31,000.
Income Taxes
- ------------
The Company is currently delinquent on its corporate federal and state income
tax filings. The Company expects that its net operating loss carryforwards will
be sufficient to offset any taxable income. As a result, no provision for income
taxes or any related penalties or interest has been recorded for the years ended
June 30, 2004 and 2003.
Government Contracts
- --------------------
The Company's billings related to certain U.S. Government contracts are based on
provisional general & administrative and overhead rates which are subject to
audit by the contracting government agency. The Company has limited experience
with these audits.
13. INCOME TAXES
There was no provision for federal or state income taxes for the fiscal year's
ended June 30, 2004 and 2003, due to the Company's operating losses and a full
valuation reserve.
The Company's deferred tax asset before valuation allowance is approximately
$6,600,000 and consist primarily at June 30, 2004 of the net operating loss
carry forwards. The change in the valuation allowance for the year ended June
30, 2004 was approximately $3,200,000. When filed, the Company's net operating
loss carry forwards of approximately $19,000,000 will expire in varying amounts
through 2024. The use of the federal net operating loss carry forwards may be
limited in future years as a result of ownership changes in the Company's common
stock, as defined by section 382 of the Internal Revenue Code. The Company has
not completed an analysis of these changes.
The Company has provided a full valuation reserve against the deferred tax asset
because of the Company's loss history and significant uncertainty surrounding
the Company's ability to utilize its net operating loss and tax credit
carryforward.
14. RELATED PARTY TRANSACTIONS
During January 2003, we completed our acquisition of Ergo Systems, Inc. from
Ocean Data Equipment Corporation, now called Syqwest, Inc. Robert Tarini, our
chief executive officer, is also the chief executive officer of Syqwest, Inc.
Ergo's main asset is an annually renewable U.S. Government General Services
Administration contract to provide logistic support and product development for
five U.S. ports of entry. In exchange for Ergo we agreed to pay Syqwest $400,000
in cash, due in installments that are triggered with the completion of research
milestones. Syqwest also performs software and engineering services related to
our border security business. During the year ended June 30, 2004, $1,244,327
was paid to Syqwest for these services and there was a payable due to Syqwest of
$40,607 at the year end.
On July 24, 2003, we entered into an agreement with Syqwest, Inc., in which we
issued 750,000 shares of our common stock in exchange for the forgiveness of
$450,000 for unpaid services performed by Syqwest in connection with research
conducted in relation to our vehicle stopping technology. We have the right at
any time by written notice to repurchase these shares from Syqwest at a price
equal to $.60 per share.
F-40
MARKLAND TECHNOLOGIES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
YEARS ENDED JUNE 30, 2004 AND 2003
In September 30, 2003 we acquired one hundred percent (100%) of the outstanding
stock of Science and Technology Research, Inc., which produces our U.S. Navy
shipboard automatic chemical agent detection and alarm system product. We paid
the stockholder of Science and Technology Research a total of $6,475,000
consisting of $900,000 in cash, common stock valued at $5,100,000, a promissory
note of $375,000, and acquisition costs of $100,000. To finance this acquisition
we executed a two year, twelve percent (12%), secured Promissory Note with Bay
View Capital, LLC for $1,400,000. Bay View Capital, LLC is controlled by Robert
Tarini, our chief executive officer, and Chad Verdi, a consultant to Markland.
The outstanding balance and accrued interest of this note were repaid in full on
April, 2004.
ipPartners and Asset Growth Company are consulting firms owned by Robert Tarini
and Ken Ducey Jr., our president, respectively. Payments to these companies
during the year ended June 30, 2004 amounted to $17,500 and $170,000 and were in
accordance with their respective consulting contracts with the Company.
The Company believes that all transactions described above were made on terms no
less favorable to it than those obtainable from unaffiliated third parties. All
future transactions, if any, with its executive officers, directors and
affiliates will be on terms no less favorable to it than those that will be
obtainable from unrelated third parties at the time such transactions are made.
15. LITIGATION
On June 28, 2004, Charles Wainer filed a civil suit against the Company in
Florida state court alleging breach of a stock purchase agreement and breach of
an employment agreement stemming from Wainer's sale of his business to a
predecessor of the Company and his subsequent employment thereat. In the
complaint, Wainer alleges Markland owes him $300,000 cash, some unspecified
portion of $700,000 in stock, some unspecified portion of $86,000 cash for lease
payments, and approximately $20,000 in back-pay. The Company believes that these
claims are without merit and plans to vigorously defend the action. On August
11, 2004, answered the complaint and denied any liability.
In addition, we are subject to legal proceedings, claims, and litigation arising
in the ordinary course of business. While the outcome of these matters is
currently not determinable, we do not expect that the ultimate costs to resolve
these matters will have a material adverse effect on our consolidated financial
position, results of operations, or cash flows.
F-41
MARKLAND TECHNOLOGIES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
YEARS ENDED JUNE 30, 2004 AND 2003
16. SUBSEQUENT EVENTS
Litigation
- ----------
On or about September 16, 2004, Joseph R. Moulton, Sr. initiated a lawsuit in
the Circuit Court of Spotsylvania County, Virginia, against the Company, EOIR,
our wholly owned subsidiary, and our Chief Executive Officer and Director,
Robert Tarini. Mr. Moulton was the largest single shareholder of EOIR prior to
its acquisition by the Company, owning approximately 67% of the EOIR capital
stock. Mr. Moulton received approximately $5,863,000 in cash and a promissory
note of EOIR in the approximate principal amount of $6,967,000 for his shares of
EOIR at the closing of the acquisition of EOIR by the Company. In his complaint
Mr. Moulton asserts, among other things, that the Company breached its
obligations under the Stock Purchase Agreement, dated June 29, 2004, pursuant to
which the Company acquired EOIR, by terminating Mr. Moulton's employment with
EOIR and removing him from the EOIR board of directors. Mr. Moulton is seeking
damages allegedly suffered by his loss of employment, extreme emotional
distress, and costs incurred to enforce his contractual rights. In addition, he
is seeking certain other equitable relief including, the appointment of a
receiver to oversee the management of EOIR until these promissory notes issued
to former EOIR shareholders at the closing of the acquisition are paid in full
and a declaratory judgment that the Company's actions constitute an event of
default under these promissory notes allowing for the acceleration of all
amounts (approximately $11,000,000) due thereunder. The Company is a guarantor
of these notes. The Company believes that the allegations in this lawsuit are
entirely without merit and expects to file an answer denying Mr. Moulton's
allegations and opposing vigorously all equitable relief sought. The Company is
considering bringing various claims against Mr. Moulton either by counterclaim
or in a separate action.
F-42
MARKLAND TECHNOLOGIES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
YEARS ENDED JUNE 30, 2004 AND 2003
Convertible Note and Warrant Purchase Agreement
- -----------------------------------------------
On September 21, 2004, Markland Technologies, Inc. (the "Company" or "we")
entered into a Purchase Agreement with DKR Soundshore Oasis Holding Fund, Ltd.
and DKR Soundshore Strategic Holding Fund, Ltd. (together the "Investors")
pursuant to which we sold warrants to purchase shares of common stock (the
"Warrants") and secured convertible promissory notes (the "Convertibles Notes")
for the aggregate consideration of $4,000,000. The Convertible Notes are
initially convertible into $5,200,000 of common stock at a price of $0.80 per
share, subject to certain adjustments as defined in the agreement.
The Purchase Agreement contains standard representations, covenants and events
of default. Occurrence of an event of default allows the Investors to accelerate
the payment of the Convertible Notes and/or exercise other legal remedies,
including foreclosing on collateral.
The Warrants entitle the Investors to purchase an aggregate of 5,200,000 shares
of our common stock, at any time and from time to time, through September 21,
2009. The Convertible Notes are in the aggregate principal amount of five
million two hundred thousand dollars ($5,200,000) and accrue interest daily at
the rate of eight percent (8%) per year on the then outstanding and unconverted
principal balance of the Convertible Notes. Under the terms of the Convertible
Notes, we are required to pay $4,000,000 of the outstanding principal and
interest by March 15, 2005, and the remaining outstanding balance by September
21, 2005. At anytime, and at the option of the Investors, the outstanding
principal and accrued interest of the Convertible Notes may be converted into
shares of our common stock.
We have granted a security interest in and a lien on substantially all of our
assets to the Investors pursuant to the terms of a Security Agreement, dated
September 21, 2004.
As part of this financing, James LLC, the largest holder of our Series D
Preferred Stock, agreed not to sell any of its holdings of Series D Preferred
Stock until the earlier to occur of: (1) notice from the us and the investors
that the transactions contemplated had been completed had been terminated, or
(2) March 15, 2005. However, pursuant to the terms of the lock-up agreement,
James, LLC may still convert their Series D shares and sell the underlying
shares of common stock in accordance with Rule 144 of the Securities Act of
1933, as amended. In exchange, Markland agreed that under certain conditions, if
they did not redeem the Series D stock by January 15, 2005, they would issue to
James LLC a warrant to purchase 1,088,160 shares of our common stock at $.80 per
share.
Subject to conditions set forth in the agreement, the Company may require the
Investor to purchase $1,000,000 of Additional Notes on the Additional Closing
Date. The Company shall indicate its intent to sell the Additional Notes by
delivery to the Investor of a written notice which may be delivered between
March 15, 2005 and March 30, 2005, provided, that the Company may only deliver
such written notice if, on the date of such delivery and on the closing date of
such transaction, it is in compliance in all material respects with the terms
and conditions of the Transaction Documents, no Event of Default shall exist
under the Initial Notes, there is an effective Registration Statement covering
the Underlying Shares and the Warrant Shares and the Company's Common Stock
shall have a closing sales price on its Trading Market of at least $0.40 per
share for the ten (10) consecutive Trading Days immediately preceding the
delivery of the written notice. Notwithstanding the foregoing, with the consent
of the Investor, the Company may extend the period by which it may offer the
Additional Notes to the Investor. The Company may only exercise the right to
elect to require the purchase of Additional Notes on a single occasion, and
there may not be more than a single Additional Closing. If the Company shall
have timely delivered such notice, then subject to the satisfaction of the
conditions set forth in the agreement, on the Additional Closing Date, the
Company shall issue to the Investor the Additional Notes and Second Warrants for
an aggregate purchase price equal to one million dollars ($1,000,000). At the
Additional Closing, the Company will deliver to the Purchaser: (1) the
Additional Notes, in exactly the same form as the Initial Notes, except that the
maturity date shall be one year from the Additional Closing Date, registered in
the name of the Investor, in the aggregate principal amount of $1,300,000 (as
indicated in the Company's notice to elect the sale and issuance of the
Additional Notes), (2) the Second Warrants (equal to 100% of the number of
shares into which the Additional Notes may be converted) and (3) a bring-down of
the legal opinion of Company Counsel delivered on the Closing Date, addressed to
the Investor.
Subsequent stock issuances
- --------------------------
During the period ending June 30, 2004, and October 12, 2004, various holders of
the Company's Series D Convertible Preferred converted their shares into shares
of common stock. The total shares issued under such conversions is approximately
14,568,926. Based on employment agreements, on July 1, and October 1, 2004,
executives and consultants of the company were issued 6,637,145 shares of common
stock.
The company issued 160,000 shares to other consultants under existing contacts
which represented the final issuance under their contract. Based on an
employment agreement, the company issued 30,000 shares to an employee on August
26th. Based on a consulting agreement, on September 9, 2004, 248,418 shares were
issued to a consultant as part of their agreement to help the company with
Mergers and Acquisitions.
Based on a release of rights with regard to adjustments on future financings, on
September 22, 2004, 833,333 shares were issued to investors that participated in
the company's earlier financing.
F-43
PART II
INFORMATION NOT REQUIRED IN PROSPECTUS
ITEM 24. INDEMNIFICATION OF DIRECTORS AND OFFICERS.
Section 607.0850 the Florida Business Corporation Act permits the
indemnification of directors and officers of Florida corporations. Our charter
provides that we shall indemnify our directors and officers to the fullest
extent permitted by Florida law.
Under Florida law, we have the power to indemnify our directors and
officers against claims arising in connection with their service to us except
when an director's or officer's conduct involves: (a) violations of criminal
laws, unless the director had reasonable cause to believe his conduct was lawful
or had no reasonable cause to believe his conduct was unlawful; (b) deriving an
improper personal benefit from a transaction; (c) voting for or assenting to an
unlawful distribution; or (d) willful misconduct or conscious disregard for our
best interests in a proceeding by or in the right of a shareholder.
In addition, we have entered into employment agreements with our
directors and officers that contain provisions requiring us to indemnify them to
the fullest extent permitted by Florida law. The indemnification agreements
require us to indemnify our directors and officers to the extent permitted by
our charter and to advance their expenses incurred in connection with a
proceeding with respect to which they are entitled to indemnification.
Insofar as indemnification for liabilities arising under the Securities
Act of 1933 may be permitted to our directors, officers or persons in control
pursuant to the foregoing provisions, we have been informed that in the opinion
of the Securities and Exchange Commission, such indemnification is against
public policy as expressed in the act and is therefore unenforceable.
Article II, Section 4 of our bylaws limits the liability of current and
former directors for monetary damages if they have acted in good faith and
conformed to a standard of reasonable care. Furthermore, and notwithstanding
anything to the contrary in our charter or bylaws, Section 607.0831 of the
Florida Business Corporation Act limits the liability of directors for monetary
damages for any statement, vote, decision or failure to act relating to
management or policy of us unless he or she breached or failed to perform her
duties as a director, and the breach or failure constitutes:
(a) a violation of criminal law, unless the director had reasonable
cause to believe the conduct was lawful or had no reasonable cause to believe it
was unlawful;
(b) a transaction from which the director derived an improper personal
benefit;
(c) an unlawful distribution;
(d) in a proceeding by or in the right of us or one or more of our
shareholders, conscious disregard for our best interests or willful misconduct;
or
(e) in a proceeding brought by someone other than us or one or more of
our shareholders, recklessness or an act or omission committed in bad faith,
with malicious purpose, or in a manner exhibiting willful disregard of human
rights, safety or property.
We have purchased insurance with respect to, among other things, the
liabilities that may arise under the statutory provisions referred to above. Our
directors and officers are also insured against certain liabilities, including
certain liabilities arising under the Securities Act of 1933, which might be
incurred by them in such capacities and against which they are not indemnified
by us.
II-1
ITEM 25. OTHER EXPENSES OF ISSUANCE AND DISTRIBUTIONS.
The following table provides information regarding the various
anticipated expenses payable by Markland in connection with the issuance and
distribution of the securities being registered. We are paying the expenses
incurred in registering the shares, but all selling and other expenses incurred
by the selling stockholders will be borne by the selling stockholders. All
amounts shown are estimates except the Securities and Exchange Commission
registration fee.
NATURE OF EXPENSE AMOUNT
----------------------------------------------------------
SEC registration fee...................... $ 4,548
Accounting fees and expenses.............. $ 30,000
Legal fees and expenses................... $ 150,000
Transfer agent fees....................... $ 1,500
Printing and related fees................. $ 10,000
Miscellaneous............................. $ 50,000
--------------
Total..................................... $ 246,048
==============
ITEM 26. RECENT SALES OF UNREGISTERED SECURITIES.
We have issued the following unregistered securities within the last
three years. The following information regarding our securities has been
adjusted to reflect a 1-for-40 reverse stock split effected on June 21, 2001 and
a 1-for-60 reverse stock split effected on October 27, 2003.
2001
On March 16, 2001, we issued 10 shares of our Series B Convertible
Preferred Stock to Vidikron of America, Inc. The issuance of these securities
was exempt under Section 4(2) of the Securities Act of 1933, as amended, as a
sale not involving a public offering.
On December 31, 2001, we issued a promissory note to James LLC, a
Cayman Island limited liability company, in the amount of $1,314,367. The
issuance of this security was exempt from registration under Section 4(2) of the
Securities Act of 1933, as amended, as a sale not involving a public offering.
2002
On December 9, 2002, we entered into an Exchange Agreement with James
LLC, a Cayman Island limited liability company, and Market LLC, a Cayman Island
limited liability company, wherein we issued to them an aggregate of 5,225
shares of our Series C Convertible Preferred Stock (with a stated value of
$1,000 per share) in exchange for the cancellation of promissory notes in the
aggregate amount of $5,250,000. The issuance of these securities was exempt from
registration under Section 4(2) of the Securities Act of 1933, as amended, as a
sale not involving a public offering.
On December 9, 2002, we executed an Exchange Agreement with Eurotech,
Ltd., a District of Columbia corporation, and Crypto.com, Inc., a Delaware
corporation, wherein we issued 3,998,789 shares of our common stock in exchange
for certain assets related to the Acoustic Core(TM) technology for illicit
material detection. In addition, we issued 499,848 shares of our common stock to
ipPartners, Inc., a Rhode Island corporation, in connection with this
acquisition of assets. The issuance of these securities was exempt from
registration under Section 4(2) of the Securities Act of 1933, as amended, as a
sale not involving a public offering.
On December 10, 2002, we issued a convertible promissory note to Market
LLC, a Cayman Island limited liability company, in the amount of $500,000. The
issuance of this security was exempt from registration under Section 4(2) of the
Securities Act of 1933, as amended, as a sale not involving a public offering.
II-2
2003
At various times during 2003, we issued to our employees, directors and
consultants the following number of shares of our common stock on the following
dates as compensation for their services. The issuance of these securities was
exempt from registration under Section 4(2) of the Securities Act of 1933, as
amended, as a sale not involving a public offering.
NAME NUMBER OF SHARES
- -------------------------------------------------------------------------------
Commonwealth Acquisitions, Inc. (1)......................... 16,667
David Danovitch (1)......................................... 3,334
Dean Denuccio............................................... 280,000
Rodney Dodd................................................. 7,937
Kenneth Ducey, Jr.(2)....................................... 221,568
ECON Investor Relations, Inc. (1)........................... 12,049
Oscar Hayes................................................. 21,035
Edward Kessler.............................................. 7,937
Delmar Kintner (2).......................................... 119,303
MarketShare Recovery, Inc. (1).............................. 27,272
George Martin (1)........................................... 4,546
Ernie Mercier (1)........................................... 8,334
Jo-Ann Nichols (2).......................................... 3,571
Joe O'Neill (1)............................................. 8,334
John Readey................................................. 65,000
Lawrence Shatsoff (1)....................................... 1,667
Stuart Siller (1)........................................... 13,636
The Research Works, Inc. (1)................................ 37,099
Robert Tarini (1)........................................... 221,568
Verdi Consulting (1)........................................ 201,568
(1) Acquired shares in consideration of consulting services. (2) Acquired shares
pursuant to an employment agreement.
On February 11, 2003, we issued 170 shares of our Series C Preferred
stock to James LLC, a Cayman Island limited liability company, for a purchase
price of $170,000. The issuance of these securities was exempt from registration
under Section 4(2) of the Securities Act of 1933, as amended, as a sale not
involving a public offering.
On March 19, 2003, we executed a Technology Purchase Agreement with ASI
Technology Corporation, a Nevada corporation, wherein we acquired certain gas
plasma antenna assets for 283,333 shares of our common stock. In connection with
this acquisition, we also issued shares of our common stock to Patriot
Scientific Corporation. The issuance of these securities was exempt from
registration under Section 4(2) of the Securities Act of 1933, as amended, as a
sale not involving a public offering.
On March 27, 2003, we executed an Exchange Agreement with Eurotech,
Ltd. wherein we issued 16,000 shares of our Series D preferred stock in exchange
for 1,666,666 shares of our common stock. The issuance of these securities was
exempt from registration under Section 4(2) of the Securities Act of 1933, as
amended, as a sale not involving a public offering.
In July 2003, we entered into a consulting agreement with Emerging
Concepts. As consideration for the consulting services, we issued 25,000 shares
of our common stock to Emerging Concepts in reliance upon the exemption from
registration afforded by Section 4(2) of the Securities Act of 1933, as amended,
for transactions by an issuer not involving any public offering.
On July 24, 2003, we issued 750,000 shares of our common stock to
Syqwest, Inc., a Rhode Island corporation formerly known as Ocean Data Equipment
Corporation, for unpaid services valued at $450,000. The issuance of these
securities was exempt from registration under Section 4(2) of the Securities Act
of 1933, as amended, as a sale not involving a public offering.
On September 30, 2003, we executed an Agreement and Plan of Merger with
Science and Technology Research, Inc. In connection with the merger, we issued
1,539,779 shares of our common stock and a promissory note in the amount of
$375,000 to George Yang, the sole stockholder of Science and Technology
Research, Inc. The issuance of these securities was exempt from registration
under Section 4(2) of the Securities Act of 1933, as amended, as a sale not
involving a public offering.
II-3
On each of October 1, 2003, November 3, 2003 and December 1, 2003, we
sold to James LLC, a Cayman Island limited liability company, an aggregate of
385 shares of our Series D preferred stock for an aggregate purchase price of
$385,000. The issuance of these securities was exempt from registration under
Section 4(2) of the Securities Act of 1933, as amended, as a sale not involving
a public offering.
On November 12, 2003, we issued 37,099 shares of our common stock to
Research Works, Inc., a New Jersey corporation, for the preparation of an equity
research report. The issuance of these securities was exempt from registration
under Section 4(2) of the Securities Act of 1933, as amended, as a sale not
involving a public offering.
2004
During January 2004, we issued 208,906 shares of our common stock to
each of Kenneth Ducey, Jr., and Robert Tarini and 209,006 shares of our common
stock to Verdi Consulting in connection with employment and consulting
agreements. The issuance of these securities was exempt from registration under
Section 4(2) of the Securities Act of 1933, as amended, as a sale not involving
a public offering.
On February 2, 2004, we sold 277 shares of our Series D preferred stock
to James LLC, a Cayman Island limited liability company, for $152,000. The
issuance of these securities was exempt from registration under Section 4(2) of
the Securities Act of 1933, as amended, as a sale not involving a public
offering.
On ten different occasions between August 2003 and March 2004, we
issued an aggregate of 4,096 shares of our Series D Preferred Stock to a single
institutional investor for an aggregate consideration of $4,096,000. The
issuance of these securities was exempt under Section 4(2) of the Securities Act
of 1933, as amended, as a sale not involving a public offering.
On April 2, 2004, we issued 3,333,333 shares of our common stock and
warrants to purchase 3,333,333 shares of our common stock at $1.00 per share to
three institutional investors for consideration of $200,000. We also issued a
warrant to purchase 333,333 share of our common stock and paid $200,000 to a
finder in connection with this transaction. The issuance of these securities was
exempt under Section 4(2) of the Securities Act of 1933, as amended, as a sale
not involving a public offering.
On April 16, 2004, we issued 2,500,000 shares of our common stock and
warrants to purchase 2,500,000 shares of our commons stock at $1.50 per share to
ten institutional investors for consideration of $2,000,000. We also issued
warrants to purchase 25,000 shares of our common stock at $2.00 per share and
paid $100,000 to a finder in connection with this transaction. The issuance of
these securities was exempt under Section 4(2) of the Securities Act of 1933, as
amended, as a sale not involving a public offering.
On April 20, 2004, we issued in the aggregate 300,000 shares to the
three investors in our April 2, 2004 private placement in consideration of their
consent to permit us to proceed with a private placement that was subsequently
consummated on May 3, 2004. We also issued warrants to purchase 50,000 shares of
our common stock to counsel for these investors in connection with this
transaction. The issuance of these securities was exempt under Section 4(2) of
the Securities Act of 1933, as amended, as a sale not involving a public
offering.
On May 3, 2004 and May 7, 2004, we issued and aggregate of 7,098,750
shares of our common stock and redeemable warrants to purchase 7,098,750 shares
of our common stock at $1.50 per share to 26 institutional investors 8
individual investors for consideration of $5,679,000. We also issued redeemable
warrants to purchase an aggregate of 529,800 shares of our common stock and paid
an aggregate of $545,140 to five finders in connection with this transaction.
The issuance of these securities was exempt under Section 4(2) of the Securities
Act of 1933, as amended, as a sale not involving a public offering.
On June 1, 2004, we issued 1,525,248 shares of our common stock to each
of Verdi Consulting and Robert Tarini, 305,050 shares of our common stock to
Kenneth Ducey, Jr., and 1,220,198 shares of our common stock to Asset Growth
Company (which is wholly owned by Kenneth Ducey, Jr.) in connection with their
services as employees and consultants and pursuant to the compensation terms of
our agreements with them. The issuance of these securities was exempt from
registration under Section 4(2) of the Securities Act of 1933, as amended, as a
sale not involving a public offering.
II-4
On June 29, 2004, in connection with our acquisition of E-OIR
Technologies, Inc., we issued 3,500 shares of our Series D Preferred Stock to a
single institutional investor for consideration of $2 million. The Series D
preferred stock is convertible at the option of the stockholder at any time. The
number of shares of our common stock into which each share of Series D preferred
is convertible is determined by dividing $1,000 by the discounted bid price.
On June 29, 2004, also in connection with the acquisition of E-OIR
Technologies, Inc., we adopted a Stock Incentive Plan under which we issued
options to purchase 9,345,740 shares of its common stock to key employees of
EOIR for an exercise price of $.3775 per share. The options will vest in five
equal annual installments. In addition, we granted to another key employees of
EOIR options to purchase a number of shares of our common stock equal to
$471,983 divided by one-half of the market price for the common stock on the
date of vesting. These options also vest in five equal annual installments. We
have also agreed to grant options to purchase an additional 5,000,000 shares of
common stock to employees of EOIR in the future.
On September 15, 2004, we entered into an employment agreement with
Darylene Wanek. This agreement provides for the issuance of 30,000 shares of our
restricted common stock as part of the remuneration paid. The offer and sale of
these securities was made in reliance on Section 4(2) of Securities Act of 1933,
as amended.
On September 21, 2004, we entered into a Purchase Agreement with DKR
Soundshore Oasis Holding Fund, Ltd. and DKR Soundshore Strategic Holding Fund,
Ltd. pursuant to which we sold warrants to purchase shares of common stock and
secured convertible promissory notes for the aggregate consideration of
$4,000,000. At any time, and at the option of the investors, the outstanding
principal and accrued interest of the notes may be converted into shares of our
common stock. The offer and sale of these securities was made in reliance on
Section 4(2) of Securities Act of 1933, as amended.
On October 1, 2004, we issued 1,205,479 shares of our common stock to
each of Verdi Consulting and Robert Tarini, 301,370 shares of our common stock
to Kenneth Ducey, Jr., and 904,110 shares of our common stock to Asset Growth
Company (which is wholly owned by Kenneth Ducey, Jr.) in connection with their
services as employees and consultants and pursuant to the compensation terms of
our agreements with them. The issuance of these securities was exempt from
registration under Section 4(2) of the Securities Act of 1933, as amended, as a
sale not involving a public offering.
On November 9, 2004, we entered into a Securities Purchase Agreement
with Harborview Master Fund L.P. and Southridge Partners LP, pursuant to which
we sold warrants to purchase shares of our common stock and secured promissory
notes for the aggregate consideration of $1,350,000. At any time, and at the
option of the investors, the outstanding principal and accrued interest of the
notes may be converted into shares of our common stock. The offer and sale of
these securities was made in reliance on Section 4(2) of Securities Act of 1933,
as amended.
II-5
ITEM 27. EXHIBITS.
FILED WITH INCORPORATED BY REFERENCE
EXHIBIT THIS FORM ----------------------------------------------
NO. DESCRIPTION SB-2 FORM FILING DATE EXHIBIT NO.
------- ------------------------------------------ ---------- ---------- --------------- ------------
2.1 Stock Purchase Agreement by and between 8-K June 30, 2004 2.1
Markland and EOIR, dated June 30,
2004
2.2 Forms of Promissory Note 8-K June 30, 2004 2.2
2.3 Security Agreement by and between EOIR and
sellers of EOIR stock, dated June 30, 8-K June 30, 2004 2.3
2.4 2004 Stock Option Plan, adopted June 30, 8-K June 30, 2004 2.4
2004
2.5 Preferred Securities Purchase Agreement 8-K June 30, 2004 2.5
2.6 Pledge and Security Agreement 8-K June 30, 2004 2.6
2.7 Forms of Stock Option 8-K June 30, 2004 2.7
3.1 Articles of Incorporation of Quest Net 8-K March 20, 2000 1.3
Corp., filed with the Florida Secretary of
State on December 28, 1998
3.2 Articles of Merger filed with the Florida 8-K March 20, 2000 1.2
Secretary of State on March 15, 2000
3.3 Articles of Amendment to the Articles of 8-K April 10, 2001 3.1
Incorporation of Quest Net Corp., filed
with the Florida Secretary of State on
April 4, 2001
3.4 Articles of Amendment to the Articles of 8-K April 10, 2001 3.3
Incorporation of Quest Net Corp., filed
with the Florida Secretary of State on June
21, 2001
3.5 Articles of Amendment to the Articles of SB-2 May 11, 2004 3.5
Incorporation of Markland Technologies,
Inc. filed with the Florida Secretary of
State on December 21, 2001
3.6 Articles of Amendment to the Articles of 10-KSB October 14, 2003 3.6
Incorporation of Markland Technologies,
Inc. filed with the Florida Secretary of
State on September 16, 2003
3.7 Certificate of Designations of Rights and 10-KSB October 14, 2003 3.7
Preferences of the Series A Non-Voting
Convertible Preferred Stock
3.8 Certificate of Designations of Rights and 8-K December 20, 2002 3.5
Preferences of the Series C Cumulative
Convertible Preferred Stock
II-6
FILED WITH INCORPORATED BY REFERENCE
EXHIBIT THIS FORM ----------------------------------------------
NO. DESCRIPTION SB-2 FORM FILING DATE EXHIBIT NO.
------- ------------------------------------------ ---------- ---------- --------------- ------------
3.9 Certificate of Designations of Rights and 10-KSB October 14, 2003 3.5
Preferences of the Series D Cumulative
Convertible Preferred Stock
3.10 Amended and Restated By-Laws 8-K March 20, 2000 1.4
4.1 Form of common stock certificate of 10-QSB February 14, 2003 4.1
Markland Technologies, Inc.
4.2 Registration Rights Agreement between SB-2 May 11, 2004 4.2
Markland Technologies, Inc., Montana View
Corporation, Elite Properties, Ltd.,
Sparrow Ventures, Inc., dated April 2, 2004
4.3 Form of Common Stock Purchase Warrant dated SB-2 May 11, 2004 4.3
April 2, 2004
4.4 Form of Common Stock Purchase Warrant dated SB-2 May 11, 2004 4.4
April 16, 2004
4.5 Form of Common Stock Purchase Warrant dated SB-2 May 11, 2004 4.5
May 3, 2004
4.6 Registration Rights Agreement, dated March 10-KSB October 14, 2003 10.10
19, 2003, by and between ASI Technology
Corporation and Markland Technologies, Inc.
4.7 Registration Rights Agreement by and 10-KSB October 14, 2003 10.17
between Markland Technologies, Inc. and
Brittany Capital Management limited, dated
September 10, 2003
4.8 Consulting Agreement by and between 8K November 12, 2003 10.3
Markland Technologies, Inc. and George
Yang, dated September 30, 2003
4.9 Consulting Agreement by and between SB-2 May 11, 2004 4.9
Markland Technologies, Inc. and
Commonwealth Acquisitions, Ltd., dated
March 24, 2003
4.10 Consulting Agreement by and between ECON SB-2 May 11, 2004 4.10
Investor Relations, Inc., dated January 18,
2003
4.11 Consulting Agreement by and between SB-2 May 11, 2004 4.11
Markland Technologies, Inc. and Marketshare
Recovery, Inc., dated October 29, 2003
4.12 Consulting Agreement by and between 10-QSB February 23, 2004 10.4
Markland Technologies, Inc. and Emerging
Concepts, Inc., dated July 7, 2003
4.13 Research Agreement by and between Markland SB-2 May 11, 2004 4.13
Technologies, Inc. and The Research Works,
Inc., dated October 29, 2003
II-7
FILED WITH INCORPORATED BY REFERENCE
EXHIBIT THIS FORM ----------------------------------------------
NO. DESCRIPTION SB-2 FORM FILING DATE EXHIBIT NO.
------- ------------------------------------------ ---------- ---------- --------------- ------------
4.14 Employment Agreement by and between SB-2 May 11, 2004 4.14
Markland Technologies, Inc. and Jo-Ann
Nichols, dated October 27, 2003
4.15 Registration Rights Agreement by and 8-K September 23, 2004 99.3
between Markland Technologies, Inc. and the
investors named therein, dated September
21, 2004
4.16 Form of Common Stock Purchase Warrant 8-K September 23, 2004 99.5
issued by Markland Technologies, Inc. on
September 21, 2004
4.17 Lock-up Agreement by and among Markland 8-K September 23, 2004 99.7
Technologies, Inc., Robert Tarini, and
Kenneth Ducey, Jr.
4.18 Lock-up Agreement by and between Markland 8-K September 23, 2004 99.6
Technologies, Inc. and James, LLC
4.19 Waiver Agreement by and among Markland 8-K September 23, 2004 99.8
Technologies, Inc. and the parties named
therein, dated September 21, 2004
5.1 Opinion of Foley Hoag LLP *
10.1 Securities Purchase Agreement, between SB-2 May 11, 2004 10.1
Markland Technologies, Inc., Montana View
Corporation, Elite Properties, Ltd., and
Sparrow Ventures, Inc., dated April 2, 2004
10.2 Securities Purchase Agreement by and among SB-2 May 11, 2004 10.2
Markland Technologies, Inc. and the
Investors named therein, dated April 16,
2004
10.3 Securities Purchase Agreement by and SB-2 May 11, 2004 10.3
between Markland Technologies, Inc. and the
Investors named therein, dated May 3, 2004
10.4 Agreement and Plan of Merger by and among 8K November 12, 2003 10.1
Markland Technologies, Inc. and STR
Acquisition Corp., Security Technology,
Inc., Science and Technology Research,
Inc., and George Yang, dated September 30,
2003
10.5 Promissory Note made by Markland 8K November 12, 2003 10.4
Technologies, Inc., in favor of George
Yang, dated September 30, 2003
10.6 Security Agreement by and between Markland SB-2 May 11, 2004 10.6
Technologies, Inc. and George Yang, dated
September 30, 2003
FILED WITH INCORPORATED BY REFERENCE
EXHIBIT THIS FORM ----------------------------------------------
NO. DESCRIPTION SB-2 FORM FILING DATE EXHIBIT NO.
------- ------------------------------------------ ---------- ---------- --------------- ------------
10.7 Guaranty by Markland Technologies, Inc. in SB-2 May 11, 2004 10.7
favor of George Yang, dated September 30,
2003
10.8 Amendment and Payment Extension Agreement SB-2 May 11, 2004 10.8
by and between Markland Technologies, Inc.
and George Yang, dated March 17, 2004
10.9 Loan Agreement by and between Security 8K November 12, 2003 10.2
Technology, Inc. and Bay View Capital LLC,
dated September 30, 2003
10.10 Promissory Note by and among Markland 8K November 12, 2003 10.5
Technologies, Inc., Security Technology,
Inc., and Bay View Capital LLC, dated
September 30, 2003.
10.11 Security Agreement by and between Security SB-2 May 11, 2004 10.11
Technology, Inc. and Bay View Capital LLC,
dated September 30, 2003.
10.12 Security Agreement by and between Markland SB-2 May 11, 2004 10.12
Technologies, Inc. and Bay View Capital LLC
10.13 Sublicense Agreement by and between SB-2 May 11, 2004 10.13
Markland Technologies, Inc. and ASI
Technology Corporation, dated March 19,
2004
10.14 ASI Technology Corporation SBIR Phase II SB-2/1A June 16, 2004 10.14
Proposal, dated October 8,
2001
10.15 ASI Technology Corporation Contract SB-2/1A June 16, 2004 10.15
with Air Force Office of Scientific
Research, dated August 1, 2002
10.16 ASI Technology Corporation Contract with SB-2/1A June 16, 2004 10.16
Naval Surface Warfare Center, dated January
31, 2003
10.17 Stock Purchase Agreement by and among Ocean 8-K January 28, 2003 10.1
Data Equipment Corporation, Ergo Systems,
Markland Technologies, and Security
Technology, Inc., dated December 9, 2002
10.18 Exchange Agreement, dated December 9, 2002, 8-K December 20, 2002 10.4
by and among Markland Technologies, Inc.,
Market LLC, and James LLC
10.19 Exchange Agreement, dated December 9, 2002, 8-K December 20, 2002 10.5
by and among Eurotech, Ltd., Crypto.com
Inc., Markland Technologies, Inc., Security
Technology, Inc. ipPartners, Inc., Market
LLC, and James LLC
II-9
FILED WITH INCORPORATED BY REFERENCE
EXHIBIT THIS FORM ----------------------------------------------
NO. DESCRIPTION SB-2 FORM FILING DATE EXHIBIT NO.
------- ------------------------------------------ ---------- ---------- --------------- ------------
10.20 First Amendment to Exchange Agreement, 10-QSB February 14, 2003 10.6
dated December 9, 2002, by and among
Eurotech, Ltd., Crypto.com Inc., Markland
Technologies, Inc., Security Technology,
Inc. ipPartners, Inc., Market LLC, and
James LLC
10.21 Restated and Amended Convertible Revolving 10-QSB February 14, 2003 10.2
Credit Note Agreement, dated December 10,
2002, by and between Markland Technologies,
Inc. and Market LLC.
10.22 Letter from Sherb & Co., LLP to the 8-K March 17, 2003 16.1
Commission, dated March 12, 2003,
concerning change in certifying accountant
10.23 Technology Purchase Agreement between 8-K April 4, 2003 10.1
Markland Technologies, Inc. and ASI
Technology Corporation, dated March 19,
2003
10.24 Exchange Agreement, dated March 27, 2003, 8-K April 4, 2003 10.2
by and between Eurotech, Ltd. and Markland
Technologies, Inc.
10.25 Registration Rights Agreement, dated March 10-KSB October 14, 2003 10.12
27, 2003, by and between Eurotech, Ltd. and
Markland Technologies, Inc.
10.26 Amended and Restated Exchange Agreement, 8-K July 30, 2003 10.1
dated July 24, 2003, by and between
Markland Technologies, Inc. and Syqwest,
Inc.
10.27 Preferred Securities Purchase Agreement by 10-KSB October 14, 2003 10.14
and between Markland Technologies, Inc. and
James LLC, dated February 2, 2003, relating
to the issuance of 170 shares of Series C
5% Convertible Preferred Stock
10.28 Preferred Securities Purchase Agreement by 10-KSB October 14, 2003 10.15
and between Markland Technologies, Inc.,
and James LLC, dated April 1, 2003,
relating to the issuance of Series D
Convertible Preferred Stock
10.29 Private Equity Credit Agreement by and 10-KSB October 14, 2003 10.16
between Markland Technologies, Inc. and
Brittany Capital Management Limited, dated
September 10, 2003
10.30 Employment and consulting agreements, dated 10-KSB October 14, 2003 10.18
December 5, 2002, for Delmar Kintner,
Kenneth Ducey, Robert Tarini, and Verdi
Consulting
II-10
FILED WITH INCORPORATED BY REFERENCE
EXHIBIT THIS FORM ----------------------------------------------
NO. DESCRIPTION SB-2 FORM FILING DATE EXHIBIT NO.
------- ------------------------------------------ ---------- ---------- --------------- ------------
10.31 Nonexclusive License Agreement by and SB-2 May 11, 2004 10.31
Science & Technology Research, Inc. and
the Secretary of the State, dated 11/4/03
10.32 International Distribution Agreement SB-2 May 11, 2004 10.32
between Markland Technologies, Inc. and
Tradeways
10.33 Science & Technology Research contract SB-2 May 11, 2004 10.33
Naval Surface Warfare Center, dated January
31, 2003
10.34 Subcontract Agreement by and between ERGO SB-2 May 11, 2004 10.34
Systems, Inc. and Computer Sciences
Corporation ,dated December 8, 2003
10.35 Lease for Property in Fredericksburg, SB-2/1A June 16, 2004 10.35
Virginia
10.36 Co-Operative Research and Development SB-2/1A June 16, 2004 10.35
Agreement between Markland Technologies,
Inc. and the U.S. Air Force
10.37 Employment Agreement by and between 10-QSB May 24, 2004 10.32
Markland Technologies, Inc. and Robert
Tarini, dated May 12, 2004
10.38 Employment Agreement by and between 10-QSB May 24, 2004 10.33
Markland Technologies, Inc. and Kenneth
Ducey, Jr., dated January 2, 2004
10.39 Strategic Operations Contractor Agreement 10-QSB May 24, 2004 10.34
by and between Markland Technologies, Inc.
and Asset Growth Company, dated May 12,
2004
10.40 Consulting Agreement by and between 10-QSB May 24, 2004 10.35
Markland Technologies, Inc. and Chad A.
Verdi, dated May 12, 2004
10.41 Amendment to Employment Agreement between SB-2/1A June 16, 2004 10.41
Markland Technologies Inc. and Robert
Tarini dated June 14, 2004
10.42 Amendment to the Employment Agreement SB-2/1A June 16, 2004 10.42
between Markland Technologies Inc.
and Kenneth P. Ducey, dated June 14,
2004
10.43 Amendment to the Consulting Agreement SB-2/1A June 16, 2004 10.43
between Markland Technologies Inc. and
Verdi Consulting, dated June 14, 2004
10.44 Amendment to the Strategic Operations SB-2/1A June 16, 2004 10.44
Contractor Agreement by and between
Markland Technologies, Inc. and Asset
Growth Company, dated June 14, 2004
II-11
FILED WITH INCORPORATED BY REFERENCE
EXHIBIT THIS FORM ----------------------------------------------
NO. DESCRIPTION SB-2 FORM FILING DATE EXHIBIT NO.
------- ------------------------------------------ ---------- ---------- --------------- ------------
10.45 Purchase Agreement between Markland 8-K September 23, 2004 99.1
Technologies, Inc. and the investors named
therein, dated September 21, 2004
10.46 Security Agreement between Markland 8-K September 23, 2004 99.2
Technologies, Inc. and the investors named
therein, dated September 21, 2004
10.47 Form of Secured Convertible Promissory Note 8-K September 23, 2004 99.4
issued by Markland Technologies, Inc., on
September 21, 2004
10.48 Night Vision Electronic Sensors Directorate 10-KSB October 13, 2004 10.48
(NVESD) Omnibus Contract between E-OIR
Measurement Inc., a subsidiary of EOIR and
United States Army Night Vision and
Electronic Sensors Directorate
10.49 Letter from Marcum & Kliegman regarding the 8-K/A July 15, 2004 16.1
change in certifying accountants
10.50 Securities Purchase Agreement between
Markland Technologies, Inc., Harborview
Master Fund L.P. and Southridge Partners
LP dated November 9, 2004 X
10.51 Form of Convertible Note issued to
Harborview Master Fund L.P. and Southridge
Partners LP X
10.52 Form of Warrant issued to Harborview
Master Fund L.P. and Southridge
Partners LP X
10.53 Subordination Agreement between DKR
Soundshore Oasis Holding Fund, LLC DKR
Soundshore Strategic Holding Fund, LLC,
Harborview Master Fund L.P., Southridge
Partners LP, and Markland Technologies,
Inc., dated November 9, 2004. X
10.54 Conditional Waiver and Consent
between DKR Soundshore Oasis Holding
Fund, LLC DKR Soundshore Strategic Holding
Fund, LLC, Harborview Master Fund L.P.,
Southridge Partners LP, and Markland
Technologies, Inc., dated November 9,
2004. X
23.1 Consent of Foley Hoag LLP *
23.2 Consent of Wolf & Company, P.C. X
23.3 Consent of Marcum & Kliegman LLP X
24.1 Power of Attorney (contained on the X
signature age of this registration
statement)
* To be filed with Amendment No. 1 to Form SB-2
ITEM 28. UNDERTAKINGS.
(a) The undersigned registrant hereby undertakes:
(1) File, during any period in which it offers or sells securities, a
post-effective amendment to this registration statement to:
(i) Include any prospectus required by section 10(a)(3) of the
Securities Act;
(ii) Reflect in the prospectus any facts or events which,
individually or together, represent a fundamental change in the
information in the registration statement. Notwithstanding the
foregoing, any increase or decrease in volume of securities offered
(if the total dollar value of securities offered would not exceed that
which was registered) and any deviation from the low or high end of
the estimated maximum offering range may be reflected in the form of
prospectus filed with the Commission pursuant to Rule 424(b) if, in
the aggregate, the changes in volume and price represent no more than
a 20% change in the maximum aggregate offering price set forth in the
"Calculation of Registration Fee" table in the effective registration
statement; and
(iii) Include any additional or changed material information
on the plan of distribution.
(2) For determining liability under the Securities Act of 1933, treat
each post-effective amendment as a new registration statement of the securities
offered, and the offering of the securities at that time to be the initial bona
fide offering.
(3) File a post-effective amendment to remove from registration any of
the securities that remain unsold at the end of the offering.
(b) Insofar as indemnification for liabilities arising under the Securities Act
of 1933 may be permitted to directors, officers and controlling persons of the
small business issuer pursuant to the foregoing provisions, or otherwise, the
small business issuer has been advised that in the opinion of the Securities and
Exchange Commission such indemnification is against public policy as expressed
in the Act and is, therefore, unenforceable.
II-12
SIGNATURES
In accordance with the requirements of the Securities Act of 1933, the
registrant certifies that it has reasonable grounds to believe that it meets all
of the requirements of filing on Form SB-2 and authorized this registration
statement to be signed on its behalf by the undersigned, in the City of
Ridgefield, State of Connecticut, on November 10, 2004.
MARKLAND TECHNOLOGIES, INC.
By: /s/ Kenneth P. Ducey, Jr.
-------------------------------------
Kenneth P. Ducey, Jr.
President and Chief Financial Officer
POWER OF ATTORNEY
KNOW ALL MEN BY THESE PRESENTS, that each individual whose signature
appears below constitutes and appoints Kenneth P. Ducey and Robert Tarini, and
each of them, his true and lawful attorney-in-fact and agent, with full power of
substitution and re-substitution, for him and in his name, place and stead, in
any and all capacities, to sign any and all amendments (including post-effective
amendments) to this Registration Statement, and to file the same, with all
exhibits and schedules thereto, and all other documents in connection therewith,
with the Securities and Exchange Commission, granting unto said
attorneys-in-fact and agents, and each of them, full power and authority to do
and perform each and every act and thing, which they, or either of them, may
deem necessary or advisable to be done in connection with this Registration
Statement, as fully to all intents and purposes as he might or could do in
person, hereby ratifying and confirming all that said attorneys-in-fact and
agents or any of them, or their substitute or substitutes or any of them, may
lawfully do or cause to be done by virtue hereof.
In accordance with the requirements of the Securities Act of 1933, this
registration statement was signed by the following persons in the capacities and
on the dates stated:
SIGNATURE TITLE DATE
--------- ----- ----
/s/ Robert Tarini Chief Executive Officer and November 10, 2004
- -------------------------- Chairman of the Board of Directors
Robert Tarini
/s/ Kenneth P. Ducey, Jr. President, Chief Financial Officer November 10, 2004
- -------------------------- and Director
Kenneth P. Ducey, Jr.
/s/Joseph P. Mackin Director November 10, 2004
- --------------------------
Joseph P. Mackin
II-13